2025-01-23 08:46:41 - openai._base_client - INFO - Retrying request to /chat/completions in 0.479405 seconds
2025-01-23 08:48:22 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:48:23 - root - INFO - SQL:
SELECT DISTINCT `ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD'
   LIMIT 100;
Results:
ParticipantBarcode
TCGA-2J-AAB1
TCGA-2J-AAB4
TCGA-2J-AAB6
TCGA-2J-AAB8
TCGA-2J-AAB9
TCGA-2J-AABA
TCGA-2J-AABE
TCGA-2J-AABF
TCGA-2J-AABH
TCGA-2J-AABI
TCGA-2J-AABK
TCGA-2J-AABO
TCGA-2J-AABP
TCGA-2J-AABT
TCGA-2J-AABU
TCGA-2J-AABV
TCGA-2L-AAQA
TCGA-2L-AAQE
TCGA-2L-AAQI
TCGA-2L-AAQJ
TCGA-2L-AAQL
TCGA-2L-AAQM
TCGA-3A-A9I5
TCGA-3A-A9I7
TCGA-3A-A9I9
TCGA-3A-A9IB
TCGA-3A-A9IC
TCGA-3A-A9IH
TCGA-3A-A9IJ
TCGA-3A-A9IL
TCGA-3A-A9IN
TCGA-3A-A9IO
TCGA-3A-A9IR
TCGA-3A-A9IS
TCGA-3A-A9IU
TCGA-3A-A9IV
TCGA-3A-A9IX
TCGA-3A-A9IZ
TCGA-3A-A9J0
TCGA-3E-AAAY
TCGA-3E-AAAZ
TCGA-F2-6879
TCGA-F2-A44G
TCGA-F2-A44H
TCGA-F2-A7TX
TCGA-F2-A8YN
TCGA-FB-A4P5
TCGA-FB-A545
TCGA-FB-A5VM
TCGA-FB-A78T
TCGA-FB-A7DR
TCGA-FB-AAPP
TCGA-FB-AAPQ
TCGA-FB-AAPS
TCGA-FB-AAPU
TCGA-FB-AAPY
TCGA-FB-AAPZ
TCGA-FB-AAQ0
TCGA-FB-AAQ1
TCGA-FB-AAQ2
TCGA-FB-AAQ3
TCGA-FB-AAQ6
TCGA-FZ-5919
TCGA-FZ-5920
TCGA-FZ-5921
TCGA-FZ-5922
TCGA-FZ-5923
TCGA-FZ-5924
TCGA-FZ-5926
TCGA-H6-8124
TCGA-H6-A45N
TCGA-H8-A6C1
TCGA-HV-A5A3
TCGA-HV-A5A4
TCGA-HV-A5A5
TCGA-HV-A5A6
TCGA-HV-A7OL
TCGA-HV-A7OP
TCGA-HV-AA8V
TCGA-HV-AA8X
TCGA-HZ-7289
TCGA-HZ-7918
TCGA-HZ-7919
TCGA-HZ-7920
TCGA-HZ-7922
TCGA-HZ-7925
TCGA-HZ-7926
TCGA-HZ-8001
TCGA-HZ-8002
TCGA-HZ-8003
TCGA-HZ-8005
TCGA-HZ-8315
TCGA-HZ-8317
TCGA-HZ-8636
TCGA-HZ-8637
TCGA-HZ-A49G
TCGA-HZ-A49H
TCGA-HZ-A49I
TCGA-HZ-A4BH
TCGA-HZ-A4BK

2025-01-23 08:48:25 - root - INFO - SQL:
SELECT `ParticipantBarcode`, `Hugo_Symbol`, `Variant_Classification`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
   LIMIT 100;
Results:
ParticipantBarcode,Hugo_Symbol,Variant_Classification
TCGA-2J-AAB4,KRAS,Missense_Mutation
TCGA-2J-AABO,KRAS,Missense_Mutation
TCGA-2J-AABT,KRAS,Missense_Mutation
TCGA-2L-AAQA,KRAS,Missense_Mutation
TCGA-2L-AAQI,KRAS,Missense_Mutation
TCGA-2L-AAQL,KRAS,Missense_Mutation
TCGA-3A-A9I7,KRAS,Missense_Mutation
TCGA-3A-A9IC,KRAS,Missense_Mutation
TCGA-3A-A9IZ,KRAS,Missense_Mutation
TCGA-F2-A8YN,KRAS,Missense_Mutation
TCGA-FB-A78T,KRAS,Missense_Mutation
TCGA-FB-A78T,KRAS,Missense_Mutation
TCGA-FB-A7DR,KRAS,Missense_Mutation
TCGA-FB-AAPQ,KRAS,Missense_Mutation
TCGA-FB-AAPU,KRAS,Missense_Mutation
TCGA-FB-AAPY,KRAS,Missense_Mutation
TCGA-FB-AAQ3,KRAS,Missense_Mutation
TCGA-FB-AAQ6,KRAS,Missense_Mutation
TCGA-FZ-5922,KRAS,Missense_Mutation
TCGA-FZ-5923,KRAS,Missense_Mutation
TCGA-H6-8124,KRAS,Missense_Mutation
TCGA-H8-A6C1,KRAS,Missense_Mutation
TCGA-HV-A7OP,KRAS,Missense_Mutation
TCGA-HV-AA8V,KRAS,Missense_Mutation
TCGA-HV-AA8X,KRAS,Missense_Mutation
TCGA-HZ-7919,KRAS,Missense_Mutation
TCGA-HZ-A49G,KRAS,Missense_Mutation
TCGA-HZ-A49H,KRAS,Missense_Mutation
TCGA-HZ-A4BH,KRAS,Missense_Mutation
TCGA-HZ-A77O,KRAS,Missense_Mutation
TCGA-HZ-A8P1,KRAS,Missense_Mutation
TCGA-IB-7645,KRAS,Missense_Mutation
TCGA-IB-7649,KRAS,Missense_Mutation
TCGA-IB-7886,KRAS,Missense_Mutation
TCGA-IB-7887,KRAS,Missense_Mutation
TCGA-IB-7893,KRAS,Missense_Mutation
TCGA-IB-A5SS,KRAS,Missense_Mutation
TCGA-IB-A6UF,KRAS,Missense_Mutation
TCGA-IB-A7LX,KRAS,Missense_Mutation
TCGA-IB-AAUN,KRAS,Missense_Mutation
TCGA-M8-A5N4,KRAS,Missense_Mutation
TCGA-OE-A75W,KRAS,Missense_Mutation
TCGA-RB-A7B8,KRAS,Missense_Mutation
TCGA-S4-A8RM,KRAS,Missense_Mutation
TCGA-2J-AAB1,KRAS,Missense_Mutation
TCGA-2J-AAB6,KRAS,Missense_Mutation
TCGA-2J-AAB8,KRAS,Missense_Mutation

2025-01-23 08:48:27 - root - INFO - SQL:
SELECT `ParticipantBarcode`, `Hugo_Symbol`, `Variant_Classification`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
   LIMIT 100;
Results:
ParticipantBarcode,Hugo_Symbol,Variant_Classification
TCGA-2J-AAB6,TP53,Missense_Mutation
TCGA-2J-AAB9,TP53,Nonsense_Mutation
TCGA-2J-AABH,TP53,Frame_Shift_Del
TCGA-2J-AABU,TP53,Missense_Mutation
TCGA-2L-AAQA,TP53,Missense_Mutation
TCGA-2L-AAQE,TP53,Nonsense_Mutation
TCGA-3A-A9I9,TP53,Missense_Mutation
TCGA-3A-A9IB,TP53,Missense_Mutation
TCGA-3A-A9IX,TP53,Frame_Shift_Del
TCGA-3A-A9J0,TP53,Splice_Site
TCGA-3E-AAAY,TP53,Nonsense_Mutation
TCGA-F2-6879,TP53,Missense_Mutation
TCGA-FB-AAPS,TP53,Missense_Mutation
TCGA-FB-AAQ0,TP53,Missense_Mutation
TCGA-FB-AAQ1,TP53,Frame_Shift_Ins
TCGA-FB-AAQ3,TP53,Frame_Shift_Ins
TCGA-FZ-5919,TP53,Missense_Mutation
TCGA-FZ-5924,TP53,Missense_Mutation
TCGA-FZ-5926,TP53,Missense_Mutation
TCGA-H6-8124,TP53,Missense_Mutation
TCGA-HV-A5A5,TP53,Missense_Mutation
TCGA-HV-A5A6,TP53,Frame_Shift_Del
TCGA-HV-A7OL,TP53,Missense_Mutation
TCGA-HV-AA8X,TP53,Missense_Mutation
TCGA-HZ-7925,TP53,Nonsense_Mutation
TCGA-HZ-7926,TP53,Frame_Shift_Ins
TCGA-HZ-8005,TP53,Splice_Site
TCGA-HZ-8315,TP53,Missense_Mutation
TCGA-HZ-8636,TP53,In_Frame_Ins
TCGA-HZ-8637,TP53,Missense_Mutation
TCGA-HZ-A77P,TP53,Frame_Shift_Ins
TCGA-HZ-A9TJ,TP53,Missense_Mutation
TCGA-IB-7645,TP53,Nonsense_Mutation
TCGA-IB-7647,TP53,Missense_Mutation
TCGA-IB-7649,TP53,Splice_Site
TCGA-IB-7652,TP53,Missense_Mutation
TCGA-IB-7887,TP53,Missense_Mutation
TCGA-IB-A5SO,TP53,Nonsense_Mutation
TCGA-IB-A5SS,TP53,Missense_Mutation
TCGA-IB-A6UF,TP53,Missense_Mutation
TCGA-OE-A75W,TP53,Nonsense_Mutation
TCGA-S4-A8RO,TP53,Missense_Mutation
TCGA-XD-AAUL,TP53,Missense_Mutation
TCGA-XN-A8T3,TP53,Missense_Mutation
TCGA-2J-AAB4,TP53,Missense_Mutation
TCGA-2J-AABF,TP53,Nonsense_Mutation
TCGA-2J-AABI,TP53,Frame_Shift_Ins

2025-01-23 08:48:49 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:48:49 - root - INFO - It looks like there's a syntax error in your SQL query due to a mismatched quotation mark in the `WHERE` clause. Specifically, the closing quotation mark for `'PAAD'` is incorrect.

**Problematic line:**

```sql
WHERE m1.`Study` = 'PAAD' AND m2.`Study` = 'PAAD`
```

In the condition `m2.\`Study\` = 'PAAD\``, the closing quotation mark for the string literal `'PAAD'` is a backtick (\`) instead of a single quote ('), resulting in an unclosed string literal.

**Here's the corrected query:**

```sql
SELECT DISTINCT m1.`ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
WHERE m1.`Study` = 'PAAD' AND m2.`Study` = 'PAAD'
  AND m1.`Hugo_Symbol` = 'KRAS'
  AND m2.`Hugo_Symbol` = 'TP53'
LIMIT 100;
```

**Explanation:**

- Ensure that all string literals are enclosed with matching single quotes `'`.
- The corrected condition is `m2.\`Study\` = 'PAAD'`.

**Additionally, double-check the closing quotation marks in other lines:**

- Make sure all your string literals and backticks are correctly matched.
- For example, verify that all instances of `'PAAD'` are correctly enclosed.

**Now, your query should run without syntax errors.**

Let me know if you need further assistance or have any other questions!
2025-01-23 08:49:21 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:49:21 - root - INFO - It appears that there are still mismatched quotation marks in your SQL query, which is causing the syntax errors. Specifically, the closing quotation marks for `'PAAD'` are incorrect in multiple places, and this leads to the SQL parser getting confused, resulting in errors like "Unexpected keyword WHERE at [1:1]".

**Here's your query with all corrections applied:**

```sql
SELECT DISTINCT m1.`ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
WHERE m1.`Study` = 'PAAD' AND m2.`Study` = 'PAAD'
  AND m1.`Hugo_Symbol` = 'KRAS'
  AND m2.`Hugo_Symbol` = 'TP53'
LIMIT 100;
```

**Explanation:**

- **Quotation Marks:** In your original query, some of the closing single quotes `'` around `'PAAD'` were mistakenly typed as backticks `` ` ``, which is causing the parser to misinterpret the string literals.

  - Incorrect: `m2.\`Study\` = 'PAAD\``
  - Corrected: `m2.\`Study\` = 'PAAD'`

- **Consistent Use of Quotes:** Ensure all string literals (like `'PAAD'`, `'KRAS'`, and `'TP53'`) are enclosed with matching single quotes `'`.

- **Syntax Errors:** Mismatched quotation marks can lead to the SQL parser thinking that the string literal isn't properly closed, causing it to misread the query structure entirely.

  - This is why the error mentions `Unexpected keyword WHERE at [1:1]`; the parser might think everything before `WHERE` is part of an unclosed string.

**Please use the corrected query above.**

**Additional Tips:**

- **Copy-Paste Carefully:** When copying the corrected query, ensure that all quotation marks are exactly as shown. Even a small mismatch can cause syntax errors.

- **Check for Other Mismatches:** In longer queries, verify all other string literals and identifiers to ensure they are properly enclosed.

**Let me know if you continue to experience issues or have any further questions!**
2025-01-23 08:51:41 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:51:41 - root - INFO - SQL:
SELECT DISTINCT m1.`ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
WHERE m1.`Study` = 'PAAD' AND m2.`Study` = 'PAAD'
  AND m1.`Hugo_Symbol` = 'KRAS'
  AND m2.`Hugo_Symbol` = 'TP53'
LIMIT 100;
Results:
ParticipantBarcode
TCGA-2J-AAB6
TCGA-2J-AAB8
TCGA-2J-AABH
TCGA-2J-AABI
TCGA-2J-AABK
TCGA-2L-AAQE
TCGA-3A-A9I9
TCGA-3A-A9IB
TCGA-3A-A9IH
TCGA-FB-A5VM
TCGA-FB-AAQ0
TCGA-FZ-5919
TCGA-FZ-5920
TCGA-FZ-5921
TCGA-FZ-5924
TCGA-FZ-5926
TCGA-HV-A5A6
TCGA-HV-A7OL
TCGA-HZ-7922
TCGA-HZ-7925
TCGA-HZ-8636
TCGA-HZ-A9TJ
TCGA-IB-7644
TCGA-IB-7646
TCGA-IB-7647
TCGA-IB-8127
TCGA-IB-AAUU
TCGA-PZ-A5RE
TCGA-XN-A8T3
TCGA-YH-A8SY
TCGA-2J-AAB4
TCGA-2J-AABO
TCGA-2J-AABT
TCGA-2L-AAQA
TCGA-2L-AAQI
TCGA-2L-AAQL
TCGA-3A-A9IC
TCGA-3A-A9IZ
TCGA-F2-A8YN
TCGA-FB-A78T
TCGA-FB-AAPQ
TCGA-FB-AAPY
TCGA-FB-AAQ3
TCGA-FB-AAQ6
TCGA-H6-8124
TCGA-H8-A6C1
TCGA-HV-AA8V
TCGA-HV-AA8X
TCGA-HZ-A49G
TCGA-HZ-A4BH
TCGA-HZ-A77O
TCGA-IB-7645
TCGA-IB-7649
TCGA-IB-7886
TCGA-IB-7887
TCGA-IB-7893
TCGA-IB-A5SS
TCGA-IB-A6UF
TCGA-IB-AAUN
TCGA-M8-A5N4
TCGA-OE-A75W
TCGA-2J-AABF
TCGA-2J-AABU
TCGA-2L-AAQJ
TCGA-F2-6879
TCGA-F2-A7TX
TCGA-FB-A545
TCGA-FB-AAPZ
TCGA-FB-AAQ1
TCGA-FB-AAQ2
TCGA-HV-A5A3
TCGA-HZ-7926
TCGA-HZ-8005
TCGA-HZ-8315
TCGA-HZ-8637
TCGA-HZ-A49I
TCGA-HZ-A4BK
TCGA-HZ-A77Q
TCGA-IB-7652
TCGA-IB-7889
TCGA-IB-7890
TCGA-IB-A5SO
TCGA-IB-A5SP
TCGA-IB-A6UG
TCGA-IB-A7M4
TCGA-IB-AAUQ
TCGA-S4-A8RO
TCGA-US-A779
TCGA-XD-AAUI
TCGA-XD-AAUL

2025-01-23 08:51:43 - root - INFO - SQL:
SELECT DISTINCT `ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
  AND `ParticipantBarcode` NOT IN (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
  )
LIMIT 100
Results:
ParticipantBarcode
TCGA-2J-AABE
TCGA-3E-AAAZ
TCGA-HV-A5A4
TCGA-IB-7651
TCGA-S4-A8RP
TCGA-YY-A8LH
TCGA-3A-A9I7
TCGA-FB-A7DR
TCGA-FB-AAPU
TCGA-FZ-5922
TCGA-FZ-5923
TCGA-HV-A7OP
TCGA-HZ-7919
TCGA-HZ-A49H
TCGA-HZ-A8P1
TCGA-IB-A7LX
TCGA-RB-A7B8
TCGA-S4-A8RM
TCGA-2J-AAB1
TCGA-3A-A9IU
TCGA-F2-A44G
TCGA-HZ-A8P0
TCGA-IB-AAUM
TCGA-IB-AAUO
TCGA-Q3-AA2A
TCGA-US-A77G
TCGA-YB-A89D

2025-01-23 08:51:45 - root - INFO - SQL:
SELECT DISTINCT `ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
  AND `ParticipantBarcode` NOT IN (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
  )
LIMIT 100
Results:
ParticipantBarcode
TCGA-2J-AABP
TCGA-H6-A45N
TCGA-IB-7888
TCGA-LB-A7SX
TCGA-RB-AA9M
TCGA-XD-AAUG
TCGA-HZ-8001
TCGA-IB-7891
TCGA-LB-A9Q5
TCGA-Z5-AAPL
TCGA-2J-AAB9
TCGA-3A-A9IX
TCGA-3A-A9J0
TCGA-3E-AAAY
TCGA-FB-AAPS
TCGA-HV-A5A5
TCGA-HZ-A77P

2025-01-23 08:51:47 - root - INFO - SQL:
SELECT DISTINCT `bcr_patient_barcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup`
WHERE `acronym` = 'PAAD'
LIMIT 100
Results:
bcr_patient_barcode
TCGA-HZ-A49I
TCGA-FZ-5920
TCGA-HZ-7922
TCGA-S4-A8RO
TCGA-H8-A6C1
TCGA-XD-AAUI
TCGA-HZ-7926
TCGA-HZ-8519
TCGA-F2-A8YN
TCGA-HZ-8003
TCGA-HZ-A77O
TCGA-HZ-A77P
TCGA-HZ-7923
TCGA-FZ-5926
TCGA-L1-A7W4
TCGA-FZ-5924
TCGA-LB-A7SX
TCGA-FZ-5922
TCGA-HZ-7289
TCGA-HZ-A4BK
TCGA-IB-A6UG
TCGA-IB-A6UF
TCGA-F2-A7TX
TCGA-HZ-A77Q
TCGA-F2-A44H
TCGA-HZ-8638
TCGA-IB-AAUP
TCGA-Q3-AA2A
TCGA-HZ-7918
TCGA-IB-AAUN
TCGA-IB-AAUU
TCGA-Q3-A5QY
TCGA-HZ-7925
TCGA-FB-A78T
TCGA-FB-A7DR
TCGA-HZ-A4BH
TCGA-HZ-A49G
TCGA-IB-AAUW
TCGA-IB-A7LX
TCGA-XD-AAUL
TCGA-LB-A9Q5
TCGA-XD-AAUH
TCGA-HZ-A8P0
TCGA-HZ-8002
TCGA-HZ-8317
TCGA-HZ-7919
TCGA-RB-A7B8
TCGA-HZ-7924
TCGA-IB-AAUV
TCGA-FB-A4P5
TCGA-IB-AAUM
TCGA-PZ-A5RE
TCGA-FB-A5VM
TCGA-LB-A8F3
TCGA-IB-AAUR
TCGA-F2-A44G
TCGA-HZ-8315
TCGA-IB-AAUT
TCGA-HZ-A49H
TCGA-IB-A5ST
TCGA-HZ-8637
TCGA-H6-8124
TCGA-HZ-7920
TCGA-IB-AAUS
TCGA-FB-A4P6
TCGA-FZ-5919
TCGA-FZ-5923
TCGA-IB-AAUO
TCGA-HZ-8001
TCGA-FB-A545
TCGA-XD-AAUG
TCGA-YB-A89D
TCGA-IB-A7M4
TCGA-HZ-A9TJ
TCGA-OE-A75W
TCGA-IB-AAUQ
TCGA-H6-A45N
TCGA-HZ-A8P1
TCGA-HZ-8636
TCGA-RB-AA9M
TCGA-HZ-8005
TCGA-F2-7276
TCGA-Z5-AAPL
TCGA-S4-A8RM
TCGA-F2-7273
TCGA-2L-AAQJ
TCGA-HV-A5A5
TCGA-HV-A7OL
TCGA-2J-AABI
TCGA-F2-6879
TCGA-YH-A8SY
TCGA-3A-A9I9
TCGA-IB-8126
TCGA-3A-A9J0
TCGA-US-A77J
TCGA-XN-A8T5
TCGA-2J-AAB1
TCGA-2L-AAQL
TCGA-3A-A9I7
TCGA-2J-AABV

2025-01-23 08:51:49 - root - INFO - SQL:
SELECT DISTINCT `ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.BarcodeMap`
WHERE `Study` = 'PAAD'
  AND `ParticipantBarcode` NOT IN (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` IN ('KRAS', 'TP53')
  )
LIMIT 100
Results:
ParticipantBarcode
TCGA-2J-AABA
TCGA-2J-AABR
TCGA-2J-AABV
TCGA-3A-A9I5
TCGA-3A-A9IJ
TCGA-3A-A9IL
TCGA-3A-A9IN
TCGA-3A-A9IO
TCGA-3A-A9IR
TCGA-3A-A9IS
TCGA-3A-A9IV
TCGA-F2-6880
TCGA-F2-7273
TCGA-F2-7276
TCGA-F2-A44H
TCGA-FB-A4P5
TCGA-FB-A4P6
TCGA-HZ-7289
TCGA-HZ-7918
TCGA-HZ-7920
TCGA-HZ-7923
TCGA-HZ-7924
TCGA-HZ-8002
TCGA-HZ-8003
TCGA-HZ-8317
TCGA-HZ-8519
TCGA-HZ-8638
TCGA-IB-7654
TCGA-IB-7885
TCGA-IB-7897
TCGA-IB-8126
TCGA-IB-A5SQ
TCGA-IB-A5ST
TCGA-IB-AAUP
TCGA-IB-AAUR
TCGA-IB-AAUS
TCGA-IB-AAUT
TCGA-IB-AAUV
TCGA-IB-AAUW
TCGA-L1-A7W4
TCGA-LB-A8F3
TCGA-Q3-A5QY
TCGA-RL-AAAS
TCGA-XN-A8T5
TCGA-2L-AAQM
TCGA-FB-AAPP
TCGA-US-A774
TCGA-US-A776
TCGA-US-A77E
TCGA-US-A77J
TCGA-XD-AAUH
TCGA-07-0227
TCGA-AV-A03D

2025-01-23 08:51:50 - root - INFO - SQL:
SELECT c.`bcr_patient_barcode`, c.`vital_status`, m.`Hugo_Symbol`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
ON c.`bcr_patient_barcode` = m.`ParticipantBarcode`
WHERE c.`acronym` = 'PAAD' AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
LIMIT 100
Results:
bcr_patient_barcode,vital_status,Hugo_Symbol
TCGA-HZ-A49I,Dead,TP53
TCGA-HZ-A49I,Dead,KRAS
TCGA-FZ-5920,Dead,TP53
TCGA-FZ-5920,Dead,KRAS
TCGA-HZ-7922,Alive,TP53
TCGA-HZ-7922,Alive,KRAS
TCGA-S4-A8RO,Alive,KRAS
TCGA-S4-A8RO,Alive,TP53
TCGA-H8-A6C1,Alive,TP53
TCGA-H8-A6C1,Alive,KRAS
TCGA-XD-AAUI,Dead,KRAS
TCGA-XD-AAUI,Dead,TP53
TCGA-HZ-7926,Dead,KRAS
TCGA-HZ-7926,Dead,TP53
TCGA-F2-A8YN,Alive,TP53
TCGA-F2-A8YN,Alive,KRAS
TCGA-HZ-A77O,Dead,TP53
TCGA-HZ-A77O,Dead,KRAS
TCGA-HZ-A77P,Alive,TP53
TCGA-FZ-5926,Dead,KRAS
TCGA-FZ-5926,Dead,TP53
TCGA-FZ-5924,Dead,KRAS
TCGA-FZ-5924,Dead,TP53
TCGA-LB-A7SX,Dead,TP53
TCGA-FZ-5922,Dead,KRAS
TCGA-HZ-A4BK,Alive,KRAS
TCGA-HZ-A4BK,Alive,TP53
TCGA-IB-A6UG,Dead,KRAS
TCGA-IB-A6UG,Dead,TP53
TCGA-IB-A6UF,Alive,KRAS
TCGA-IB-A6UF,Alive,TP53
TCGA-F2-A7TX,Dead,KRAS
TCGA-F2-A7TX,Dead,TP53
TCGA-HZ-A77Q,Alive,KRAS
TCGA-HZ-A77Q,Alive,TP53
TCGA-Q3-AA2A,Alive,KRAS
TCGA-IB-AAUN,Dead,TP53
TCGA-IB-AAUN,Dead,KRAS
TCGA-IB-AAUU,Alive,TP53
TCGA-IB-AAUU,Alive,KRAS
TCGA-HZ-7925,Dead,KRAS
TCGA-HZ-7925,Dead,TP53
TCGA-FB-A78T,Dead,KRAS
TCGA-FB-A78T,Dead,KRAS
TCGA-FB-A78T,Dead,TP53
TCGA-FB-A7DR,Dead,KRAS
TCGA-HZ-A4BH,Alive,TP53
TCGA-HZ-A4BH,Alive,KRAS
TCGA-HZ-A49G,Alive,TP53
TCGA-HZ-A49G,Alive,KRAS
TCGA-IB-A7LX,Dead,KRAS
TCGA-XD-AAUL,Alive,KRAS
TCGA-XD-AAUL,Alive,TP53
TCGA-LB-A9Q5,Dead,TP53
TCGA-HZ-A8P0,Alive,KRAS
TCGA-HZ-7919,Dead,KRAS
TCGA-RB-A7B8,Dead,KRAS
TCGA-IB-AAUM,Alive,KRAS

2025-01-23 08:51:52 - root - INFO - SQL:
SELECT DISTINCT `Variant_Classification`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
LIMIT 100
Results:
Variant_Classification
Missense_Mutation

2025-01-23 08:51:54 - root - INFO - SQL:
SELECT m1.`ParticipantBarcode`, c.`OS_time`
FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR` AS c
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
ON c.`ParticipantBarcode` = m1.`ParticipantBarcode`
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
WHERE c.`Study` = 'PAAD'
  AND m1.`Hugo_Symbol` = 'KRAS'
  AND m2.`Hugo_Symbol` = 'TP53'
LIMIT 100
Results:
ParticipantBarcode,OS_time
TCGA-IB-7649,467
TCGA-OE-A75W,267
TCGA-FB-AAPQ,1130
TCGA-3A-A9IB,224
TCGA-FZ-5920,61
TCGA-IB-AAUN,144
TCGA-HV-AA8V,920
TCGA-HZ-A4BH,194
TCGA-IB-A6UG,41
TCGA-3A-A9IH,1021
TCGA-M8-A5N4,584
TCGA-HZ-7922,4
TCGA-2J-AABI,969
TCGA-XN-A8T3,951
TCGA-HV-A7OL,252
TCGA-HZ-A49G,660
TCGA-HZ-A9TJ,603
TCGA-HZ-A9TJ,603
TCGA-HZ-A9TJ,603
TCGA-HZ-A9TJ,603
TCGA-H8-A6C1,671
TCGA-HZ-A77Q,33
TCGA-HZ-A4BK,657
TCGA-YH-A8SY,388
TCGA-2J-AAB8,80
TCGA-F2-A8YN,517
TCGA-IB-A6UF,666
TCGA-2J-AABO,440
TCGA-IB-A5SP,482
TCGA-2J-AABT,319
TCGA-H6-8124,392
TCGA-HZ-8637,517
TCGA-2J-AABH,1287
TCGA-2J-AABH,1287
TCGA-FB-AAQ3,31
TCGA-S4-A8RO,525
TCGA-FB-AAPY,1059
TCGA-IB-7652,1116
TCGA-IB-7886,123
TCGA-HV-A5A3,128
TCGA-FB-AAPZ,716
TCGA-FB-AAQ0,473
TCGA-2J-AAB4,729
TCGA-IB-A7M4,483
TCGA-2J-AABK,484
TCGA-IB-8127,522
TCGA-HV-A5A6,2036
TCGA-XD-AAUL,498
TCGA-IB-AAUU,245
TCGA-FB-AAQ6,244
TCGA-F2-A7TX,95
TCGA-FB-AAQ1,123
TCGA-2L-AAQI,103
TCGA-HZ-8636,545
TCGA-HZ-A49I,308
TCGA-3A-A9IC,738
TCGA-3A-A9I9,634
TCGA-FZ-5919,741
TCGA-HV-AA8X,532
TCGA-HZ-8315,299
TCGA-2L-AAQJ,394
TCGA-FZ-5921,155
TCGA-IB-7647,666
TCGA-IB-A5SO,365
TCGA-HZ-7926,518
TCGA-2J-AABF,691
TCGA-2L-AAQL,292
TCGA-IB-7644,394
TCGA-HZ-8005,120
TCGA-IB-7893,117
TCGA-2J-AABU,277
TCGA-2J-AAB6,293
TCGA-US-A779,511
TCGA-IB-7889,481
TCGA-IB-7890,598
TCGA-PZ-A5RE,470
TCGA-2L-AAQA,143
TCGA-XD-AAUI,366
TCGA-2L-AAQE,684
TCGA-FB-A5VM,498
TCGA-FZ-5924,480
TCGA-FB-AAQ2,153
TCGA-IB-7887,110
TCGA-3A-A9IZ,308
TCGA-FZ-5926,541
TCGA-IB-7645,1502
TCGA-IB-7646,145
TCGA-IB-AAUQ,183
TCGA-IB-A5SS,460
TCGA-HZ-A77O,160
TCGA-HZ-7925,614
TCGA-FB-A78T,375
TCGA-FB-A78T,375

2025-01-23 08:51:56 - root - INFO - SQL:
SELECT `ParticipantBarcode`, COUNT(*) AS `num_mutations`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
GROUP BY `ParticipantBarcode`
LIMIT 100
Results:
ParticipantBarcode,num_mutations
TCGA-2J-AABE,1
TCGA-2J-AABF,1
TCGA-2J-AABH,2
TCGA-2J-AABU,1
TCGA-2L-AAQJ,1
TCGA-3E-AAAZ,1
TCGA-F2-6879,1
TCGA-F2-A7TX,1
TCGA-FB-A545,1
TCGA-FB-AAPZ,1
TCGA-FB-AAQ1,1
TCGA-FB-AAQ2,1
TCGA-HV-A5A3,1
TCGA-HV-A5A4,1
TCGA-HZ-7926,1
TCGA-HZ-8005,1
TCGA-HZ-8315,1
TCGA-HZ-8637,1
TCGA-HZ-A49I,1
TCGA-HZ-A4BK,1
TCGA-HZ-A77Q,1
TCGA-HZ-A9TJ,2
TCGA-IB-7651,1
TCGA-IB-7652,1
TCGA-IB-7889,1
TCGA-IB-7890,1
TCGA-IB-A5SO,1
TCGA-IB-A5SP,1
TCGA-IB-A6UG,1
TCGA-IB-A7M4,1
TCGA-IB-AAUQ,1
TCGA-S4-A8RO,1
TCGA-S4-A8RP,1
TCGA-US-A779,1
TCGA-XD-AAUI,1
TCGA-XD-AAUL,1
TCGA-YY-A8LH,1
TCGA-2J-AAB4,1
TCGA-2J-AABO,1
TCGA-2J-AABT,1
TCGA-2L-AAQA,1
TCGA-2L-AAQI,1
TCGA-2L-AAQL,1
TCGA-3A-A9I7,1
TCGA-3A-A9IC,1
TCGA-3A-A9IZ,1
TCGA-F2-A8YN,1
TCGA-FB-A78T,2
TCGA-FB-A7DR,1
TCGA-FB-AAPQ,1
TCGA-FB-AAPU,1
TCGA-FB-AAPY,1
TCGA-FB-AAQ3,1
TCGA-FB-AAQ6,1
TCGA-FZ-5922,1
TCGA-FZ-5923,1
TCGA-H6-8124,1
TCGA-H8-A6C1,1
TCGA-HV-A7OP,1
TCGA-HV-AA8V,1
TCGA-HV-AA8X,1
TCGA-HZ-7919,1
TCGA-HZ-A49G,1
TCGA-HZ-A49H,1
TCGA-HZ-A4BH,1
TCGA-HZ-A77O,1
TCGA-HZ-A8P1,1
TCGA-IB-7645,1
TCGA-IB-7649,1
TCGA-IB-7886,1
TCGA-IB-7887,1
TCGA-IB-7893,1
TCGA-IB-A5SS,1
TCGA-IB-A6UF,1
TCGA-IB-A7LX,1
TCGA-IB-AAUN,1
TCGA-M8-A5N4,1
TCGA-OE-A75W,1
TCGA-RB-A7B8,1
TCGA-S4-A8RM,1
TCGA-2J-AAB1,1
TCGA-2J-AAB6,1
TCGA-2J-AAB8,1
TCGA-2J-AABI,1
TCGA-2J-AABK,1
TCGA-2L-AAQE,1
TCGA-3A-A9I9,1

2025-01-23 08:51:57 - root - INFO - SQL:
SELECT c.`ParticipantBarcode`, c.`OS`, m.`Hugo_Symbol`
FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR` AS c
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
ON c.`ParticipantBarcode` = m.`ParticipantBarcode`
WHERE c.`Study` = 'PAAD' AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
LIMIT 100
Results:
ParticipantBarcode,OS,Hugo_Symbol
TCGA-IB-7649,1,TP53
TCGA-IB-7649,1,KRAS
TCGA-S4-A8RP,1,KRAS
TCGA-OE-A75W,1,TP53
TCGA-OE-A75W,1,KRAS
TCGA-FB-AAPQ,1,TP53
TCGA-FB-AAPQ,1,KRAS
TCGA-3A-A9IB,1,TP53
TCGA-3A-A9IB,1,KRAS
TCGA-FZ-5920,1,KRAS
TCGA-FZ-5920,1,TP53
TCGA-IB-AAUN,1,TP53
TCGA-IB-AAUN,1,KRAS
TCGA-HV-AA8V,0,TP53
TCGA-HV-AA8V,0,KRAS
TCGA-HZ-A4BH,0,TP53
TCGA-HZ-A4BH,0,KRAS
TCGA-IB-A6UG,1,KRAS
TCGA-IB-A6UG,1,TP53
TCGA-3A-A9IH,0,KRAS
TCGA-3A-A9IH,0,TP53
TCGA-M8-A5N4,0,KRAS
TCGA-M8-A5N4,0,TP53
TCGA-FB-AAPS,0,TP53
TCGA-HV-A7OP,0,KRAS
TCGA-HZ-7922,0,KRAS
TCGA-HZ-7922,0,TP53
TCGA-2J-AABI,0,TP53
TCGA-2J-AABI,0,KRAS
TCGA-XN-A8T3,0,KRAS
TCGA-XN-A8T3,0,TP53
TCGA-HV-A7OL,0,KRAS
TCGA-HV-A7OL,0,TP53
TCGA-LB-A7SX,1,TP53
TCGA-HZ-A49G,0,TP53
TCGA-HZ-A49G,0,KRAS
TCGA-HZ-A9TJ,0,KRAS
TCGA-HZ-A9TJ,0,TP53
TCGA-HZ-A9TJ,0,TP53
TCGA-HZ-A9TJ,0,KRAS
TCGA-H8-A6C1,0,TP53
TCGA-H8-A6C1,0,KRAS
TCGA-HZ-A77Q,0,KRAS
TCGA-HZ-A77Q,0,TP53
TCGA-RB-AA9M,0,TP53
TCGA-HZ-A4BK,0,KRAS
TCGA-HZ-A4BK,0,TP53
TCGA-3A-A9J0,0,TP53
TCGA-YH-A8SY,0,TP53
TCGA-YH-A8SY,0,KRAS
TCGA-2J-AAB8,0,KRAS
TCGA-2J-AAB8,0,TP53
TCGA-F2-A8YN,0,TP53
TCGA-F2-A8YN,0,KRAS
TCGA-HZ-A8P0,0,KRAS
TCGA-IB-AAUM,0,KRAS
TCGA-US-A77G,1,KRAS
TCGA-IB-A6UF,0,TP53
TCGA-IB-A6UF,0,KRAS
TCGA-2J-AABO,0,TP53
TCGA-2J-AABO,0,KRAS
TCGA-Q3-AA2A,0,KRAS
TCGA-3A-A9I7,0,KRAS
TCGA-3E-AAAZ,1,KRAS
TCGA-IB-A5SP,0,KRAS
TCGA-IB-A5SP,0,TP53
TCGA-XD-AAUG,0,TP53
TCGA-2J-AABT,0,KRAS
TCGA-2J-AABT,0,TP53
TCGA-HZ-A8P1,0,KRAS
TCGA-H6-8124,0,TP53
TCGA-H6-8124,0,KRAS

2025-01-23 08:52:00 - root - INFO - SQL:
SELECT c.`bcr_patient_barcode`, c.`vital_status`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
WHERE c.`acronym` = 'PAAD' AND c.`bcr_patient_barcode` NOT IN (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` IN ('KRAS', 'TP53')
)
LIMIT 100
Results:
bcr_patient_barcode,vital_status
TCGA-HZ-8519,Alive
TCGA-HZ-8003,Dead
TCGA-HZ-7923,Alive
TCGA-L1-A7W4,Dead
TCGA-HZ-7289,Dead
TCGA-F2-A44H,Alive
TCGA-HZ-8638,Dead
TCGA-IB-AAUP,Alive
TCGA-HZ-7918,Alive
TCGA-Q3-A5QY,Alive
TCGA-IB-AAUW,Dead
TCGA-XD-AAUH,Alive
TCGA-HZ-8002,Dead
TCGA-HZ-8317,Dead
TCGA-HZ-7924,Alive
TCGA-IB-AAUV,Alive
TCGA-FB-A4P5,Dead
TCGA-LB-A8F3,Alive
TCGA-IB-AAUR,Alive
TCGA-IB-AAUT,Alive
TCGA-IB-A5ST,Alive
TCGA-HZ-7920,Dead
TCGA-IB-AAUS,Alive
TCGA-FB-A4P6,Alive
TCGA-F2-7276,Dead
TCGA-F2-7273,Dead
TCGA-IB-8126,Alive
TCGA-US-A77J,Dead
TCGA-XN-A8T5,Alive
TCGA-2J-AABV,Dead
TCGA-RL-AAAS,Alive
TCGA-3A-A9I5,Alive
TCGA-3A-A9IJ,Alive
TCGA-FB-AAPP,Dead
TCGA-2L-AAQM,Alive
TCGA-US-A774,Dead
TCGA-US-A77E,Dead
TCGA-2J-AABA,Dead
TCGA-IB-A5SQ,Dead
TCGA-F2-6880,Alive
TCGA-US-A776,Alive
TCGA-3A-A9IS,Alive
TCGA-3A-A9IO,Alive
TCGA-3A-A9IL,Alive
TCGA-3A-A9IN,Alive
TCGA-3A-A9IV,Alive
TCGA-3A-A9IR,Alive
TCGA-2J-AABR,Alive
TCGA-IB-7885,Alive
TCGA-IB-7897,Dead

2025-01-23 08:52:02 - root - INFO - SQL:
SELECT DISTINCT `HGVSp_Short`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
LIMIT 100
Results:
HGVSp_Short
p.G12V
p.G12R
p.Q61R
p.G12D
p.G13C
p.G12A
p.Q61H
p.G12C
p.G12S

2025-01-23 08:52:04 - root - INFO - SQL:
SELECT `ParticipantBarcode`, `Hugo_Symbol`, `HGVSp_Short`, `Variant_Classification`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
LIMIT 100
Results:
ParticipantBarcode,Hugo_Symbol,HGVSp_Short,Variant_Classification
TCGA-2J-AABE,KRAS,p.G12R,Missense_Mutation
TCGA-2J-AABF,KRAS,p.G12D,Missense_Mutation
TCGA-2J-AABH,KRAS,p.G12V,Missense_Mutation
TCGA-2J-AABU,KRAS,p.G12R,Missense_Mutation
TCGA-2L-AAQJ,KRAS,p.G12D,Missense_Mutation
TCGA-3E-AAAZ,KRAS,p.G12V,Missense_Mutation
TCGA-F2-6879,KRAS,p.G12V,Missense_Mutation
TCGA-F2-A7TX,KRAS,p.G12D,Missense_Mutation
TCGA-FB-A545,KRAS,p.G12V,Missense_Mutation
TCGA-FB-AAPZ,KRAS,p.G12R,Missense_Mutation
TCGA-FB-AAQ1,KRAS,p.G12D,Missense_Mutation
TCGA-FB-AAQ2,KRAS,p.G12D,Missense_Mutation
TCGA-HV-A5A3,KRAS,p.G12D,Missense_Mutation
TCGA-HV-A5A4,KRAS,p.G12V,Missense_Mutation
TCGA-HZ-7926,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-8005,KRAS,p.Q61H,Missense_Mutation
TCGA-HZ-8315,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-8637,KRAS,p.G12V,Missense_Mutation
TCGA-HZ-A49I,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-A4BK,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-A77Q,KRAS,p.G12R,Missense_Mutation
TCGA-HZ-A9TJ,KRAS,p.G12V,Missense_Mutation
TCGA-IB-7651,KRAS,p.G12D,Missense_Mutation
TCGA-IB-7652,KRAS,p.G12R,Missense_Mutation
TCGA-IB-7889,KRAS,p.G12V,Missense_Mutation
TCGA-IB-7890,KRAS,p.Q61R,Missense_Mutation
TCGA-IB-A5SO,KRAS,p.G12D,Missense_Mutation
TCGA-IB-A5SP,KRAS,p.G12D,Missense_Mutation
TCGA-IB-A6UG,KRAS,p.G12D,Missense_Mutation
TCGA-IB-A7M4,KRAS,p.G12D,Missense_Mutation
TCGA-IB-AAUQ,KRAS,p.G12D,Missense_Mutation
TCGA-S4-A8RO,KRAS,p.G12D,Missense_Mutation
TCGA-S4-A8RP,KRAS,p.G12R,Missense_Mutation
TCGA-US-A779,KRAS,p.G12D,Missense_Mutation
TCGA-XD-AAUI,KRAS,p.G12V,Missense_Mutation
TCGA-XD-AAUL,KRAS,p.G12R,Missense_Mutation
TCGA-YY-A8LH,KRAS,p.G12V,Missense_Mutation
TCGA-2J-AAB4,KRAS,p.G12V,Missense_Mutation

2025-01-23 08:52:05 - root - INFO - SQL:
SELECT `Variant_Classification`, COUNT(*) AS `mutation_count`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
GROUP BY `Variant_Classification`
LIMIT 100
Results:
Variant_Classification,mutation_count
Missense_Mutation,120

2025-01-23 08:52:07 - root - INFO - SQL:
SELECT DISTINCT m.`ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
WHERE m.`Study` = 'PAAD'
  AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
  AND m.`Variant_Classification` IN (
    'Frame_Shift_Del', 'Frame_Shift_Ins', 'In_Frame_Del', 'In_Frame_Ins',
    'Missense_Mutation', 'Nonsense_Mutation', 'Nonstop_Mutation',
    'Splice_Site', 'Translation_Start_Site'
  )
LIMIT 100
Results:
ParticipantBarcode
TCGA-2J-AAB4
TCGA-2J-AABE
TCGA-2J-AABF
TCGA-2J-AABH
TCGA-2J-AABI
TCGA-2J-AABU
TCGA-2L-AAQJ
TCGA-2L-AAQL
TCGA-3A-A9IC
TCGA-3A-A9IZ
TCGA-3E-AAAZ
TCGA-F2-6879
TCGA-F2-A7TX
TCGA-FB-A545
TCGA-FB-AAPY
TCGA-FB-AAPZ
TCGA-FB-AAQ1
TCGA-FB-AAQ2
TCGA-FB-AAQ6
TCGA-HV-A5A3
TCGA-HV-A5A4
TCGA-HV-AA8V
TCGA-HZ-7926
TCGA-HZ-8001
TCGA-HZ-8005
TCGA-HZ-8315
TCGA-HZ-8637
TCGA-HZ-A49I
TCGA-HZ-A4BH
TCGA-HZ-A4BK
TCGA-HZ-A77Q
TCGA-HZ-A9TJ
TCGA-IB-7644
TCGA-IB-7651
TCGA-IB-7652
TCGA-IB-7886
TCGA-IB-7889
TCGA-IB-7890
TCGA-IB-7891
TCGA-IB-7893
TCGA-IB-8127
TCGA-IB-A5SO
TCGA-IB-A5SP
TCGA-IB-A6UG
TCGA-IB-A7M4
TCGA-IB-AAUN
TCGA-IB-AAUQ
TCGA-LB-A9Q5
TCGA-S4-A8RO
TCGA-S4-A8RP
TCGA-US-A779
TCGA-XD-AAUI
TCGA-XD-AAUL
TCGA-YH-A8SY
TCGA-YY-A8LH
TCGA-Z5-AAPL
TCGA-2J-AAB8
TCGA-2J-AABK
TCGA-2J-AABO
TCGA-2J-AABP
TCGA-2J-AABT
TCGA-2L-AAQA
TCGA-2L-AAQI
TCGA-3A-A9I7
TCGA-3A-A9IH
TCGA-F2-A8YN
TCGA-FB-A5VM
TCGA-FB-A78T
TCGA-FB-A7DR
TCGA-FB-AAPQ
TCGA-FB-AAPU
TCGA-FB-AAQ3
TCGA-FZ-5920
TCGA-FZ-5921
TCGA-FZ-5922
TCGA-FZ-5923
TCGA-H6-8124
TCGA-H6-A45N
TCGA-H8-A6C1
TCGA-HV-A7OP
TCGA-HV-AA8X
TCGA-HZ-7919
TCGA-HZ-7922
TCGA-HZ-A49G
TCGA-HZ-A49H
TCGA-HZ-A77O
TCGA-HZ-A8P1
TCGA-IB-7645
TCGA-IB-7646
TCGA-IB-7649
TCGA-IB-7887
TCGA-IB-7888
TCGA-IB-A5SS
TCGA-IB-A6UF
TCGA-IB-A7LX
TCGA-IB-AAUU
TCGA-LB-A7SX
TCGA-M8-A5N4
TCGA-OE-A75W
TCGA-PZ-A5RE

2025-01-23 08:52:09 - root - INFO - SQL:
SELECT c.`bcr_patient_barcode`, c.`vital_status`, c.`days_to_last_followup`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
WHERE c.`acronym` = 'PAAD' AND c.`bcr_patient_barcode` NOT IN (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` IN ('KRAS', 'TP53')
)
LIMIT 100
Results:
bcr_patient_barcode,vital_status,days_to_last_followup
TCGA-HZ-8519,Alive,454.0
TCGA-HZ-8003,Dead,21
TCGA-HZ-7923,Alive,314.0
TCGA-L1-A7W4,Dead,164
TCGA-HZ-7289,Dead,240
TCGA-F2-A44H,Alive,586.0
TCGA-HZ-8638,Dead,91
TCGA-IB-AAUP,Alive,431.0
TCGA-HZ-7918,Alive,969.0
TCGA-Q3-A5QY,Alive,416.0
TCGA-IB-AAUW,Dead,179
TCGA-XD-AAUH,Alive,395.0
TCGA-HZ-8002,Dead,24
TCGA-HZ-8317,Dead,16
TCGA-HZ-7924,Alive,840.0
TCGA-IB-AAUV,Alive,404.0
TCGA-FB-A4P5,Dead,4
TCGA-LB-A8F3,Alive,379.0
TCGA-IB-AAUR,Alive,338.0
TCGA-IB-AAUT,Alive,287.0
TCGA-IB-A5ST,Alive,635.0
TCGA-HZ-7920,Dead,0
TCGA-IB-AAUS,Alive,225.0
TCGA-FB-A4P6,Alive,767.0
TCGA-F2-7276,Dead,
TCGA-F2-7273,Dead,360.0
TCGA-IB-8126,Alive,462.0
TCGA-US-A77J,Dead,
TCGA-XN-A8T5,Alive,720.0
TCGA-2J-AABV,Dead,
TCGA-RL-AAAS,Alive,9.0
TCGA-3A-A9I5,Alive,1794.0
TCGA-3A-A9IJ,Alive,1854.0
TCGA-FB-AAPP,Dead,
TCGA-2L-AAQM,Alive,1383.0
TCGA-US-A774,Dead,
TCGA-US-A77E,Dead,
TCGA-2J-AABA,Dead,
TCGA-IB-A5SQ,Dead,
TCGA-F2-6880,Alive,289.0
TCGA-US-A776,Alive,1216.0
TCGA-3A-A9IS,Alive,998.0
TCGA-3A-A9IO,Alive,1942.0
TCGA-3A-A9IL,Alive,2741.0
TCGA-3A-A9IN,Alive,2084.0
TCGA-3A-A9IV,Alive,1103.0
TCGA-3A-A9IR,Alive,1542.0
TCGA-2J-AABR,Alive,438.0
TCGA-IB-7885,Alive,1257.0
TCGA-IB-7897,Dead,

2025-01-23 08:52:11 - root - INFO - SQL:
SELECT m.`ParticipantBarcode`, m.`Hugo_Symbol`, COUNT(*) AS `mutation_count`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
WHERE m.`Study` = 'PAAD' AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
GROUP BY m.`ParticipantBarcode`, m.`Hugo_Symbol`
LIMIT 100
Results:
ParticipantBarcode,Hugo_Symbol,mutation_count
TCGA-2J-AAB4,TP53,1
TCGA-2J-AABE,KRAS,1
TCGA-2J-AABF,KRAS,1
TCGA-2J-AABF,TP53,1
TCGA-2J-AABH,KRAS,2
TCGA-2J-AABI,TP53,1
TCGA-2J-AABU,KRAS,1
TCGA-2L-AAQJ,TP53,1
TCGA-2L-AAQJ,KRAS,1
TCGA-2L-AAQL,TP53,1
TCGA-3A-A9IC,TP53,1
TCGA-3A-A9IZ,TP53,1
TCGA-3E-AAAZ,KRAS,1
TCGA-F2-6879,KRAS,1
TCGA-F2-A7TX,KRAS,1
TCGA-FB-A545,KRAS,1
TCGA-FB-A545,TP53,1
TCGA-FB-AAPY,TP53,1
TCGA-FB-AAPZ,TP53,1
TCGA-FB-AAPZ,KRAS,1
TCGA-FB-AAQ1,KRAS,1
TCGA-FB-AAQ2,KRAS,1
TCGA-FB-AAQ6,TP53,1
TCGA-HV-A5A3,KRAS,1
TCGA-HV-A5A3,TP53,1
TCGA-HV-A5A4,KRAS,1
TCGA-HV-AA8V,TP53,1
TCGA-HZ-7926,KRAS,1
TCGA-HZ-8001,TP53,1
TCGA-HZ-8005,KRAS,1
TCGA-HZ-8315,KRAS,1
TCGA-HZ-8637,KRAS,1
TCGA-HZ-A49I,TP53,1
TCGA-HZ-A49I,KRAS,1
TCGA-HZ-A4BH,TP53,1
TCGA-HZ-A4BK,KRAS,1
TCGA-HZ-A77Q,KRAS,1
TCGA-HZ-A9TJ,KRAS,2
TCGA-HZ-A9TJ,TP53,2
TCGA-IB-7644,TP53,1
TCGA-IB-7651,KRAS,1
TCGA-IB-7652,KRAS,1
TCGA-IB-7886,TP53,1
TCGA-IB-7889,TP53,1
TCGA-IB-7889,KRAS,1
TCGA-IB-7890,TP53,1
TCGA-IB-7890,KRAS,1
TCGA-IB-7891,TP53,1
TCGA-IB-7893,TP53,1
TCGA-IB-8127,TP53,1
TCGA-IB-A5SO,KRAS,1
TCGA-IB-A5SP,KRAS,1
TCGA-IB-A5SP,TP53,1
TCGA-IB-A6UG,KRAS,1
TCGA-IB-A7M4,TP53,1
TCGA-IB-A7M4,KRAS,1
TCGA-IB-AAUN,TP53,1
TCGA-IB-AAUQ,TP53,1
TCGA-IB-AAUQ,KRAS,1
TCGA-LB-A9Q5,TP53,1
TCGA-S4-A8RO,KRAS,1

2025-01-23 08:52:11 - root - INFO - itercount: 0
2025-01-23 08:52:11 - root - INFO - Database Name: isb-cgc-bq
Schema Name: pancancer_atlas
DDL describes table information.
,0
table_name,Original_TCGA_RPPA_pancan_clean
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Original_TCGA_RPPA_pancan_clean`
(
  AliquotBarcode STRING ,
  Study STRING ,
  Protein STRING , eg P53, JNK_pT183Y185""),
  Value FLOAT64 .Examples: 0.204238725,-0.01826295"")
)
OPTIONS(
  friendly_name=""PanCancer RPPA Final"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains normalized and batch corrected data of protein concentration, generated using the reverse phase protein array (RPPA) platform.  \n\nMore details:  https://gdc.cancer.gov/about-data/publications/PanCan-CellOfOrigin, file:TCGA-RPPA-pancan-clean.txt. \n\nFor data annotated with pertinent TCGA Barcodes and filtered by the barcode white list, table Filtered_TCGA_RPPA_pancan_clean is recommended."",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""protein_expression""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,1
table_name,Filtered_MC3_MAF_V5_one_per_tumor_sample
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
(
  ParticipantBarcode STRING ,
  Tumor_SampleBarcode STRING ,
  Tumor_AliquotBarcode STRING ,
  Normal_SampleBarcode STRING ,
  Normal_AliquotBarcode STRING ,
  Normal_SampleTypeLetterCode STRING ,
  Study STRING ,
  Hugo_Symbol STRING . \""Unknown\"" is used for regions that do not correspond to a gene""),
  HGVSp_Short STRING ,
  Variant_Classification STRING ,
  HGVSc STRING ,
  CENTERS STRING ,
  FILTER STRING , or \""PASS\"" indicating the variant has passed all filters."")
)
OPTIONS(
  friendly_name=""PanCancer Filtered Merged MAF"",
  description=""Extracted from the PanCancer Atlas initiative on the GDC in Sept 2016 (file name pancan.merged.v0.2.5.filtered.maf.gz). Contains Somatic mutation calls.    \n\nNote: Data was filtered such that the only rows with the Variant_Classification in {Frame_Shift_Del, Frame_Shift_Ins, In_Frame_Del, In_Frame_Ins, Missense_Mutation, Nonsense_Mutation, Nonstop_Mutation, Splice_Site, Translation_Start_Site} were retained (Consistent with e.g. ISB, MSKCC, Broad definition of mutated gene). Moreover, Additional annotations were added (e.g. ParticipantBarcode). FPPP project aliquots were removed, and Rows with a solid tissue normal reference were removed if a corresponding blood derived normal reference was available.   \n\nMore details https://gdc.cancer.gov/about-data/publications/PanCan-MYC-2018"",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""somatic_mutation""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,2
table_name,Filtered_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  SampleTypeLetterCode STRING ,
  SampleType STRING ,
  Study STRING ,
  Symbol STRING ,
  Entrez STRING ,
  normalized_count FLOAT64 
)
OPTIONS(
  friendly_name=""PanCancer Filtered RNA Final"",
  description=""Data extracted from the PanCancer Atlas initiative on the GDC in April 2018. Contains batch normalized RNASeqV2 mRNA data annotated with pertinent TCGA Barcodes.  \n\nNote: the data was extracted from the BigQuery Table isb-cgc:pancancer_atlas.EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp. The table was annotated with pertinent TCGA Barcodes, and participants were subsequently filtered using the PanCancer Atlas whitelist (table Whitelist_ParticipantBarcodes ).  \n\nMore details: BigQuery table: isb-cgc-bq:pancancer_atlas.Original_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp and https://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""access"", ""open""), (""category"", ""processed_-omics_data""), (""data_type"", ""gene_expression""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_0"", ""gdc""), (""source_1"", ""literature""), (""status"", ""current"")]
);"

,3
table_name,Filtered_TCGA_RPPA_pancan_clean
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_TCGA_RPPA_pancan_clean`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  SampleTypeLetterCode STRING ,
  SampleType STRING ,
  Study STRING ,
  Protein STRING , eg P53, JNK_pT183Y185""),
  Value FLOAT64 .Examples: 0.204238725,-0.01826295"")
)
OPTIONS(
  friendly_name=""PanCancer Filtered RPPA Final"",
  description=""Data extracted from the PanCancer Atlas initiative on the GDC in April 2018. Contains normalized and batch corrected data of protein concentration.  \nNote: the data was extracted from the BigQuery Table isb-cgc-bq:pancancer_atlas.Original_TCGA_RPPA_pancan_clean. The data is annotated with pertinent TCGA Barcodes, and participants were subsequently filtered using the PanCancer Atlas whitelist (table Whitelist_ParticipantBarcodes) \n\nMore details:  BigQuery table: isb-cgc-bq:pancancer_atlas.Original_TCGA_RPPA_pancan_clean \nand https://gdc.cancer.gov/about-data/publications/PanCan-CellOfOrigin"",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""protein_expression""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,4
table_name,Filtered_clinical_PANCAN_patient_with_followup
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup`
(
  bcr_patient_uuid STRING ,
  bcr_patient_barcode STRING ,
  acronym STRING ,
  gender STRING ,
  vital_status STRING ,
  days_to_birth FLOAT64 ""),
  days_to_death STRING  relative to the date of diagnosis.""),
  days_to_last_followup STRING .""),
  days_to_initial_pathologic_diagnosis INT64 ,
  age_at_initial_pathologic_diagnosis INT64 ,
  icd_10 STRING . Examples: C01, C55, C40.3""),
  tissue_retrospective_collection_indicator STRING ,
  icd_o_3_histology STRING  and the histology (morphology) of neoplasms""),
  tissue_prospective_collection_indicator STRING ,
  history_of_neoadjuvant_treatment STRING ""),
  icd_o_3_site STRING  and the histology (morphology) of neoplasms. Examples:C01.9, C20.9, C32.1""),
  tumor_tissue_site STRING ,
  new_tumor_event_after_initial_treatment STRING ,
  radiation_therapy STRING ,
  race STRING ,
  project_code STRING ,
  prior_dx STRING ,
  disease_code STRING ,
  ethnicity STRING ,
  informed_consent_verified STRING ,
  person_neoplasm_cancer_status STRING ,
  patient_id STRING ,
  year_of_initial_pathologic_diagnosis INT64 ,
  histological_type STRING ,
  tissue_source_site STRING ,
  form_completion_date STRING ,
  pathologic_T STRING ,
  pathologic_M STRING ,
  clinical_M STRING ,
  pathologic_N STRING ,
  system_version STRING ,
  pathologic_stage STRING ,
  stage_other STRING ,
  clinical_stage STRING ,
  clinical_T STRING ,
  clinical_N STRING ,
  extranodal_involvement STRING ,
  postoperative_rx_tx STRING ,
  primary_therapy_outcome_success STRING ,
  lymph_node_examined_count STRING ,
  primary_lymph_node_presentation_assessment STRING ,
  initial_pathologic_diagnosis_method STRING ,
  number_of_lymphnodes_positive_by_he STRING ,
  eastern_cancer_oncology_group STRING ,
  anatomic_neoplasm_subdivision STRING ,
  residual_tumor STRING ,
  histological_type_other STRING ,
  init_pathology_dx_method_other STRING ,
  karnofsky_performance_score STRING ,
  neoplasm_histologic_grade STRING ,
  height STRING ,
  weight STRING ,
  history_of_radiation_metastatic_site STRING ,
  days_to_patient_progression_free STRING ,
  days_to_first_response STRING ,
  days_to_first_partial_response STRING ,
  days_to_first_complete_response STRING ,
  days_to_tumor_progression STRING ,
  er_estimated_duration_response STRING ,
  er_disease_extent_prior_er_treatment STRING ,
  er_solid_tumor_response_documented_type STRING ,
  er_solid_tumor_response_documented_type_other STRING ,
  er_response_type STRING ,
  history_of_radiation_primary_site STRING ,
  history_prior_surgery_type STRING ,
  patient_progression_status STRING ,
  history_prior_surgery_type_other STRING ,
  history_prior_surgery_indicator STRING ,
  field STRING ,
  molecular_abnormality_results_other STRING ,
  molecular_abnormality_results STRING ,
  number_of_lymphnodes_positive_by_ihc STRING ,
  tobacco_smoking_history STRING ,
  number_pack_years_smoked STRING ,
  stopped_smoking_year STRING ,
  performance_status_scale_timing STRING ,
  laterality STRING ,
  targeted_molecular_therapy STRING ,
  year_of_tobacco_smoking_onset STRING ,
  anatomic_neoplasm_subdivision_other STRING ,
  patient_death_reason STRING ,
  tumor_tissue_site_other STRING ,
  menopause_status STRING .""),
  age_began_smoking_in_years STRING ,
  margin_status STRING ,
  kras_gene_analysis_performed STRING ,
  kras_mutation_found STRING ,
  death_cause_text STRING ,
  lactate_dehydrogenase_result STRING , to help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time. NCI CDE: 3113468""),
  days_to_sample_procurement STRING ,
  hbv_test STRING  test""),
  on_haart_therapy_at_cancer_diagnosis STRING  at the time of cancer diagnosis NCI CDE: 2922679""),
  hcv_test STRING ,
  prior_aids_conditions STRING ,
  on_haart_therapy_prior_to_cancer_diagnosis STRING  before or prior to the time of cancer diagnosis. NCI CDE: 3335156""),
  kshv_hhv8_test STRING  test was completed for an individual. NCI CDE: 3335774""),
  days_to_hiv_diagnosis STRING ,
  hiv_status STRING ,
  hiv_rna_load_at_diagnosis STRING  assay performed on an individual at the time of diagnosis. NCI CDE: 2922674""),
  cdc_hiv_risk_group STRING . NCI CDE: 2542215""),
  history_of_other_malignancy STRING ,
  history_immunosuppresive_dx STRING ,
  nadir_cd4_counts STRING ,
  history_relevant_infectious_dx_other STRING ,
  history_relevant_infectious_dx STRING ,
  cd4_counts_at_diagnosis STRING ,
  history_immunological_disease_other STRING ,
  hpv_test STRING ,
  history_immunosuppressive_dx_other STRING ,
  history_immunological_disease STRING ,
  lost_follow_up STRING ,
  venous_invasion STRING ,
  lymphatic_invasion STRING ,
  perineural_invasion_present STRING ,
  her2_erbb_method_calculation_method_text STRING ,
  her2_immunohistochemistry_level_result STRING ,
  breast_carcinoma_immunohistochemistry_pos_cell_score STRING ,
  distant_metastasis_present_ind2 STRING ,
  her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text STRING  positivity in a specimen or sample. NCI CDE: 3087929""),
  breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale STRING ,
  breast_carcinoma_primary_surgical_procedure_name STRING ,
  er_level_cell_percentage_category STRING ,
  breast_carcinoma_progesterone_receptor_status STRING ,
  breast_carcinoma_surgical_procedure_name STRING ,
  breast_neoplasm_other_surgical_procedure_descriptive_text STRING ,
  er_detection_method_text STRING ,
  pos_finding_progesterone_receptor_other_measurement_scale_text STRING  positivity. NCI CDE: 3086857""),
  her2_erbb_pos_finding_cell_percent_category STRING ,
  her2_and_centromere_17_positive_finding_other_measurement_scale_text STRING ,
  pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text STRING  positivity. NCI CDE: 3131877""),
  metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category STRING  positive results expressed as a percentage value. NCI CDE: 3131891""),
  metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text STRING  positivity. NCI CDE: 3131992""),
  fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range STRING ,
  first_recurrent_non_nodal_metastatic_anatomic_site_descriptive_text STRING ,
  first_nonlymph_node_metastasis_anatomic_site STRING ,
  immunohistochemistry_positive_cell_score STRING ,
  axillary_lymph_node_stage_method_type STRING  of axillary lymph nodes from the area of the armpit. NCI CDE: 2516112""),
  axillary_lymph_node_stage_other_method_descriptive_text STRING  from the area of the armpit/axilla that is different from the options previously identified. NCI CDE: 3124496""),
  metastatic_breast_carcinoma_progesterone_receptor_status STRING  testing. NCI CDE: 3131884""),
  metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score STRING ,
  metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score STRING ,
  metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status STRING ,
  metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value STRING ,
  surgical_procedure_purpose_other_text STRING ,
  metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text STRING  positivity in a specimen or sample of metastatic breast carcinoma. NCI CDE: 3132910""),
  metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category STRING ,
  breast_cancer_surgery_margin_status STRING ,
  metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text STRING ,
  breast_carcinoma_estrogen_receptor_status STRING  testing. NCI CDE: 2957359""),
  her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count STRING ,
  pgr_detection_method_text STRING . NCI CDE: 785""),
  pos_finding_her2_erbb2_other_measurement_scale_text STRING ,
  breast_carcinoma_immunohistochemistry_er_pos_finding_scale STRING ,
  positive_finding_estrogen_receptor_other_measurement_scale_text STRING  positivity. NCI CDE: 3086851""),
  metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result STRING ,
  metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text STRING ,
  her2_neu_chromosone_17_signal_ratio_value STRING ,
  cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator STRING ,
  metastatic_breast_carcinoma_estrogen_receptor_detection_method_text STRING ,
  metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type STRING  assay. NCI CDE: 3132455""),
  metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text STRING ,
  lab_proc_her2_neu_immunohistochemistry_receptor_status STRING ,
  progesterone_receptor_level_cell_percent_category STRING ,
  metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category STRING  positive results expressed as a percentage value. NCI CDE: 3131869""),
  metastatic_breast_carcinoma_estrogen_receptor_status STRING  testing. NCI CDE: 3131865""),
  lab_procedure_her2_neu_in_situ_hybrid_outcome_type STRING  assay. NCI CDE: 2854089""),
  her2_neu_breast_carcinoma_copy_analysis_input_total_number STRING , expressed as a range of values. NCI CDE: 3133738""),
  metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range STRING ,
  her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count STRING ,
  her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number STRING , expressed as a range of values NCI CDE: 3133734""),
  metastatic_breast_carcinoma_progesterone_receptor_detection_method_text STRING  in a sample of metastatic breast carcinoma, e.g., dextran coated charcoal. NCI CDE: 3131993""),
  additional_pharmaceutical_therapy STRING ,
  additional_radiation_therapy STRING ,
  lymphovascular_invasion_present STRING ,
  pos_lymph_node_location_other STRING ,
  pos_lymph_node_location STRING ,
  location_in_lung_parenchyma STRING ,
  pulmonary_function_test_performed STRING ,
  pre_bronchodilator_fev1_fvc_percent STRING  divided by the Forced Vital Capacity (FVC) pre-bronchodilator. NCI CDE: 3302955""),
  kras_mutation_result STRING ,
  post_bronchodilator_fev1_percent STRING  divided by the Forced Vital Capacity (FVC) post-bronchodilator. NCI CDE: 3302956""),
  pre_bronchodilator_fev1_percent STRING  divided by the Forced Vital Capacity (FVC) pre-bronchodilator. NCI CDE: 3302955""),
  dlco_predictive_percent STRING ,
  egfr_mutation_performed STRING ,
  diagnosis STRING ,
  eml4_alk_translocation_result STRING ,
  egfr_mutation_result STRING ,
  post_bronchodilator_fev1_fvc_percent STRING  divided by the Forced Vital Capacity (FVC) post-bronchodilator. NCI CDE: 3302956""),
  eml4_alk_translocation_performed STRING ,
  eml4_alk_translocation_method STRING ,
  days_to_new_tumor_event_after_initial_treatment STRING ,
  hemoglobin_result STRING ,
  serum_calcium_result STRING ,
  platelet_qualitative_result STRING . NCI CDE: 3104944""),
  number_of_lymphnodes_positive STRING ,
  erythrocyte_sedimentation_rate_result STRING . NCI CDE: 3104952""),
  white_cell_count_result STRING ,
  malignant_neoplasm_metastatic_involvement_site STRING ,
  other_metastatic_involvement_anatomic_site STRING ,
  birth_control_pill_history_usage_category STRING ,
  alcohol_history_documented STRING ,
  frequency_of_alcohol_consumption STRING ,
  source_of_patient_death_reason STRING ,
  days_to_diagnostic_mri_performed STRING ,
  days_to_diagnostic_computed_tomography_performed STRING  scan to the date of initial pathologic diagnosis, represented as a calculated number of days.""),
  amount_of_alcohol_consumption_per_day STRING ,
  family_history_of_cancer STRING . NCI CDE: 2436860""),
  loss_expression_of_mismatch_repair_proteins_by_ihc_result STRING ,
  preoperative_pretreatment_cea_level STRING ,
  microsatellite_instability STRING ,
  number_of_loci_tested STRING ,
  history_of_colon_polyps STRING ,
  number_of_first_degree_relatives_with_cancer_diagnosis STRING  diagnosed with cancer.""),
  number_of_abnormal_loci STRING ,
  circumferential_resection_margin STRING ,
  non_nodal_tumor_deposits STRING ,
  braf_gene_analysis_result STRING ,
  colon_polyps_present STRING ,
  kras_mutation_codon STRING ,
  braf_gene_analysis_performed STRING ,
  synchronous_colon_cancer_present STRING ,
  loss_expression_of_mismatch_repair_proteins_by_ihc STRING ,
  barretts_esophagus STRING ,
  city_of_procurement STRING ,
  reflux_history STRING ,
  country_of_procurement STRING ,
  antireflux_treatment_type STRING ,
  h_pylori_infection STRING ,
  hypertension STRING ,
  horm_ther STRING ,
  pln_pos_ihc STRING ,
  surgical_approach STRING ,
  pregnancies STRING ,
  diabetes STRING ,
  peritoneal_wash STRING ,
  pct_tumor_invasion STRING ,
  prior_tamoxifen_administered_usage_category STRING . Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. (NCI04)_A manner, or usual, or accepted practice of using something._Category; used informally to mean a class of things. NCI CDE: 3104234""),
  colorectal_cancer STRING ,
  total_aor_lnp STRING ,
  pln_pos_light_micro STRING ,
  total_pelv_lnp STRING ,
  total_pelv_lnr STRING ,
  aln_pos_light_micro STRING ,
  aln_pos_ihc STRING .""),
  total_aor_lnr STRING ,
  post_surgical_procedure_assessment_thyroid_gland_carcinoma_status STRING ,
  metastatic_neoplasm_confirmed_diagnosis_method_text STRING  site of growth to another site that is not already specified or mentioned. NCI CDE: 3178376""),
  metastatic_neoplasm_confirmed_diagnosis_method_name STRING  site of growth to another site. NCI CDE: 3178364""),
  prior_glioma STRING ""),
  tumor_residual_disease STRING  status, 1-10 mm, >20 mm,11-20 mm""),
  jewish_origin STRING ,
  distant_metastasis_anatomic_site STRING ,
  new_neoplasm_event_type STRING ,
  lymphnode_dissection_method_left STRING ,
  lymphnode_neck_dissection STRING ,
  egfr_amplication_status STRING ,
  hpv_status_by_ish_testing STRING ,
  presence_of_pathological_nodal_extracapsular_spread STRING ,
  p53_gene_analysis STRING ,
  hpv_status_by_p16_testing STRING ,
  lymphnode_dissection_method_right STRING ,
  eml4_alk_translocation_identified STRING ,
  egfr_mutation_identified STRING ,
  supratentorial_localization STRING ,
  mold_or_dust_allergy_history STRING ,
  motor_movement_changes STRING ,
  inherited_genetic_syndrome_found STRING ,
  seizure_history STRING ,
  asthma_history STRING ,
  first_diagnosis_age_asth_ecz_hay_fev_mold_dust STRING ,
  first_diagnosis_age_of_food_allergy STRING ,
  ldh1_mutation_found STRING ,
  tumor_location STRING ,
  ldh1_mutation_test_method STRING ,
  animal_insect_allergy_types STRING  of the specified type of allergy to animals or insects.""),
  first_presenting_symptom STRING ,
  animal_insect_allergy_history STRING ,
  first_presenting_symptom_longest_duration STRING ,
  ldh1_mutation_tested STRING ,
  visual_changes STRING ,
  first_diagnosis_age_of_animal_insect_allergy STRING ,
  history_ionizing_rt_to_head STRING ,
  sensory_changes STRING ,
  food_allergy_history STRING ,
  mental_status_changes STRING ,
  hay_fever_history STRING . NCI CDE: 3133930""),
  preoperative_corticosteroids STRING ,
  preoperative_antiseizure_meds STRING ,
  family_history_of_primary_brain_tumor STRING ,
  inherited_genetic_syndrome_result STRING ,
  days_to_initial_score_performance_status_scale STRING ,
  food_allergy_types STRING ,
  headache_history STRING ,
  eczema_history STRING ,
  other_genotyping_outcome_lab_results_text STRING ,
  extrathyroid_carcinoma_present_extension_status STRING ,
  i_131_first_administered_dose STRING ,
  i_131_subsequent_administered_dose STRING ,
  i_131_total_administered_dose STRING ,
  primary_neoplasm_focus_type STRING ,
  i_131_total_administered_preparation_technique STRING ,
  person_lifetime_risk_radiation_exposure_indicator STRING ,
  ret_ptc_rearrangement_genotyping_outcome_lab_results_text STRING ,
  genotyping_results_gene_mutation_not_reported_reason STRING ,
  neoplasm_depth STRING , to the bottom of the tumor, with metastatic rates correlating closely with tumor thickness. NCI CDE: 2593061""),
  genotype_analysis_performed_indicator STRING ,
  ras_family_gene_genotyping_outcome_lab_results_text STRING ,
  neoplasm_length STRING ,
  neoplasm_width STRING ,
  radiosensitizing_agent_administered_indicator STRING ,
  braf_gene_genotyping_outcome_lab_results_text STRING ,
  lymph_node_preoperative_scan_indicator STRING ,
  radiation_therapy_administered_preparation_technique_text STRING ,
  lymph_node_preoperative_assessment_diagnostic_imaging_type STRING ,
  patient_personal_medical_history_thyroid_gland_disorder_name STRING ,
  first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_type STRING ,
  radiation_therapy_administered_dose_text STRING ,
  patient_personal_medical_history_thyroid_other_specify_text STRING ,
  primary_thyroid_gland_neoplasm_location_anatomic_site STRING ,
  lymphnodes_examined STRING ,
  zone_of_origin STRING ,
  days_to_bone_scan_performed STRING ,
  diagnostic_mri_performed STRING ,
  diagnostic_mri_result STRING ,
  psa_value STRING  present in a sample. NCI CDE: 7063440""),
  days_to_first_biochemical_recurrence STRING ,
  secondary_pattern STRING ,
  primary_pattern STRING ,
  diagnostic_ct_abd_pelvis_result STRING ,
  bone_scan_results STRING ,
  biochemical_recurrence STRING ,
  tumor_level STRING  within the prostate zonal anatomy used to identify the location of the tumor. NCI CDE: 7063204""),
  gleason_score STRING ,
  number_of_lymphnodes_examined STRING ,
  days_to_psa STRING ,
  tertiary_pattern STRING ,
  diagnostic_ct_abd_pelvis_performed STRING ,
  family_medical_history_relative_family_member_relationship_type STRING ,
  tumor_type STRING ,
  primary_tumor_multiple_present_ind STRING ,
  prior_systemic_therapy_type STRING ,
  melanoma_clark_level_value STRING ,
  melanoma_origin_skin_anatomic_site STRING ,
  malignant_neoplasm_mitotic_count_rate STRING ,
  breslow_depth_value STRING , to the bottom of the tumor; metastatic rates correlate closely with tumor thickness. (from On-line Medical Dictionary) NCI CDE: 2593055""),
  tumor_tissue_site_1 STRING ,
  melanoma_ulceration_indicator STRING ,
  primary_neoplasm_melanoma_dx STRING ,
  new_tumor_dx_prior_submitted_specimen_dx STRING ,
  primary_anatomic_site_count STRING , Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Named locations of or within the body._Count of the number of tumors classified as primaries, not sites of metastatic disease. NCI CDE: 2967294""),
  interferon_90_day_prior_excision_admin_indicator STRING ,
  primary_melanoma_at_diagnosis_count STRING ,
  days_to_submitted_specimen_dx STRING ,
  antireflux_treatment STRING ,
  number_of_relatives_with_stomach_cancer STRING  who have been diagnosed with stomach cancer.""),
  family_history_of_stomach_cancer STRING ,
  state_province_country_of_procurement STRING ,
  specimen_collection_method_name STRING ,
  child_pugh_classification_grade STRING ,
  hist_of_non_mibc STRING ,
  occupation_primary_job STRING ,
  person_concomitant_prostate_carcinoma_occurrence_indicator STRING ,
  person_concomitant_prostate_carcinoma_pathologic_t_stage STRING ,
  cancer_diagnosis_cancer_type_icd9_text_name STRING ,
  non_mibc_tx STRING ,
  bladder_carcinoma_extracapsular_extension_status STRING ,
  chemical_exposure_text STRING ,
  resp_maint_from_bcg_admin_month_dur STRING ,
  maint_therapy_course_complete STRING ,
  induction_course_complete STRING ,
  person_occupation_years_number STRING ,
  person_primary_industry_text STRING ,
  disease_extracapsular_extension_ind_3 STRING ,
  complete_response_observed STRING ,
  diagnosis_subtype STRING ,
  diagnosis_age STRING ,
  mibc_90day_post_resection_bcg STRING ,
  person_occupation_description_text STRING ,
  surgical_procedure_name_other_specify_text STRING ,
  relative_family_cancer_history_ind_3 STRING ,
  vascular_tumor_cell_invasion_type STRING ,
  viral_hepatitis_serology STRING ,
  liver_fibrosis_ishak_score_category STRING ,
  ablation_embolization_tx_adjuvant STRING ,
  laboratory_procedure_prothrombin_time_result_value STRING ,
  laboratory_procedure_creatinine_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_alpha_fetoprotein_outcome_value STRING ,
  laboratory_procedure_alpha_fetoprotein_outcome_upper_limit_of_normal_value STRING . NCI CDE: 2932064""),
  laboratory_procedure_alpha_fetoprotein_outcome_lower_limit_of_normal_value STRING . NCI CDE: 3171861""),
  laboratory_procedure_albumin_result_upper_limit_of_normal_value STRING ,
  laboratory_procedure_albumin_result_specified_value STRING ,
  laboratory_procedure_creatinine_result_upper_limit_of_normal_value STRING ,
  laboratory_prcoedure_platelet_result_upper_limit_of_normal_value STRING ,
  lab_procedure_platelet_result_specified_value STRING . NCI CDE: 58304""),
  days_to_definitive_surgical_procedure_performed STRING ,
  hematology_serum_creatinine_laboratory_result_value_in_mg_dl STRING . Creatinine is derived from a constituent of muscle tissue, which is used to evaluate kidney glomerular filtration. [Manually-curated] NCI CDE: 2655822""),
  history_hepato_carcinoma_risk_factor STRING  that arises from hepatocytes resulting in hepatocellular carcinoma, or as diffuse liver involvement. NCI CDE: 7118713""),
  history_hepato_carcinoma_risk_factor_other STRING ,
  cancer_diagnosis_first_degree_relative_number STRING  diagnosed with cancer. NCI CDE: 3171640""),
  laboratory_prcoedure_platelet_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_international_normalization_ratio_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_albumin_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_total_bilirubin_result_specified_lower_limit_of_normal_value STRING ,
  laboratory_procedure_total_bilirubin_result_specified_upper_limit_of_normal_value STRING ,
  laboratory_procedure_total_bilirubin_result_upper_limit_normal_value STRING  for the procedure that involves testing or manipulating a sample of blood in a laboratory setting for total bilirubin, a breakdown product of hemoglobin, liver lab. NCI CDE: 2004060""),
  adjacent_hepatic_tissue_inflammation_extent_type STRING ,
  laboratory_procedure_international_normalization_ratio_result_upper_limit_of_normal_value STRING ,
  mitotic_count STRING ,
  oligonucleotide_primer_pair_laboratory_procedure_performed_name STRING ,
  radiation_type_notes STRING ,
  number_of_successful_pregnancies_which_resulted_in_at_least_1_live_birth STRING ,
  external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose STRING ,
  concurrent_chemotherapy_dose STRING _The total quantity or strength of a substance (drug or radiation) administered at one time. (NCI) NCI CDE: 3166172""),
  chemotherapy_regimen_type STRING ,
  chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason STRING ,
  postoperative_rx_tx_1 STRING ,
  dose_frequency_text STRING ,
  rt_pelvis_administered_total_dose STRING ,
  cervical_neoplasm_pathologic_margin_involved_type STRING ,
  cervical_neoplasm_pathologic_margin_involved_text STRING ,
  cervical_carcinoma_pelvic_extension_text STRING ,
  cervical_carcinoma_corpus_uteri_involvement_indicator STRING ,
  ectopic_pregnancy_count STRING ,
  rt_administered_type STRING ,
  oligonucleotide_primer_pair_laboratory_procedure_performed_text STRING ,
  other_chemotherapy_agent_administration_specify STRING ,
  radiation_therapy_not_administered_reason STRING ,
  patient_pregnancy_therapeutic_abortion_count STRING ,
  days_to_laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result STRING  Tumor Marker Result to the date of initial pathologic diagnosis, represented as a calculated number of days. NCI CDE: 5654374""),
  days_to_performance_status_assessment STRING ,
  prescribed_dose_units STRING  associated with a prescribed dose for treatment. NCI CDE: 3065815""),
  diagnostic_ct_result_outcome STRING ,
  patient_pregnancy_spontaneous_abortion_count STRING ,
  patient_pregnancy_count STRING ,
  fdg_or_ct_pet_performed_outcome STRING ,
  female_breast_feeding_or_pregnancy_status_indicator STRING ,
  standardized_uptake_value_cervix_uteri_assessment_measurement STRING ,
  pregnant_at_diagnosis STRING ,
  pregnancy_stillbirth_count STRING ,
  patient_history_immune_system_and_related_disorders_text STRING ,
  patient_history_immune_system_and_related_disorders_name STRING ,
  days_to_fdg_or_ct_pet_performed STRING ,
  diagnostic_mri_result_outcome STRING ,
  radiation_therapy_1 STRING ,
  radiation_therapy_not_administered_specify STRING ,
  human_papillomavirus_laboratory_procedure_performed_name STRING ,
  chemotherapy_negation_radiation_therapy_concurrent_administered_text STRING ,
  lymph_node_location_positive_pathology_name STRING ,
  keratinizing_squamous_cell_carcinoma_present_indicator STRING ,
  laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result_value STRING ,
  total_number_of_pregnancies STRING ,
  hysterectomy_Performed_Ind_3 STRING ,
  hysterectomy_performed_text STRING ,
  human_papillomavirus_other_type_text STRING  previously specified or mentioned._Something distinguishable as an identifiable class based on common qualities._Text; the words of something written. NCI CDE: 3166168""),
  hysterectomy_performed_type STRING ,
  lymphovascular_invasion_indicator STRING ,
  brachytherapy_first_reference_point_administered_total_dose STRING ,
  brachytherapy_method_other_specify_text STRING ,
  lymph_node_location_positive_pathology_text STRING ,
  tumor_response_cdus_type STRING ,
  brachytherapy_method_type STRING ,
  agent_total_dose_count STRING ,
  live_birth_number STRING ,
  human_papillomavirus_laboratory_procedure_performed_text STRING ,
  human_papillomavirus_type STRING ,
  performance_status_assessment_timepoint_category_other_text STRING ,
  ct_scan STRING  scan. NCI CDE: 2004007""),
  new_neoplasm_event_occurrence_anatomic_site STRING ,
  radiologic_tumor_width STRING ,
  contiguous_organ_resection_site STRING ,
  radiologic_tumor_depth STRING ,
  radiologic_tumor_burden STRING ,
  tumor_depth STRING ,
  pathologic_tumor_width STRING ,
  tumor_multifocal STRING ,
  other_contiguous_organ_resection_site STRING ,
  contiguous_organ_invaded STRING ,
  pathologic_tumor_length STRING ,
  pathologic_tumor_depth STRING ,
  pathologic_tumor_burden STRING ,
  radiologic_tumor_length STRING ,
  tumor_total_necrosis_percent STRING ,
  primary_tumor_lower_uterus_segment STRING  with an elongated lower part (neck), at the extremity of which is the opening (os). The upper rounded portion of the uterus, opposite the os, is the fundus, at each extremity of which is the horn marking the part where the uterine tube joins the uterus and through which the ovum reaches the uterine cavity after leaving the ovary. The organ is supported in the pelvic cavity by the broad ligaments, round ligaments, cardinal ligaments, and rectouterine and vesicouterine folds or ligaments. SYN metra, womb._One of the parts into which something naturally divides._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied. NCI CDE: 2775554""),
  days_to_well_differentiated_liposarcoma_resection STRING ,
  metastatic_site_at_diagnosis_other STRING  within the body; may be referenced in primary site of disease, surgical intervention, or extent of disease documentation. NCI CDE: 2967298""),
  metastatic_site_at_diagnosis STRING  site to another location in the body._Name of the organ site (single) within the body; may be referenced in primary site of disease, surgical intervention, or extent of disease documentation. NCI CDE: 2967298""),
  ss18_ssx_testing_method STRING ,
  ss18_ssx_fusion_status STRING ,
  specific_tumor_total_necrosis_percent STRING ,
  leiomyosarcoma_histologic_subtype STRING ,
  metastatic_neoplasm_confirmed STRING  site to another location in the body has been established or verified. NCI CDE: 65384""),
  local_disease_recurrence STRING ,
  days_to_well_differentiated_liposarcoma_primary_dx STRING ,
  mpnst_neurofibromatosis STRING ,
  mpnst_exisiting_plexiform_neurofibroma STRING ,
  mpnst_nf1_genetic_testing STRING ,
  mpnst_specific_mutations STRING ,
  well_differentiated_liposarcoma_primary_dx STRING ,
  leiomyosarcoma_major_vessel_involvement STRING ,
  discontiguous_lesion_count STRING  An area of abnormal tissue change._Quantity; how much there is of something that you can measure._the quantity of specified lesions. NCI CDE: 3162604""),
  mpnst_neurofibromatosis_heredity STRING ,
  maximum_tumor_dimension STRING ,
  alcoholic_exposure_category STRING ,
  planned_surgery_status STRING ,
  esophageal_tumor_involvement_site STRING ,
  esophageal_tumor_cental_location STRING ,
  lymph_node_metastasis_radiographic_evidence STRING ,
  days_to_pancreatitis_onset STRING ,
  days_to_diabetes_onset STRING ,
  adenocarcinoma_invasion STRING ,
  surgery_performed_type STRING ,
  columnar_metaplasia_present STRING ,
  relative_cancer_type STRING ,
  amt_alcohol_consumption_per_day STRING ,
  columnar_mucosa_goblet_cell_present STRING ,
  history_of_chronic_pancreatitis STRING ,
  history_of_diabetes STRING ,
  goblet_cells_present STRING ,
  history_of_esophageal_cancer STRING ,
  histologic_grading_tier_category STRING ,
  columnar_mucosa_dysplasia STRING ,
  number_of_relatives_diagnosed STRING ,
  state_province_of_procurement STRING ,
  treatment_prior_to_surgery STRING ,
  initial_diagnosis_by STRING ,
  surgery_performed_type_other STRING ,
  country_of_birth STRING ,
  disease_detected_on_screening STRING ,
  history_pheo_or_para_include_benign STRING ,
  outside_adrenal STRING ,
  history_pheo_or_para_anatomic_site STRING ,
  family_member_relationship_type STRING ,
  post_op_ablation_embolization_tx STRING ,
  days_to_pre_orchi_serum_test STRING ,
  post_orchi_hcg STRING ,
  bilateral_diagnosis_timing_type STRING ,
  post_orchi_ldh STRING ,
  testis_tumor_microextent STRING ,
  undescended_testis_corrected STRING ,
  post_orchi_lh STRING ,
  post_orchi_lymph_node_dissection STRING ,
  post_orchi_testosterone STRING ,
  serum_markers STRING ""),
  undescended_testis_corrected_age STRING ,
  undescended_testis_method_left STRING ,
  relation_testicular_cancer STRING ,
  postoperative_tx STRING ,
  testis_tumor_macroextent STRING ,
  synchronous_tumor_histology_pct STRING ,
  pre_orchi_afp STRING ,
  pre_orchi_hcg STRING ,
  pre_orchi_ldh STRING ,
  pre_orchi_lh STRING ,
  pre_orchi_testosterone STRING ,
  synchronous_tumor_histology_type STRING ,
  relative_family_cancer_hx_text STRING ,
  days_to_post_orchi_serum_test STRING ,
  undescended_testis_method_right STRING ,
  testis_tumor_macroextent_other STRING ,
  days_to_bilateral_tumor_dx STRING ,
  level_of_non_descent STRING ,
  post_orchi_afp STRING ,
  intratubular_germ_cell_neoplasm STRING ,
  igcccg_stage STRING ,
  history_of_undescended_testis STRING ,
  molecular_test_result STRING ,
  history_hypospadias STRING ,
  history_fertility STRING ,
  histological_percentage STRING ,
  first_treatment_success STRING ,
  family_history_testicular_cancer STRING ,
  family_history_other_cancer STRING ,
  masaoka_stage STRING ,
  history_myasthenia_gravis STRING ,
  section_myasthenia_gravis STRING ,
  new_neoplasm_occurrence_anatomic_site_text STRING ,
  percent_tumor_sarcomatoid STRING ,
  presence_of_sarcomatoid_features STRING ,
  tmem127 STRING ,
  therapeutic_mitotane_lvl_recurrence STRING ,
  therapeutic_mitotane_lvl_macroscopic_residual STRING ,
  therapeutic_mitotane_levels_achieved STRING ,
  metastatic_neoplasm_initial_diagnosis_anatomic_site STRING ,
  mitoses_count STRING ,
  mitotane_therapy STRING ,
  mitotane_therapy_adjuvant_setting STRING ,
  mitotane_therapy_for_macroscopic_residual_disease STRING ,
  mitotic_rate STRING ,
  sinusoid_invasion STRING ,
  therapeutic_mitotane_lvl_progression STRING ,
  excess_adrenal_hormone_diagnosis_method_type STRING ,
  molecular_analysis_performed_indicator STRING ,
  excess_adrenal_hormone_history_type STRING ,
  necrosis STRING ,
  sdhd STRING ,
  sdhc STRING ,
  nuclear_grade_III_IV STRING ,
  sdhb STRING ,
  sdhaf2_sdh5 STRING ,
  sdha STRING ,
  atypical_mitotic_figures STRING ,
  ct_scan_findings STRING ,
  ret STRING ,
  cytoplasm_presence_less_than_equal_25_percent STRING ,
  weiss_venous_invasion STRING ,
  weiss_score STRING ,
  vhl STRING ,
  invasion_of_tumor_capsule STRING ,
  diffuse_architecture STRING ,
  serum_mesothelin_lower_limit STRING ,
  asbestos_exposure_type STRING ,
  pleurodesis_performed_90_days STRING ,
  mesothelioma_detection_method STRING ,
  history_asbestos_exposure STRING ,
  pleurodesis_performed_prior STRING ,
  family_history_cancer_type STRING ,
  family_history_cancer_type_other STRING ,
  asbestos_exposure_age STRING ,
  serum_mesothelin_prior_tx STRING ,
  asbestos_exposure_years STRING ,
  serum_mesothelin_upper_limit STRING ,
  asbestos_exposure_source STRING ,
  suv_of_pleura_max STRING ,
  primary_occupation STRING ,
  primary_occupation_years_worked STRING ,
  primary_occupation_other STRING ,
  creatinine_norm_range_lower STRING ,
  creatinine_norm_range_upper STRING ,
  asbestos_exposure_age_last STRING ,
  creatinine_prior_tx STRING ,
  tumor_basal_diameter STRING ,
  tumor_basal_diameter_mx STRING ,
  metastatic_site STRING ,
  tumor_thickness STRING ,
  microvascular_density_mvd STRING  of the tissue specimen. NCI CDE: 3874272""),
  tumor_shape_pathologic_clinical STRING ,
  tumor_infiltrating_lymphocytes STRING ,
  tumor_morphology_percentage STRING ,
  tumor_thickness_measurement STRING ,
  tumor_infiltrating_macrophages STRING ,
  pet_ct_standardized_values STRING ,
  eye_color STRING ,
  other_metastatic_site STRING  previously specified or mentioned [Manually-curated] NCI CDE: 2760050""),
  extravascular_matrix_patterns STRING ,
  histological_type_1 STRING ,
  extranocular_nodule_size STRING ,
  extrascleral_extension STRING ,
  gene_expression_profile STRING ,
  cytogenetic_abnormality STRING , loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Indicator of Yes, No, Unknown, Not Done, or Not Applicable to a question.[manually curated] NCI CDE: 2760479""),
  result_of_immunophenotypic_analysis STRING ,
  prior_immunosuppressive_therapy_other STRING ,
  prior_immunosuppressive_therapy_type STRING ,
  prior_infectious_disease STRING ,
  igk_genotype_results_1 STRING ,
  immunophenotypic_analysis_method STRING ,
  igk_genotype_results STRING ,
  bone_marrow_biopsy_done STRING ,
  bone_marrow_involvement STRING ,
  bone_marrow_involvement_1 STRING ,
  prior_infectious_disease_other STRING ,
  ebv_positive_malignant_cells_percent STRING ,
  b_lymphocyte_genotyping_method_1 STRING ,
  prior_immunologic_disease_type STRING ,
  igh_genotype_results_1 STRING ,
  b_lymphocyte_genotyping_method STRING ,
  prior_immunologic_disease_other STRING ,
  maximum_tumor_bulk_anatomic_location STRING  of the maximum tumor bulk. NCI CDE: 3233300""),
  immunophenotypic_analysis_results STRING ,
  maximum_tumor_bulk_anatomic_site STRING  of the maximum tumor bulk. NCI CDE: 3639616""),
  immunophenotypic_analysis_test STRING ,
  extranodal_sites_involvement_number STRING ,
  immunophenotypic_analysis_tested STRING ,
  ebv_status_malignant_cells_method STRING ,
  percent_ebv_positive_malignant_cells STRING ,
  tumor_resected_max_dimension STRING ,
  immunophenotypic_analysis_methodology STRING ,
  igh_genotype_results STRING ,
  ebv_diagnostic_methodology STRING ,
  follicular_component_percent STRING ,
  abnormality_tested_methodology STRING ,
  nodal_anatomic_site STRING ,
  histology_of_bone_marrow_sample STRING ,
  abnormality_tested_methodology_1 STRING ,
  ldh_upper_limit STRING ,
  number_of_involved_extranodal_sites STRING ,
  extranodal_disease_involvement_site STRING ,
  ebv_antibody_status STRING ,
  extranodal_disease_involvement_site_other STRING ,
  genetic_abnormality_tested_other STRING ,
  genetic_abnormality_tested_1 STRING ,
  genetic_abnormality_tested STRING ,
  genetic_abnormality_results_other STRING ,
  genetic_abnormality_results STRING ,
  percentage_of_follicular_component STRING ,
  pet_scan_results STRING ,
  other_genetic_abnormality_tested STRING ,
  epstein_barr_viral_status STRING ,
  lymph_node_involvement_site STRING ,
  mib1_positive_percentage_range STRING ,
  mib1_positive_percentage_range_1 STRING ,
  genetic_abnormality_method_other STRING ,
  extranodal_involvment_site_other STRING ,
  ldh_lab_value STRING ,
  hiv_positive_status STRING ,
  ldh_level STRING  exist. NCI CDE: 6323378""),
  ldh_norm_range_upper STRING . NCI CDE: 2597015""),
  abnormality_tested_results_1 STRING ,
  abnormality_tested_results STRING ,
  genetic_abnormality_method STRING ,
  bone_marrow_sample_histology STRING ,
  albumin_result_upper_limit STRING ,
  vascular_tumor_cell_type STRING ,
  albumin_result_lower_limit STRING ,
  albumin_result_specified_value STRING ,
  platelet_result_upper_limit STRING . NCI CDE: 2596499""),
  intern_norm_ratio_upper_limit STRING ,
  cholangitis_tissue_evidence STRING . NCI CDE: 3916091""),
  relative_family_cancer_history STRING ,
  platelet_result_lower_limit STRING ,
  hist_hepato_carcinoma_risk STRING ,
  hist_hepato_carc_fact STRING ,
  cancer_first_degree_relative STRING  diagnosed with cancer. NCI CDE: 3171640""),
  creatinine_lower_level STRING ,
  prothrombin_time_result_value STRING ,
  ca_19_9_level_upper STRING ,
  ca_19_9_level_lower STRING ,
  ca_19_9_level STRING ,
  creatinine_upper_limit STRING ,
  surgical_procedure_name STRING ,
  creatinine_value_in_mg_dl STRING ""),
  bilirubin_lower_limit STRING  and is measured a colorimetric method. NCI CDE: 3294386""),
  total_bilirubin_upper_limit STRING  for the procedure that involves testing or manipulating a sample of blood in a laboratory setting for total bilirubin, a breakdown product of hemoglobin, liver lab. NCI CDE: 2004060""),
  platelet_result_count STRING ,
  fibrosis_ishak_score STRING ,
  fetoprotein_outcome_value STRING ,
  fetoprotein_outcome_upper_limit STRING . NCI CDE: 2932064""),
  fetoprotein_outcome_lower_limit STRING . NCI CDE: 3171861""),
  inter_norm_ratio_lower_limit STRING ,
  family_cancer_type_txt STRING ,
  bilirubin_upper_limit STRING ,
  days_to_last_known_alive STRING 
)
OPTIONS(
  friendly_name=""PanCancer Filtered Clinical With Patient Follow-up"",
  description=""Data extracted from the PanCancer Atlas initiative on the GDC in Aug 2016. Clinical information about patient cases in the TCGA project. \n\nNote: Participants were filtered using the PanCancer Atlas whitelist (table Whitelist_ParticipantBarcodes)  \n\nMore details: BigQuery table: isb-cgc-bq:pancancer_atlas.Original_clinical_PANCAN_patient_with_followup \nand https://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""category"", ""clinical_biospecimen_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""clinical_data""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,5
table_name,Original_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Original_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16`
(
  ID STRING  contained in this table, eg hsa-mir-21 -- relevant reference information can be found in the isb-cgc:genome_reference dataset in the tables miRBase_v20 and miRBase_v20_hsa_gff3""),
  Corrected STRING ,
  AliquotBarcode STRING ,
  miRNAExp FLOAT64 "")
)
OPTIONS(
  friendly_name=""PanCancer MicroRNA Protocol Platform"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains batch effects normalized miRNA data.  \n\nMore details: https://www.synapse.org/#!Synapse:syn6171109 \nand \nhttps://gdc.cancer.gov/about-data/publications/pancanatlas, file:pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16.csv. \n\nFor data annotated with pertinent TCGA Barcodes and filtered by the barcode white list, table Filtered_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16 is recommended."",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""mirna_expression""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,6
table_name,Filtered_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  SampleTypeLetterCode STRING ,
  SampleType STRING ,
  Study STRING ,
  ID STRING  from the Illumina Human Methylation array -- please refer to the annotation table (isb-cgc-bq.annotations.methylation_annotation_hg19_illumina_current) for more details about any particular probe""),
  Beta FLOAT64 "")
)
OPTIONS(
  friendly_name=""PanCancer Filtered DNA Methylation (450K Only)"",
  description=""Data extracted from the PanCancer Atlas initiative on the GDC in April 2018. Contains DNA Methylation data generated using Illumina Human Methylation 450k.  \n\nNote: The data was annotated with pertinent TGCA barcodes data, and filtered from the BigQuery table isb-cgc-bq:pancancer_atlas.Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted using the PanCancer Atlas whitelist (table Whitelist_ParticipantBarcodes)  \n\nMore details: BigQuery table: isb-cgc-bq:pancancer_atlas.Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted \nand https://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""dna_methylation""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

Some other tables have the similar structure: ['Filtered_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted', 'Filtered_jhu_usc_edu_PANCAN_HumanMethylation27_betaValue_whitelisted']
,7
table_name,Original_clinical_PANCAN_patient_with_followup
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Original_clinical_PANCAN_patient_with_followup`
(
  bcr_patient_uuid STRING ,
  bcr_patient_barcode STRING ,
  acronym STRING ,
  gender STRING ,
  vital_status STRING ,
  days_to_birth FLOAT64 ""),
  days_to_death STRING  relative to the date of diagnosis.""),
  days_to_last_followup STRING .""),
  days_to_initial_pathologic_diagnosis INT64 ,
  age_at_initial_pathologic_diagnosis INT64 ,
  icd_10 STRING . Examples: C01, C55, C40.3""),
  tissue_retrospective_collection_indicator STRING ,
  icd_o_3_histology STRING  and the histology (morphology) of neoplasms""),
  tissue_prospective_collection_indicator STRING ,
  history_of_neoadjuvant_treatment STRING ""),
  icd_o_3_site STRING  and the histology (morphology) of neoplasms. Examples:C01.9, C20.9, C32.1""),
  tumor_tissue_site STRING ,
  new_tumor_event_after_initial_treatment STRING ,
  radiation_therapy STRING ,
  race STRING ,
  project_code STRING ,
  prior_dx STRING ,
  disease_code STRING ,
  ethnicity STRING ,
  informed_consent_verified STRING ,
  person_neoplasm_cancer_status STRING ,
  patient_id STRING ,
  year_of_initial_pathologic_diagnosis INT64 ,
  histological_type STRING ,
  tissue_source_site STRING ,
  form_completion_date STRING ,
  pathologic_T STRING ,
  pathologic_M STRING ,
  clinical_M STRING ,
  pathologic_N STRING ,
  system_version STRING ,
  pathologic_stage STRING ,
  stage_other STRING ,
  clinical_stage STRING ,
  clinical_T STRING ,
  clinical_N STRING ,
  extranodal_involvement STRING ,
  postoperative_rx_tx STRING ,
  primary_therapy_outcome_success STRING ,
  lymph_node_examined_count STRING ,
  primary_lymph_node_presentation_assessment STRING ,
  initial_pathologic_diagnosis_method STRING ,
  number_of_lymphnodes_positive_by_he STRING ,
  eastern_cancer_oncology_group STRING ,
  anatomic_neoplasm_subdivision STRING ,
  residual_tumor STRING ,
  histological_type_other STRING ,
  init_pathology_dx_method_other STRING ,
  karnofsky_performance_score STRING ,
  neoplasm_histologic_grade STRING ,
  height STRING ,
  weight STRING ,
  history_of_radiation_metastatic_site STRING ,
  days_to_patient_progression_free STRING ,
  days_to_first_response STRING ,
  days_to_first_partial_response STRING ,
  days_to_first_complete_response STRING ,
  days_to_tumor_progression STRING ,
  er_estimated_duration_response STRING ,
  er_disease_extent_prior_er_treatment STRING ,
  er_solid_tumor_response_documented_type STRING ,
  er_solid_tumor_response_documented_type_other STRING ,
  er_response_type STRING ,
  history_of_radiation_primary_site STRING ,
  history_prior_surgery_type STRING ,
  patient_progression_status STRING ,
  history_prior_surgery_type_other STRING ,
  history_prior_surgery_indicator STRING ,
  field STRING ,
  molecular_abnormality_results_other STRING ,
  molecular_abnormality_results STRING ,
  number_of_lymphnodes_positive_by_ihc STRING ,
  tobacco_smoking_history STRING ,
  number_pack_years_smoked STRING ,
  stopped_smoking_year STRING ,
  performance_status_scale_timing STRING ,
  laterality STRING ,
  targeted_molecular_therapy STRING ,
  year_of_tobacco_smoking_onset STRING ,
  anatomic_neoplasm_subdivision_other STRING ,
  patient_death_reason STRING ,
  tumor_tissue_site_other STRING ,
  menopause_status STRING .""),
  age_began_smoking_in_years STRING ,
  margin_status STRING ,
  kras_gene_analysis_performed STRING ,
  kras_mutation_found STRING ,
  death_cause_text STRING ,
  lactate_dehydrogenase_result STRING , to help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time. NCI CDE: 3113468""),
  days_to_sample_procurement STRING ,
  hbv_test STRING  test""),
  on_haart_therapy_at_cancer_diagnosis STRING  at the time of cancer diagnosis NCI CDE: 2922679""),
  hcv_test STRING ,
  prior_aids_conditions STRING ,
  on_haart_therapy_prior_to_cancer_diagnosis STRING  before or prior to the time of cancer diagnosis. NCI CDE: 3335156""),
  kshv_hhv8_test STRING  test was completed for an individual. NCI CDE: 3335774""),
  days_to_hiv_diagnosis STRING ,
  hiv_status STRING ,
  hiv_rna_load_at_diagnosis STRING  assay performed on an individual at the time of diagnosis. NCI CDE: 2922674""),
  cdc_hiv_risk_group STRING . NCI CDE: 2542215""),
  history_of_other_malignancy STRING ,
  history_immunosuppresive_dx STRING ,
  nadir_cd4_counts STRING ,
  history_relevant_infectious_dx_other STRING ,
  history_relevant_infectious_dx STRING ,
  cd4_counts_at_diagnosis STRING ,
  history_immunological_disease_other STRING ,
  hpv_test STRING ,
  history_immunosuppressive_dx_other STRING ,
  history_immunological_disease STRING ,
  lost_follow_up STRING ,
  venous_invasion STRING ,
  lymphatic_invasion STRING ,
  perineural_invasion_present STRING ,
  her2_erbb_method_calculation_method_text STRING ,
  her2_immunohistochemistry_level_result STRING ,
  breast_carcinoma_immunohistochemistry_pos_cell_score STRING ,
  distant_metastasis_present_ind2 STRING ,
  her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text STRING  positivity in a specimen or sample. NCI CDE: 3087929""),
  breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale STRING ,
  breast_carcinoma_primary_surgical_procedure_name STRING ,
  er_level_cell_percentage_category STRING ,
  breast_carcinoma_progesterone_receptor_status STRING ,
  breast_carcinoma_surgical_procedure_name STRING ,
  breast_neoplasm_other_surgical_procedure_descriptive_text STRING ,
  er_detection_method_text STRING ,
  pos_finding_progesterone_receptor_other_measurement_scale_text STRING  positivity. NCI CDE: 3086857""),
  her2_erbb_pos_finding_cell_percent_category STRING ,
  her2_and_centromere_17_positive_finding_other_measurement_scale_text STRING ,
  pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text STRING  positivity. NCI CDE: 3131877""),
  metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category STRING  positive results expressed as a percentage value. NCI CDE: 3131891""),
  metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text STRING  positivity. NCI CDE: 3131992""),
  fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range STRING ,
  first_recurrent_non_nodal_metastatic_anatomic_site_descriptive_text STRING ,
  first_nonlymph_node_metastasis_anatomic_site STRING ,
  immunohistochemistry_positive_cell_score STRING ,
  axillary_lymph_node_stage_method_type STRING  of axillary lymph nodes from the area of the armpit. NCI CDE: 2516112""),
  axillary_lymph_node_stage_other_method_descriptive_text STRING  from the area of the armpit/axilla that is different from the options previously identified. NCI CDE: 3124496""),
  metastatic_breast_carcinoma_progesterone_receptor_status STRING  testing. NCI CDE: 3131884""),
  metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score STRING ,
  metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score STRING ,
  metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status STRING ,
  metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value STRING ,
  surgical_procedure_purpose_other_text STRING ,
  metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text STRING  positivity in a specimen or sample of metastatic breast carcinoma. NCI CDE: 3132910""),
  metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category STRING ,
  breast_cancer_surgery_margin_status STRING ,
  metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text STRING ,
  breast_carcinoma_estrogen_receptor_status STRING  testing. NCI CDE: 2957359""),
  her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count STRING ,
  pgr_detection_method_text STRING . NCI CDE: 785""),
  pos_finding_her2_erbb2_other_measurement_scale_text STRING ,
  breast_carcinoma_immunohistochemistry_er_pos_finding_scale STRING ,
  positive_finding_estrogen_receptor_other_measurement_scale_text STRING  positivity. NCI CDE: 3086851""),
  metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result STRING ,
  metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text STRING ,
  her2_neu_chromosone_17_signal_ratio_value STRING ,
  cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator STRING ,
  metastatic_breast_carcinoma_estrogen_receptor_detection_method_text STRING ,
  metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type STRING  assay. NCI CDE: 3132455""),
  metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text STRING ,
  lab_proc_her2_neu_immunohistochemistry_receptor_status STRING ,
  progesterone_receptor_level_cell_percent_category STRING ,
  metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category STRING  positive results expressed as a percentage value. NCI CDE: 3131869""),
  metastatic_breast_carcinoma_estrogen_receptor_status STRING  testing. NCI CDE: 3131865""),
  lab_procedure_her2_neu_in_situ_hybrid_outcome_type STRING  assay. NCI CDE: 2854089""),
  her2_neu_breast_carcinoma_copy_analysis_input_total_number STRING , expressed as a range of values. NCI CDE: 3133738""),
  metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range STRING ,
  her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count STRING ,
  her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number STRING , expressed as a range of values NCI CDE: 3133734""),
  metastatic_breast_carcinoma_progesterone_receptor_detection_method_text STRING  in a sample of metastatic breast carcinoma, e.g., dextran coated charcoal. NCI CDE: 3131993""),
  additional_pharmaceutical_therapy STRING ,
  additional_radiation_therapy STRING ,
  lymphovascular_invasion_present STRING ,
  pos_lymph_node_location_other STRING ,
  pos_lymph_node_location STRING ,
  location_in_lung_parenchyma STRING ,
  pulmonary_function_test_performed STRING ,
  pre_bronchodilator_fev1_fvc_percent STRING  divided by the Forced Vital Capacity (FVC) pre-bronchodilator. NCI CDE: 3302955""),
  kras_mutation_result STRING ,
  post_bronchodilator_fev1_percent STRING  divided by the Forced Vital Capacity (FVC) post-bronchodilator. NCI CDE: 3302956""),
  pre_bronchodilator_fev1_percent STRING  divided by the Forced Vital Capacity (FVC) pre-bronchodilator. NCI CDE: 3302955""),
  dlco_predictive_percent STRING ,
  egfr_mutation_performed STRING ,
  diagnosis STRING ,
  eml4_alk_translocation_result STRING ,
  egfr_mutation_result STRING ,
  post_bronchodilator_fev1_fvc_percent STRING  divided by the Forced Vital Capacity (FVC) post-bronchodilator. NCI CDE: 3302956""),
  eml4_alk_translocation_performed STRING ,
  eml4_alk_translocation_method STRING ,
  days_to_new_tumor_event_after_initial_treatment STRING ,
  hemoglobin_result STRING ,
  serum_calcium_result STRING ,
  platelet_qualitative_result STRING . NCI CDE: 3104944""),
  number_of_lymphnodes_positive STRING ,
  erythrocyte_sedimentation_rate_result STRING . NCI CDE: 3104952""),
  white_cell_count_result STRING ,
  malignant_neoplasm_metastatic_involvement_site STRING ,
  other_metastatic_involvement_anatomic_site STRING ,
  birth_control_pill_history_usage_category STRING ,
  alcohol_history_documented STRING ,
  frequency_of_alcohol_consumption STRING ,
  source_of_patient_death_reason STRING ,
  days_to_diagnostic_mri_performed STRING ,
  days_to_diagnostic_computed_tomography_performed STRING  scan to the date of initial pathologic diagnosis, represented as a calculated number of days.""),
  amount_of_alcohol_consumption_per_day STRING ,
  family_history_of_cancer STRING . NCI CDE: 2436860""),
  loss_expression_of_mismatch_repair_proteins_by_ihc_result STRING ,
  preoperative_pretreatment_cea_level STRING ,
  microsatellite_instability STRING ,
  number_of_loci_tested STRING ,
  history_of_colon_polyps STRING ,
  number_of_first_degree_relatives_with_cancer_diagnosis STRING  diagnosed with cancer.""),
  number_of_abnormal_loci STRING ,
  circumferential_resection_margin STRING ,
  non_nodal_tumor_deposits STRING ,
  braf_gene_analysis_result STRING ,
  colon_polyps_present STRING ,
  kras_mutation_codon STRING ,
  braf_gene_analysis_performed STRING ,
  synchronous_colon_cancer_present STRING ,
  loss_expression_of_mismatch_repair_proteins_by_ihc STRING ,
  barretts_esophagus STRING ,
  city_of_procurement STRING ,
  reflux_history STRING ,
  country_of_procurement STRING ,
  antireflux_treatment_type STRING ,
  h_pylori_infection STRING ,
  hypertension STRING ,
  horm_ther STRING ,
  pln_pos_ihc STRING ,
  surgical_approach STRING ,
  pregnancies STRING ,
  diabetes STRING ,
  peritoneal_wash STRING ,
  pct_tumor_invasion STRING ,
  prior_tamoxifen_administered_usage_category STRING . Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. (NCI04)_A manner, or usual, or accepted practice of using something._Category; used informally to mean a class of things. NCI CDE: 3104234""),
  colorectal_cancer STRING ,
  total_aor_lnp STRING ,
  pln_pos_light_micro STRING ,
  total_pelv_lnp STRING ,
  total_pelv_lnr STRING ,
  aln_pos_light_micro STRING ,
  aln_pos_ihc STRING .""),
  total_aor_lnr STRING ,
  post_surgical_procedure_assessment_thyroid_gland_carcinoma_status STRING ,
  metastatic_neoplasm_confirmed_diagnosis_method_text STRING  site of growth to another site that is not already specified or mentioned. NCI CDE: 3178376""),
  metastatic_neoplasm_confirmed_diagnosis_method_name STRING  site of growth to another site. NCI CDE: 3178364""),
  prior_glioma STRING ""),
  tumor_residual_disease STRING  status, 1-10 mm, >20 mm,11-20 mm""),
  jewish_origin STRING ,
  distant_metastasis_anatomic_site STRING ,
  new_neoplasm_event_type STRING ,
  lymphnode_dissection_method_left STRING ,
  lymphnode_neck_dissection STRING ,
  egfr_amplication_status STRING ,
  hpv_status_by_ish_testing STRING ,
  presence_of_pathological_nodal_extracapsular_spread STRING ,
  p53_gene_analysis STRING ,
  hpv_status_by_p16_testing STRING ,
  lymphnode_dissection_method_right STRING ,
  eml4_alk_translocation_identified STRING ,
  egfr_mutation_identified STRING ,
  supratentorial_localization STRING ,
  mold_or_dust_allergy_history STRING ,
  motor_movement_changes STRING ,
  inherited_genetic_syndrome_found STRING ,
  seizure_history STRING ,
  asthma_history STRING ,
  first_diagnosis_age_asth_ecz_hay_fev_mold_dust STRING ,
  first_diagnosis_age_of_food_allergy STRING ,
  ldh1_mutation_found STRING ,
  tumor_location STRING ,
  ldh1_mutation_test_method STRING ,
  animal_insect_allergy_types STRING  of the specified type of allergy to animals or insects.""),
  first_presenting_symptom STRING ,
  animal_insect_allergy_history STRING ,
  first_presenting_symptom_longest_duration STRING ,
  ldh1_mutation_tested STRING ,
  visual_changes STRING ,
  first_diagnosis_age_of_animal_insect_allergy STRING ,
  history_ionizing_rt_to_head STRING ,
  sensory_changes STRING ,
  food_allergy_history STRING ,
  mental_status_changes STRING ,
  hay_fever_history STRING . NCI CDE: 3133930""),
  preoperative_corticosteroids STRING ,
  preoperative_antiseizure_meds STRING ,
  family_history_of_primary_brain_tumor STRING ,
  inherited_genetic_syndrome_result STRING ,
  days_to_initial_score_performance_status_scale STRING ,
  food_allergy_types STRING ,
  headache_history STRING ,
  eczema_history STRING ,
  other_genotyping_outcome_lab_results_text STRING ,
  extrathyroid_carcinoma_present_extension_status STRING ,
  i_131_first_administered_dose STRING ,
  i_131_subsequent_administered_dose STRING ,
  i_131_total_administered_dose STRING ,
  primary_neoplasm_focus_type STRING ,
  i_131_total_administered_preparation_technique STRING ,
  person_lifetime_risk_radiation_exposure_indicator STRING ,
  ret_ptc_rearrangement_genotyping_outcome_lab_results_text STRING ,
  genotyping_results_gene_mutation_not_reported_reason STRING ,
  neoplasm_depth STRING , to the bottom of the tumor, with metastatic rates correlating closely with tumor thickness. NCI CDE: 2593061""),
  genotype_analysis_performed_indicator STRING ,
  ras_family_gene_genotyping_outcome_lab_results_text STRING ,
  neoplasm_length STRING ,
  neoplasm_width STRING ,
  radiosensitizing_agent_administered_indicator STRING ,
  braf_gene_genotyping_outcome_lab_results_text STRING ,
  lymph_node_preoperative_scan_indicator STRING ,
  radiation_therapy_administered_preparation_technique_text STRING ,
  lymph_node_preoperative_assessment_diagnostic_imaging_type STRING ,
  patient_personal_medical_history_thyroid_gland_disorder_name STRING ,
  first_degree_relative_history_thyroid_gland_carcinoma_diagnosis_relationship_type STRING ,
  radiation_therapy_administered_dose_text STRING ,
  patient_personal_medical_history_thyroid_other_specify_text STRING ,
  primary_thyroid_gland_neoplasm_location_anatomic_site STRING ,
  lymphnodes_examined STRING ,
  zone_of_origin STRING ,
  days_to_bone_scan_performed STRING ,
  diagnostic_mri_performed STRING ,
  diagnostic_mri_result STRING ,
  psa_value STRING  present in a sample. NCI CDE: 7063440""),
  days_to_first_biochemical_recurrence STRING ,
  secondary_pattern STRING ,
  primary_pattern STRING ,
  diagnostic_ct_abd_pelvis_result STRING ,
  bone_scan_results STRING ,
  biochemical_recurrence STRING ,
  tumor_level STRING  within the prostate zonal anatomy used to identify the location of the tumor. NCI CDE: 7063204""),
  gleason_score STRING ,
  number_of_lymphnodes_examined STRING ,
  days_to_psa STRING ,
  tertiary_pattern STRING ,
  diagnostic_ct_abd_pelvis_performed STRING ,
  family_medical_history_relative_family_member_relationship_type STRING ,
  tumor_type STRING ,
  primary_tumor_multiple_present_ind STRING ,
  prior_systemic_therapy_type STRING ,
  melanoma_clark_level_value STRING ,
  melanoma_origin_skin_anatomic_site STRING ,
  malignant_neoplasm_mitotic_count_rate STRING ,
  breslow_depth_value STRING , to the bottom of the tumor; metastatic rates correlate closely with tumor thickness. (from On-line Medical Dictionary) NCI CDE: 2593055""),
  tumor_tissue_site_1 STRING ,
  melanoma_ulceration_indicator STRING ,
  primary_neoplasm_melanoma_dx STRING ,
  new_tumor_dx_prior_submitted_specimen_dx STRING ,
  primary_anatomic_site_count STRING , Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Named locations of or within the body._Count of the number of tumors classified as primaries, not sites of metastatic disease. NCI CDE: 2967294""),
  interferon_90_day_prior_excision_admin_indicator STRING ,
  primary_melanoma_at_diagnosis_count STRING ,
  days_to_submitted_specimen_dx STRING ,
  antireflux_treatment STRING ,
  number_of_relatives_with_stomach_cancer STRING  who have been diagnosed with stomach cancer.""),
  family_history_of_stomach_cancer STRING ,
  state_province_country_of_procurement STRING ,
  specimen_collection_method_name STRING ,
  child_pugh_classification_grade STRING ,
  hist_of_non_mibc STRING ,
  occupation_primary_job STRING ,
  person_concomitant_prostate_carcinoma_occurrence_indicator STRING ,
  person_concomitant_prostate_carcinoma_pathologic_t_stage STRING ,
  cancer_diagnosis_cancer_type_icd9_text_name STRING ,
  non_mibc_tx STRING ,
  bladder_carcinoma_extracapsular_extension_status STRING ,
  chemical_exposure_text STRING ,
  resp_maint_from_bcg_admin_month_dur STRING ,
  maint_therapy_course_complete STRING ,
  induction_course_complete STRING ,
  person_occupation_years_number STRING ,
  person_primary_industry_text STRING ,
  disease_extracapsular_extension_ind_3 STRING ,
  complete_response_observed STRING ,
  diagnosis_subtype STRING ,
  diagnosis_age STRING ,
  mibc_90day_post_resection_bcg STRING ,
  person_occupation_description_text STRING ,
  surgical_procedure_name_other_specify_text STRING ,
  relative_family_cancer_history_ind_3 STRING ,
  vascular_tumor_cell_invasion_type STRING ,
  viral_hepatitis_serology STRING ,
  liver_fibrosis_ishak_score_category STRING ,
  ablation_embolization_tx_adjuvant STRING ,
  laboratory_procedure_prothrombin_time_result_value STRING ,
  laboratory_procedure_creatinine_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_alpha_fetoprotein_outcome_value STRING ,
  laboratory_procedure_alpha_fetoprotein_outcome_upper_limit_of_normal_value STRING . NCI CDE: 2932064""),
  laboratory_procedure_alpha_fetoprotein_outcome_lower_limit_of_normal_value STRING . NCI CDE: 3171861""),
  laboratory_procedure_albumin_result_upper_limit_of_normal_value STRING ,
  laboratory_procedure_albumin_result_specified_value STRING ,
  laboratory_procedure_creatinine_result_upper_limit_of_normal_value STRING ,
  laboratory_prcoedure_platelet_result_upper_limit_of_normal_value STRING ,
  lab_procedure_platelet_result_specified_value STRING . NCI CDE: 58304""),
  days_to_definitive_surgical_procedure_performed STRING ,
  hematology_serum_creatinine_laboratory_result_value_in_mg_dl STRING . Creatinine is derived from a constituent of muscle tissue, which is used to evaluate kidney glomerular filtration. [Manually-curated] NCI CDE: 2655822""),
  history_hepato_carcinoma_risk_factor STRING  that arises from hepatocytes resulting in hepatocellular carcinoma, or as diffuse liver involvement. NCI CDE: 7118713""),
  history_hepato_carcinoma_risk_factor_other STRING ,
  cancer_diagnosis_first_degree_relative_number STRING  diagnosed with cancer. NCI CDE: 3171640""),
  laboratory_prcoedure_platelet_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_international_normalization_ratio_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_albumin_result_lower_limit_of_normal_value STRING ,
  laboratory_procedure_total_bilirubin_result_specified_lower_limit_of_normal_value STRING ,
  laboratory_procedure_total_bilirubin_result_specified_upper_limit_of_normal_value STRING ,
  laboratory_procedure_total_bilirubin_result_upper_limit_normal_value STRING  for the procedure that involves testing or manipulating a sample of blood in a laboratory setting for total bilirubin, a breakdown product of hemoglobin, liver lab. NCI CDE: 2004060""),
  adjacent_hepatic_tissue_inflammation_extent_type STRING ,
  laboratory_procedure_international_normalization_ratio_result_upper_limit_of_normal_value STRING ,
  mitotic_count STRING ,
  oligonucleotide_primer_pair_laboratory_procedure_performed_name STRING ,
  radiation_type_notes STRING ,
  number_of_successful_pregnancies_which_resulted_in_at_least_1_live_birth STRING ,
  external_beam_radiation_therapy_administered_paraaortic_region_lymph_node_dose STRING ,
  concurrent_chemotherapy_dose STRING _The total quantity or strength of a substance (drug or radiation) administered at one time. (NCI) NCI CDE: 3166172""),
  chemotherapy_regimen_type STRING ,
  chemotherapy_negation_radiation_therapy_concurrent_not_administered_reason STRING ,
  postoperative_rx_tx_1 STRING ,
  dose_frequency_text STRING ,
  rt_pelvis_administered_total_dose STRING ,
  cervical_neoplasm_pathologic_margin_involved_type STRING ,
  cervical_neoplasm_pathologic_margin_involved_text STRING ,
  cervical_carcinoma_pelvic_extension_text STRING ,
  cervical_carcinoma_corpus_uteri_involvement_indicator STRING ,
  ectopic_pregnancy_count STRING ,
  rt_administered_type STRING ,
  oligonucleotide_primer_pair_laboratory_procedure_performed_text STRING ,
  other_chemotherapy_agent_administration_specify STRING ,
  radiation_therapy_not_administered_reason STRING ,
  patient_pregnancy_therapeutic_abortion_count STRING ,
  days_to_laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result STRING  Tumor Marker Result to the date of initial pathologic diagnosis, represented as a calculated number of days. NCI CDE: 5654374""),
  days_to_performance_status_assessment STRING ,
  prescribed_dose_units STRING  associated with a prescribed dose for treatment. NCI CDE: 3065815""),
  diagnostic_ct_result_outcome STRING ,
  patient_pregnancy_spontaneous_abortion_count STRING ,
  patient_pregnancy_count STRING ,
  fdg_or_ct_pet_performed_outcome STRING ,
  female_breast_feeding_or_pregnancy_status_indicator STRING ,
  standardized_uptake_value_cervix_uteri_assessment_measurement STRING ,
  pregnant_at_diagnosis STRING ,
  pregnancy_stillbirth_count STRING ,
  patient_history_immune_system_and_related_disorders_text STRING ,
  patient_history_immune_system_and_related_disorders_name STRING ,
  days_to_fdg_or_ct_pet_performed STRING ,
  diagnostic_mri_result_outcome STRING ,
  radiation_therapy_1 STRING ,
  radiation_therapy_not_administered_specify STRING ,
  human_papillomavirus_laboratory_procedure_performed_name STRING ,
  chemotherapy_negation_radiation_therapy_concurrent_administered_text STRING ,
  lymph_node_location_positive_pathology_name STRING ,
  keratinizing_squamous_cell_carcinoma_present_indicator STRING ,
  laboratory_procedure_tumor_marker_squamous_cell_carcinoma_antigen_result_value STRING ,
  total_number_of_pregnancies STRING ,
  hysterectomy_Performed_Ind_3 STRING ,
  hysterectomy_performed_text STRING ,
  human_papillomavirus_other_type_text STRING  previously specified or mentioned._Something distinguishable as an identifiable class based on common qualities._Text; the words of something written. NCI CDE: 3166168""),
  hysterectomy_performed_type STRING ,
  lymphovascular_invasion_indicator STRING ,
  brachytherapy_first_reference_point_administered_total_dose STRING ,
  brachytherapy_method_other_specify_text STRING ,
  lymph_node_location_positive_pathology_text STRING ,
  tumor_response_cdus_type STRING ,
  brachytherapy_method_type STRING ,
  agent_total_dose_count STRING ,
  live_birth_number STRING ,
  human_papillomavirus_laboratory_procedure_performed_text STRING ,
  human_papillomavirus_type STRING ,
  performance_status_assessment_timepoint_category_other_text STRING ,
  ct_scan STRING  scan. NCI CDE: 2004007""),
  new_neoplasm_event_occurrence_anatomic_site STRING ,
  radiologic_tumor_width STRING ,
  contiguous_organ_resection_site STRING ,
  radiologic_tumor_depth STRING ,
  radiologic_tumor_burden STRING ,
  tumor_depth STRING ,
  pathologic_tumor_width STRING ,
  tumor_multifocal STRING ,
  other_contiguous_organ_resection_site STRING ,
  contiguous_organ_invaded STRING ,
  pathologic_tumor_length STRING ,
  pathologic_tumor_depth STRING ,
  pathologic_tumor_burden STRING ,
  radiologic_tumor_length STRING ,
  tumor_total_necrosis_percent STRING ,
  primary_tumor_lower_uterus_segment STRING  with an elongated lower part (neck), at the extremity of which is the opening (os). The upper rounded portion of the uterus, opposite the os, is the fundus, at each extremity of which is the horn marking the part where the uterine tube joins the uterus and through which the ovum reaches the uterine cavity after leaving the ovary. The organ is supported in the pelvic cavity by the broad ligaments, round ligaments, cardinal ligaments, and rectouterine and vesicouterine folds or ligaments. SYN metra, womb._One of the parts into which something naturally divides._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied. NCI CDE: 2775554""),
  days_to_well_differentiated_liposarcoma_resection STRING ,
  metastatic_site_at_diagnosis_other STRING  within the body; may be referenced in primary site of disease, surgical intervention, or extent of disease documentation. NCI CDE: 2967298""),
  metastatic_site_at_diagnosis STRING  site to another location in the body._Name of the organ site (single) within the body; may be referenced in primary site of disease, surgical intervention, or extent of disease documentation. NCI CDE: 2967298""),
  ss18_ssx_testing_method STRING ,
  ss18_ssx_fusion_status STRING ,
  specific_tumor_total_necrosis_percent STRING ,
  leiomyosarcoma_histologic_subtype STRING ,
  metastatic_neoplasm_confirmed STRING  site to another location in the body has been established or verified. NCI CDE: 65384""),
  local_disease_recurrence STRING ,
  days_to_well_differentiated_liposarcoma_primary_dx STRING ,
  mpnst_neurofibromatosis STRING ,
  mpnst_exisiting_plexiform_neurofibroma STRING ,
  mpnst_nf1_genetic_testing STRING ,
  mpnst_specific_mutations STRING ,
  well_differentiated_liposarcoma_primary_dx STRING ,
  leiomyosarcoma_major_vessel_involvement STRING ,
  discontiguous_lesion_count STRING  An area of abnormal tissue change._Quantity; how much there is of something that you can measure._the quantity of specified lesions. NCI CDE: 3162604""),
  mpnst_neurofibromatosis_heredity STRING ,
  maximum_tumor_dimension STRING ,
  alcoholic_exposure_category STRING ,
  planned_surgery_status STRING ,
  esophageal_tumor_involvement_site STRING ,
  esophageal_tumor_cental_location STRING ,
  lymph_node_metastasis_radiographic_evidence STRING ,
  days_to_pancreatitis_onset STRING ,
  days_to_diabetes_onset STRING ,
  adenocarcinoma_invasion STRING ,
  surgery_performed_type STRING ,
  columnar_metaplasia_present STRING ,
  relative_cancer_type STRING ,
  amt_alcohol_consumption_per_day STRING ,
  columnar_mucosa_goblet_cell_present STRING ,
  history_of_chronic_pancreatitis STRING ,
  history_of_diabetes STRING ,
  goblet_cells_present STRING ,
  history_of_esophageal_cancer STRING ,
  histologic_grading_tier_category STRING ,
  columnar_mucosa_dysplasia STRING ,
  number_of_relatives_diagnosed STRING ,
  state_province_of_procurement STRING ,
  treatment_prior_to_surgery STRING ,
  initial_diagnosis_by STRING ,
  surgery_performed_type_other STRING ,
  country_of_birth STRING ,
  disease_detected_on_screening STRING ,
  history_pheo_or_para_include_benign STRING ,
  outside_adrenal STRING ,
  history_pheo_or_para_anatomic_site STRING ,
  family_member_relationship_type STRING ,
  post_op_ablation_embolization_tx STRING ,
  days_to_pre_orchi_serum_test STRING ,
  post_orchi_hcg STRING ,
  bilateral_diagnosis_timing_type STRING ,
  post_orchi_ldh STRING ,
  testis_tumor_microextent STRING ,
  undescended_testis_corrected STRING ,
  post_orchi_lh STRING ,
  post_orchi_lymph_node_dissection STRING ,
  post_orchi_testosterone STRING ,
  serum_markers STRING ""),
  undescended_testis_corrected_age STRING ,
  undescended_testis_method_left STRING ,
  relation_testicular_cancer STRING ,
  postoperative_tx STRING ,
  testis_tumor_macroextent STRING ,
  synchronous_tumor_histology_pct STRING ,
  pre_orchi_afp STRING ,
  pre_orchi_hcg STRING ,
  pre_orchi_ldh STRING ,
  pre_orchi_lh STRING ,
  pre_orchi_testosterone STRING ,
  synchronous_tumor_histology_type STRING ,
  relative_family_cancer_hx_text STRING ,
  days_to_post_orchi_serum_test STRING ,
  undescended_testis_method_right STRING ,
  testis_tumor_macroextent_other STRING ,
  days_to_bilateral_tumor_dx STRING ,
  level_of_non_descent STRING ,
  post_orchi_afp STRING ,
  intratubular_germ_cell_neoplasm STRING ,
  igcccg_stage STRING ,
  history_of_undescended_testis STRING ,
  molecular_test_result STRING ,
  history_hypospadias STRING ,
  history_fertility STRING ,
  histological_percentage STRING ,
  first_treatment_success STRING ,
  family_history_testicular_cancer STRING ,
  family_history_other_cancer STRING ,
  masaoka_stage STRING ,
  history_myasthenia_gravis STRING ,
  section_myasthenia_gravis STRING ,
  new_neoplasm_occurrence_anatomic_site_text STRING ,
  percent_tumor_sarcomatoid STRING ,
  presence_of_sarcomatoid_features STRING ,
  tmem127 STRING ,
  therapeutic_mitotane_lvl_recurrence STRING ,
  therapeutic_mitotane_lvl_macroscopic_residual STRING ,
  therapeutic_mitotane_levels_achieved STRING ,
  metastatic_neoplasm_initial_diagnosis_anatomic_site STRING ,
  mitoses_count STRING ,
  mitotane_therapy STRING ,
  mitotane_therapy_adjuvant_setting STRING ,
  mitotane_therapy_for_macroscopic_residual_disease STRING ,
  mitotic_rate STRING ,
  sinusoid_invasion STRING ,
  therapeutic_mitotane_lvl_progression STRING ,
  excess_adrenal_hormone_diagnosis_method_type STRING ,
  molecular_analysis_performed_indicator STRING ,
  excess_adrenal_hormone_history_type STRING ,
  necrosis STRING ,
  sdhd STRING ,
  sdhc STRING ,
  nuclear_grade_III_IV STRING ,
  sdhb STRING ,
  sdhaf2_sdh5 STRING ,
  sdha STRING ,
  atypical_mitotic_figures STRING ,
  ct_scan_findings STRING ,
  ret STRING ,
  cytoplasm_presence_less_than_equal_25_percent STRING ,
  weiss_venous_invasion STRING ,
  weiss_score STRING ,
  vhl STRING ,
  invasion_of_tumor_capsule STRING ,
  diffuse_architecture STRING ,
  serum_mesothelin_lower_limit STRING ,
  asbestos_exposure_type STRING ,
  pleurodesis_performed_90_days STRING ,
  mesothelioma_detection_method STRING ,
  history_asbestos_exposure STRING ,
  pleurodesis_performed_prior STRING ,
  family_history_cancer_type STRING ,
  family_history_cancer_type_other STRING ,
  asbestos_exposure_age STRING ,
  serum_mesothelin_prior_tx STRING ,
  asbestos_exposure_years STRING ,
  serum_mesothelin_upper_limit STRING ,
  asbestos_exposure_source STRING ,
  suv_of_pleura_max STRING ,
  primary_occupation STRING ,
  primary_occupation_years_worked STRING ,
  primary_occupation_other STRING ,
  creatinine_norm_range_lower STRING ,
  creatinine_norm_range_upper STRING ,
  asbestos_exposure_age_last STRING ,
  creatinine_prior_tx STRING ,
  tumor_basal_diameter STRING ,
  tumor_basal_diameter_mx STRING ,
  metastatic_site STRING ,
  tumor_thickness STRING ,
  microvascular_density_mvd STRING  of the tissue specimen. NCI CDE: 3874272""),
  tumor_shape_pathologic_clinical STRING ,
  tumor_infiltrating_lymphocytes STRING ,
  tumor_morphology_percentage STRING ,
  tumor_thickness_measurement STRING ,
  tumor_infiltrating_macrophages STRING ,
  pet_ct_standardized_values STRING ,
  eye_color STRING ,
  other_metastatic_site STRING  previously specified or mentioned [Manually-curated] NCI CDE: 2760050""),
  extravascular_matrix_patterns STRING ,
  histological_type_1 STRING ,
  extranocular_nodule_size STRING ,
  extrascleral_extension STRING ,
  gene_expression_profile STRING ,
  cytogenetic_abnormality STRING , loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Indicator of Yes, No, Unknown, Not Done, or Not Applicable to a question.[manually curated] NCI CDE: 2760479""),
  result_of_immunophenotypic_analysis STRING ,
  prior_immunosuppressive_therapy_other STRING ,
  prior_immunosuppressive_therapy_type STRING ,
  prior_infectious_disease STRING ,
  igk_genotype_results_1 STRING ,
  immunophenotypic_analysis_method STRING ,
  igk_genotype_results STRING ,
  bone_marrow_biopsy_done STRING ,
  bone_marrow_involvement STRING ,
  bone_marrow_involvement_1 STRING ,
  prior_infectious_disease_other STRING ,
  ebv_positive_malignant_cells_percent STRING ,
  b_lymphocyte_genotyping_method_1 STRING ,
  prior_immunologic_disease_type STRING ,
  igh_genotype_results_1 STRING ,
  b_lymphocyte_genotyping_method STRING ,
  prior_immunologic_disease_other STRING ,
  maximum_tumor_bulk_anatomic_location STRING  of the maximum tumor bulk. NCI CDE: 3233300""),
  immunophenotypic_analysis_results STRING ,
  maximum_tumor_bulk_anatomic_site STRING  of the maximum tumor bulk. NCI CDE: 3639616""),
  immunophenotypic_analysis_test STRING ,
  extranodal_sites_involvement_number STRING ,
  immunophenotypic_analysis_tested STRING ,
  ebv_status_malignant_cells_method STRING ,
  percent_ebv_positive_malignant_cells STRING ,
  tumor_resected_max_dimension STRING ,
  immunophenotypic_analysis_methodology STRING ,
  igh_genotype_results STRING ,
  ebv_diagnostic_methodology STRING ,
  follicular_component_percent STRING ,
  abnormality_tested_methodology STRING ,
  nodal_anatomic_site STRING ,
  histology_of_bone_marrow_sample STRING ,
  abnormality_tested_methodology_1 STRING ,
  ldh_upper_limit STRING ,
  number_of_involved_extranodal_sites STRING ,
  extranodal_disease_involvement_site STRING ,
  ebv_antibody_status STRING ,
  extranodal_disease_involvement_site_other STRING ,
  genetic_abnormality_tested_other STRING ,
  genetic_abnormality_tested_1 STRING ,
  genetic_abnormality_tested STRING ,
  genetic_abnormality_results_other STRING ,
  genetic_abnormality_results STRING ,
  percentage_of_follicular_component STRING ,
  pet_scan_results STRING ,
  other_genetic_abnormality_tested STRING ,
  epstein_barr_viral_status STRING ,
  lymph_node_involvement_site STRING ,
  mib1_positive_percentage_range STRING ,
  mib1_positive_percentage_range_1 STRING ,
  genetic_abnormality_method_other STRING ,
  extranodal_involvment_site_other STRING ,
  ldh_lab_value STRING ,
  hiv_positive_status STRING ,
  ldh_level STRING  exist. NCI CDE: 6323378""),
  ldh_norm_range_upper STRING . NCI CDE: 2597015""),
  abnormality_tested_results_1 STRING ,
  abnormality_tested_results STRING ,
  genetic_abnormality_method STRING ,
  bone_marrow_sample_histology STRING ,
  albumin_result_upper_limit STRING ,
  vascular_tumor_cell_type STRING ,
  albumin_result_lower_limit STRING ,
  albumin_result_specified_value STRING ,
  platelet_result_upper_limit STRING . NCI CDE: 2596499""),
  intern_norm_ratio_upper_limit STRING ,
  cholangitis_tissue_evidence STRING . NCI CDE: 3916091""),
  relative_family_cancer_history STRING ,
  platelet_result_lower_limit STRING ,
  hist_hepato_carcinoma_risk STRING ,
  hist_hepato_carc_fact STRING ,
  cancer_first_degree_relative STRING  diagnosed with cancer. NCI CDE: 3171640""),
  creatinine_lower_level STRING ,
  prothrombin_time_result_value STRING ,
  ca_19_9_level_upper STRING ,
  ca_19_9_level_lower STRING ,
  ca_19_9_level STRING ,
  creatinine_upper_limit STRING ,
  surgical_procedure_name STRING ,
  creatinine_value_in_mg_dl STRING ""),
  bilirubin_lower_limit STRING  and is measured a colorimetric method. NCI CDE: 3294386""),
  total_bilirubin_upper_limit STRING  for the procedure that involves testing or manipulating a sample of blood in a laboratory setting for total bilirubin, a breakdown product of hemoglobin, liver lab. NCI CDE: 2004060""),
  platelet_result_count STRING ,
  fibrosis_ishak_score STRING ,
  fetoprotein_outcome_value STRING ,
  fetoprotein_outcome_upper_limit STRING . NCI CDE: 2932064""),
  fetoprotein_outcome_lower_limit STRING . NCI CDE: 3171861""),
  inter_norm_ratio_lower_limit STRING ,
  family_cancer_type_txt STRING ,
  bilirubin_upper_limit STRING ,
  days_to_last_known_alive STRING 
)
OPTIONS(
  friendly_name=""PanCancer Clinical With Patient Follow-up"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Clinical information about patient cases in the TCGA project.  \n\nMore details:  https://gdc.cancer.gov/about-data/publications/pancanatlas file: clinical_PANCAN_patient_with_followup.tsv  \n\nand https://www.synapse.org/#!Synapse:syn4983466.1. \n\nFor data filtered by the barcode white list, table Filtered_clinical_PANCAN_patient_with_followup is recommended."",
  labels=[(""category"", ""clinical_biospecimen_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""clinical_data""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,8
table_name,TCGA_Clinical_Data_Resource_Extra
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.TCGA_Clinical_Data_Resource_Extra`
(
  `Row` INT64 ,
  bcr_patient_barcode STRING ,
  type STRING ,
  PFI_1 INT64 ,
  PFI_time_1 INT64 ,
  PFI_2 INT64 ,
  PFI_time_2 INT64 ,
  PFS INT64 ,
  PFS_time INT64 ,
  DSS_cr INT64 ,
  DSS_time_cr INT64 ,
  DFI_cr INT64 ,
  DFI_time_cr INT64 ,
  PFI_cr INT64 ,
  PFI_time_cr INT64 ,
  PFI_1_cr INT64  with competing risk events, 0 for censored, 1 for PFI_1 event of interest, 2 for competing risk death.""),
  PFI_time_1_cr INT64 ,
  PFI_2_cr INT64  with competing risk events, 0 for censored, 1 for PFI_2 event of interest, 2 for competing risk death.""),
  PFI_time_2_cr INT64 
)
OPTIONS(
  friendly_name=""PanCancer Clinical Data Resource (CDR) Outcome and Survival - Extra"",
  description=""Data loaded from the article 'An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics' by  Liu J, et al. Contains a curated resource of extra clinical annotations and survival data for TCGA data.\nMore details:\nhttps://gdc.cancer.gov/about-data/publications/PanCan-Clinical-2018\nand\nhttps://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""access"", ""open""), (""reference_genome"", ""hg19""), (""program"", ""pancancer_atlas""), (""source"", ""gdc""), (""category"", ""clinical_biospecimen_data""), (""data_type_1"", ""survival""), (""data_type_0"", ""clinical_supplement""), (""status"", ""current"")]
);"

,9
table_name,Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted`
(
  ID STRING  from the Illumina Human Methylation array -- please refer to the annotation table (isb-cgc-bq.annotations.methylation_annotation_hg19_illumina_current) for more details about any particular probe""),
  AliquotBarcode STRING ,
  Beta FLOAT64 "")
)
OPTIONS(
  friendly_name=""PanCancer DNA Methylation (450K Only)"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains DNA Methylation data generated using Illumina Human Methylation 450k. Some samples were filtered using the PanCancer Atlas whitelist.  \n\nMore details: https://www.synapse.org/#!Synapse:syn4557792.10  \nand https://gdc.cancer.gov/about-data/publications/pancanatlas, file: jhu-usc.edu_PANCAN_HumanMethylation450.betaValue_whitelisted.tsv. \n\nFor data annotated with pertinent TCGA Barcodes and filtered by the barcode white list, table Filtered_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted is recommended."",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""dna_methylation""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

Some other tables have the similar structure: ['Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted', 'Original_jhu_usc_edu_PANCAN_HumanMethylation27_betaValue_whitelisted']
,10
table_name,Filtered_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  SampleTypeLetterCode STRING ,
  SampleType STRING ,
  Study STRING ,
  ID STRING  from the Illumina Human Methylation array -- please refer to the annotation table (isb-cgc-bq.annotations.methylation_annotation_hg19_illumina_current) for more details about any particular probe""),
  Beta FLOAT64 "")
)
OPTIONS(
  friendly_name=""PanCancer Filtered DNA Methylation (Merged 27K+450K Only)"",
  description=""Data extracted from the PanCancer Atlas initiative on the GDC in April 2018. Contains DNA Methylation (Merged from the 27K and 450K tables) annotated with pertinent TCGA barcodes.  \n\nNote: The data was filtered from the BigQuery table isb-cgc-bq:pancancer_atlas.Original_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted, using the PanCancer Atlas whitelist (table Whitelist_ParticipantBarcodes)  \n\nMore details: BigQuery Table: isb-cgc-bq:pancancer_atlas.Original_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted \nand https://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""dna_methylation""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,11
table_name,merged_sample_quality_annotations
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.merged_sample_quality_annotations`
(
  patient_barcode STRING ,
  aliquot_barcode STRING ,
  cancer_type STRING ,
  platform STRING ,
  patient_annotation STRING ,
  sample_annotation STRING ,
  aliquot_annotation STRING ,
  aliquot_annotation_updated STRING ,
  AWG_excluded_because_of_pathology STRING , or \""0.0\"" (non excluded) ""),
  AWG_pathology_exclusion_reason STRING ,
  Reviewed_by_EPC STRING , or \""0.0\"" (non excluded).""),
  Do_not_use STRING 
)
OPTIONS(
  friendly_name=""PanCancer Merged Sample Quality Annotations"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains Sample Quality Annotations. This file was created by merging the annotations available in the DCC annotations database with manually curated lists of issue samples.   \n\nMore details: https://www.synapse.org/#!Synapse:syn4551248 \nand \nhttps://gdc.cancer.gov/about-data/publications/pancanatlas , file:merged_sample_quality_annotations.tsv"",
  labels=[(""category"", ""clinical_biospecimen_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""biospecimen_supplement""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,12
table_name,Whitelist_ParticipantBarcodes
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Whitelist_ParticipantBarcodes`
(
  ParticipantBarcode STRING 
)
OPTIONS(
  friendly_name=""Pancancer Participants Whitelist"",
  description=""Extracted from PanCancer Atlas initiative on the GDC in Aug 2016. Contains participant barcodes used in by the PanCancer Atlas initiative.  \n\nMore details: https://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""category"", ""clinical_biospecimen_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""biospecimen_supplement""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,13
table_name,Original_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Original_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted`
(
  ID STRING  from the Illumina Human Methylation array -- please refer to the annotation table (isb-cgc-bq.annotations.methylation_annotation_hg19_illumina_current) for more details about any particular probe""),
  AliquotBarcode STRING ,
  Beta FLOAT64 "")
)
OPTIONS(
  friendly_name=""PanCancer DNA Methylation (Merged 27K+450K Only)"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains DNA Methylation (Merged from the 27K and 450K tables).  \n\nMore details: https://gdc.cancer.gov/about-data/publications/pancanatlas, file:jhu-usc.edu_PANCAN_merged_HumanMethylation27_HumanMethylation450.betaValue_whitelisted.tsv. \n\nFor data annotated with pertinent TCGA Barcodes and filtered by the barcode white list, table Filtered_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted is recommended."",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""dna_methylation""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,14
table_name,Filtered_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  SampleTypeLetterCode STRING ,
  SampleType STRING ,
  Study STRING ,
  ID STRING  contained in this table, eg hsa-mir-21 -- relevant reference information can be found in the isb-cgc:genome_reference dataset in the tables miRBase_v20 and miRBase_v20_hsa_gff3""),
  miRNAexpr FLOAT64 ""),
  Corrected STRING 
)
OPTIONS(
  friendly_name=""PanCancer Filtered MicroRNA"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in Aug 2016. Contains batch effects normalized miRNA data.  \n\nNote: This table was extracted from isb-cgc-bq:pancancer_atlas.Original_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16. Data was annotated with ParticipantBarcode, SampleBarcode, AliquotBarcode, SampleTypeLetterCode, SampleType and TCGA Study.  \n\nMore details: https://gdc.cancer.gov/about-data/publications/pancanatlas BigQuery table: isb-cgc-bq:pancancer_atlas.Original_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16"",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""mirna_expression""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,15
table_name,TCGA_CDR
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.TCGA_CDR`
(
  ParticipantBarcode STRING ,
  Study STRING ,
  OS INT64 ,
  OS_time INT64 ,
  DSS INT64 ,
  DSS_time INT64 ,
  DFI INT64 ,
  DFI_time INT64 ,
  PFI INT64 ,
  PFI_time INT64 ,
  Redaction STRING 
)
OPTIONS(
  friendly_name=""PanCancer Clinical Data Resource (CDR) Outcome and Survival"",
  description=""Data loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains A curated resource of the clinical annotations for TCGA data and provides recommendations for use of clinical endpoints. It is strongly recommended that this file be used for clinical elements and survival outcome data first.\nMore details: \nhttps://gdc.cancer.gov/about-data/publications/PanCan-Clinical-2018\nand\nhttps://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""source"", ""gdc""), (""category"", ""clinical_biospecimen_data""), (""status"", ""current""), (""data_type_1"", ""survival""), (""reference_genome"", ""hg19""), (""access"", ""open""), (""data_type_0"", ""clinical_supplement""), (""program"", ""pancancer_atlas"")]
);"

,16
table_name,Original_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Original_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp`
(
  symbol STRING ,
  entrez STRING ,
  AliquotBarcode STRING ,
  RPKM FLOAT64  is a normalized unit of transcript expression. It scales by transcript length to compensate for the fact that most RNA-seq protocols will generate more sequencing reads from longer RNA molecules.Examples: 0.0617, 14.9241, 2.2411"")
)
OPTIONS(
  friendly_name=""PanCancer RNA Final"",
  description=""Data was loaded from the PanCancer Atlas initiative on the GDC in April 2018. Contains batch normalized RNASeqV2 mRNA data.  \n\nMore details: https://www.synapse.org/#!Synapse:syn4976369.3  \nand \nhttps://gdc.cancer.gov/about-data/publications/pancanatlas \nfile: EBPlusPlusAdjustPANCAN_IlluminaHiSeq_RNASeqV2.geneExp.tsv. \n\nFor data annotated with pertinent TCGA Barcodes and filtered by the barcode white list, table Filtered_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp is recommended."",
  labels=[(""access"", ""open""), (""category"", ""processed_-omics_data""), (""data_type"", ""gene_expression""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_0"", ""gdc""), (""source_1"", ""literature""), (""status"", ""current"")]
);"

,17
table_name,BarcodeMap
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.BarcodeMap`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  Study STRING ,
  SampleTypeLetterCode STRING 
)
OPTIONS(
  friendly_name=""PanCancer Barcode Map"",
  description=""Generated from TCGA Aliquot Report and samples used in PanCancer Atlas initiative, Feb 19, 2016. Contains Barcode Mappings used to annotate the pan-cancer tables with  ParticipantBarcode, SampleBarcode, AliquotBarcode, SampleTypeLetterCode, SampleType and TCGA Study.  Note: The data was processed from TCGA Aliquot Report, formerly at https://tcga-data.nci.nih.gov/datareports/aliquotReport.htm\n\nMore details: https://docs.gdc.cancer.gov/Encyclopedia/pages/TCGA_Barcode/"",
  labels=[(""category"", ""clinical_biospecimen_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""biospecimen_supplement""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

,18
table_name,Filtered_all_CNVR_data_by_gene
ddl,"CREATE TABLE `isb-cgc-bq.pancancer_atlas.Filtered_all_CNVR_data_by_gene`
(
  ParticipantBarcode STRING ,
  SampleBarcode STRING ,
  AliquotBarcode STRING ,
  SampleTypeLetterCode STRING ,
  SampleType STRING ,
  Study STRING ,
  Gene_Symbol STRING ,
  Locus_ID INT64 ,
  Cytoband STRING ,
  GISTIC_Calls FLOAT64 
)
OPTIONS(
  friendly_name=""PanCancer Filtered Copy Number"",
  description=""Data extracted from the PanCancer Atlas initiative on the GDC in Aug 2016. Contains Copy Number Variation data based on the GISTIC algorithm. \n\nNote: The original data was annotated with ParticipantBarcode, SampleBarcode, AliquotBarcode, SampleTypeLetterCode, SampleType and TCGA Study; and participants were subsequently filtered using the PanCancer Atlas whitelist (table Whitelist_ParticipantBarcodes)  \n\nMore details: https://www.synapse.org/#!Synapse:syn5031907 \nand https://gdc.cancer.gov/about-data/publications/pancanatlas"",
  labels=[(""category"", ""processed_-omics_data""), (""status"", ""current""), (""access"", ""open""), (""source_0"", ""gdc""), (""data_type"", ""copy_number_segment_masked""), (""program"", ""pancancer_atlas""), (""reference_genome"", ""hg19""), (""source_1"", ""literature"")]
);"

External knowledge that might be helpful: 
None
The table structure information is ({database name: {schema name: {table name}}}): 
{'isb-cgc-bq': {'pancancer_atlas': ['BarcodeMap', 'Filtered_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp', 'Filtered_MC3_MAF_V5_one_per_tumor_sample', 'Filtered_TCGA_RPPA_pancan_clean', 'Filtered_all_CNVR_data_by_gene', 'Filtered_clinical_PANCAN_patient_with_followup', 'Filtered_jhu_usc_edu_PANCAN_HumanMethylation27_betaValue_whitelisted', 'Filtered_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted', 'Filtered_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted', 'Filtered_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16', 'Original_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp', 'Original_TCGA_RPPA_pancan_clean', 'Original_clinical_PANCAN_patient_with_followup', 'Original_jhu_usc_edu_PANCAN_HumanMethylation27_betaValue_whitelisted', 'Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted', 'Original_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted', 'Original_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16', 'TCGA_CDR', 'TCGA_Clinical_Data_Resource_Extra', 'Whitelist_ParticipantBarcodes', 'merged_sample_quality_annotations']}}
Begin Exploring Related Columns
**Relevant Columns and Potential Usage:**

- `ParticipantBarcode`: Used to uniquely identify patients and match mutation data with clinical data.
- `Hugo_Symbol`: Used to identify mutations in **KRAS** and **TP53** genes.
- `Study`: Used to filter data for pancreatic adenocarcinoma patients (`Study = 'PAAD'`).
- `Variant_Classification`: Used to filter for high-quality impactful mutations.
- `bcr_patient_barcode`: Patient identifier in clinical data, corresponding to `ParticipantBarcode` in mutation data.
- `acronym`: Represents cancer type in clinical data, used to filter for PAAD patients (`acronym = 'PAAD'`).
- **Conditions that may be used**:
  - `Study = 'PAAD'`
  - `Hugo_Symbol IN ('KRAS', 'TP53')`
  - Matching `ParticipantBarcode` between tables to ensure accurate data integration.

---

**BigQuery SQL Queries:**

1. **List all unique ParticipantBarcodes of PAAD patients from the mutation data:**

   ```sql
   SELECT DISTINCT `ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD'
   LIMIT 100;
   ```

2. **Retrieve mutations in the KRAS gene for PAAD patients:**

   ```sql
   SELECT `ParticipantBarcode`, `Hugo_Symbol`, `Variant_Classification`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
   LIMIT 100;
   ```

3. **Retrieve mutations in the TP53 gene for PAAD patients:**

   ```sql
   SELECT `ParticipantBarcode`, `Hugo_Symbol`, `Variant_Classification`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
   LIMIT 100;
   ```

4. **Find patients with mutations in both KRAS and TP53 genes:**

   ```sql
   SELECT DISTINCT m1.`ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
   INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
   ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
   WHERE m1.`Study` = 'PAAD' AND m2.`Study` = 'PAAD`
     AND m1.`Hugo_Symbol` = 'KRAS'
     AND m2.`Hugo_Symbol` = 'TP53'
   LIMIT 100;
   ```

5. **Find patients with mutations in KRAS but not in TP53:**

   ```sql
   SELECT DISTINCT `ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
     AND `ParticipantBarcode` NOT IN (
       SELECT DISTINCT `ParticipantBarcode`
       FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
       WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'TP53'
     )
   LIMIT 100;
   ```

6. **Find patients with mutations in TP53 but not in KRAS:**

   ```sql
   SELECT DISTINCT `ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'TP53'
     AND `ParticipantBarcode` NOT IN (
       SELECT DISTINCT `ParticipantBarcode`
       FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
       WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
     )
   LIMIT 100;
   ```

7. **List all PAAD patients from the clinical data:**

   ```sql
   SELECT DISTINCT `bcr_patient_barcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup`
   WHERE `acronym` = 'PAAD'
   LIMIT 100;
   ```

8. **Find patients with neither KRAS nor TP53 mutations:**

   ```sql
   SELECT DISTINCT `ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.BarcodeMap`
   WHERE `Study` = 'PAAD`
     AND `ParticipantBarcode` NOT IN (
       SELECT DISTINCT `ParticipantBarcode`
       FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
       WHERE `Study` = 'PAAD` AND `Hugo_Symbol` IN ('KRAS', 'TP53')
     )
   LIMIT 100;
   ```

9. **Retrieve clinical follow-up data for patients with mutations in KRAS or TP53:**

   ```sql
   SELECT c.`bcr_patient_barcode`, c.`vital_status`, m.`Hugo_Symbol`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
   INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
   ON c.`bcr_patient_barcode` = m.`ParticipantBarcode`
   WHERE c.`acronym` = 'PAAD` AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
   LIMIT 100;
   ```

10. **List unique types of mutations in KRAS for PAAD patients:**

    ```sql
    SELECT DISTINCT `Variant_Classification`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
    LIMIT 100;
    ```

11. **List the survival times of patients with co-occurring mutations in KRAS and TP53:**

    ```sql
    SELECT m1.`ParticipantBarcode`, c.`OS_time`
    FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR` AS c
    INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
    ON c.`ParticipantBarcode` = m1.`ParticipantBarcode`
    INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
    ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
    WHERE c.`Study` = 'PAAD`
      AND m1.`Hugo_Symbol` = 'KRAS'
      AND m2.`Hugo_Symbol` = 'TP53'
    LIMIT 100;
    ```

12. **Retrieve the number of mutations per patient in the KRAS gene:**

    ```sql
    SELECT `ParticipantBarcode`, COUNT(*) AS `num_mutations`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
    GROUP BY `ParticipantBarcode`
    LIMIT 100;
    ```

13. **List patients with mutations in either KRAS or TP53 along with their survival status:**

    ```sql
    SELECT c.`ParticipantBarcode`, c.`OS`, m.`Hugo_Symbol`
    FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR` AS c
    INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
    ON c.`ParticipantBarcode` = m.`ParticipantBarcode`
    WHERE c.`Study` = 'PAAD` AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
    LIMIT 100;
    ```

14. **Identify patients without mutations in KRAS and TP53 and retrieve their clinical data:**

    ```sql
    SELECT c.`bcr_patient_barcode`, c.`vital_status`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
    WHERE c.`acronym` = 'PAAD` AND c.`bcr_patient_barcode` NOT IN (
      SELECT DISTINCT `ParticipantBarcode`
      FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
      WHERE `Study` = 'PAAD` AND `Hugo_Symbol` IN ('KRAS', 'TP53')
    )
    LIMIT 100;
    ```

15. **List unique amino acid changes (`HGVSp_Short`) in KRAS mutations for PAAD patients:**

    ```sql
    SELECT DISTINCT `HGVSp_Short`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
    LIMIT 100;
    ```

16. **Fetch detailed mutation information for patients with KRAS mutations:**

    ```sql
    SELECT `ParticipantBarcode`, `Hugo_Symbol`, `HGVSp_Short`, `Variant_Classification`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
    LIMIT 100;
    ```

17. **Find the frequency of each mutation type in KRAS for PAAD patients:**

    ```sql
    SELECT `Variant_Classification`, COUNT(*) AS `mutation_count`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD` AND `Hugo_Symbol` = 'KRAS'
    GROUP BY `Variant_Classification`
    LIMIT 100;
    ```

18. **Identify patients with high-quality impactful mutations in KRAS and TP53:**

    ```sql
    SELECT DISTINCT m.`ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
    WHERE m.`Study` = 'PAAD`
      AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
      AND m.`Variant_Classification` IN (
        'Frame_Shift_Del', 'Frame_Shift_Ins', 'In_Frame_Del', 'In_Frame_Ins',
        'Missense_Mutation', 'Nonsense_Mutation', 'Nonstop_Mutation',
        'Splice_Site', 'Translation_Start_Site'
      )
    LIMIT 100;
    ```

19. **Retrieve clinical follow-up data for patients without mutations in KRAS and TP53:**

    ```sql
    SELECT c.`bcr_patient_barcode`, c.`vital_status`, c.`days_to_last_followup`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
    WHERE c.`acronym` = 'PAAD` AND c.`bcr_patient_barcode` NOT IN (
      SELECT DISTINCT `ParticipantBarcode`
      FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
      WHERE `Study` = 'PAAD` AND `Hugo_Symbol` IN ('KRAS', 'TP53')
    )
    LIMIT 100;
    ```

20. **List patients and their mutation counts in KRAS and TP53 genes:**

    ```sql
    SELECT m.`ParticipantBarcode`, m.`Hugo_Symbol`, COUNT(*) AS `mutation_count`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
    WHERE m.`Study` = 'PAAD` AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
    GROUP BY m.`ParticipantBarcode`, m.`Hugo_Symbol`
    LIMIT 100;
    ```

---

These queries progressively explore the data needed to calculate the chi-squared statistic by identifying patients with mutations in **KRAS** and **TP53**, those with co-occurring mutations, and incorporating clinical follow-up data to maintain data integrity and ensure accurate matching based on unique identifiers.Query:
SELECT DISTINCT `ParticipantBarcode`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD'
   LIMIT 100;
Answer:
ParticipantBarcode
TCGA-2J-AAB1
TCGA-2J-AAB4
TCGA-2J-AAB6
TCGA-2J-AAB8
TCGA-2J-AAB9
TCGA-2J-AABA
TCGA-2J-AABE
TCGA-2J-AABF
TCGA-2J-AABH
TCGA-2J-AABI
TCGA-2J-AABK
TCGA-2J-AABO
TCGA-2J-AABP
TCGA-2J-AABT
TCGA-2J-AABU
TCGA-2J-AABV
TCGA-2L-AAQA
TCGA-2L-AAQE
TCGA-2L-AAQI
TCGA-2L-AAQJ
TCGA-2L-AAQL
TCGA-2L-AAQM
TCGA-3A-A9I5
TCGA-3A-A9I7
TCGA-3A-A9I9
TCGA-3A-A9IB
TCGA-3A-A9IC
TCGA-3A-A9IH
TCGA-3A-A9IJ
TCGA-3A-A9IL
TCGA-3A-A9IN
TCGA-3A-A9IO
TCGA-3A-A9IR
TCGA-3A-A9IS
TCGA-3A-A9IU
TCGA-3A-A9IV
TCGA-3A-A9IX
TCGA-3A-A9IZ
TCGA-3A-A9J0
TCGA-3E-AAAY
TCGA-3E-AAAZ
TCGA-F2-6879
TCGA-F2-A44G
TCGA-F2-A44H
TCGA-F2-A7TX
TCGA-F2-A8YN
TCGA-FB-A4P5
TCGA-FB-A545
TCGA-FB-A5VM
TCGA-FB-A78T
TCGA-FB-A7DR
TCGA-FB-AAPP
TCGA-FB-AAPQ
TCGA-FB-AAPS
TCGA-FB-AAPU
TCGA-FB-AAPY
TCGA-FB-AAPZ
TCGA-FB-AAQ0
TCGA-FB-AAQ1
TCGA-FB-AAQ2
TCGA-FB-AAQ3
TCGA-FB-AAQ6
TCGA-FZ-5919
TCGA-FZ-5920
TCGA-FZ-5921
TCGA-FZ-5922
TCGA-FZ-5923
TCGA-FZ-5924
TCGA-FZ-5926
TCGA-H6-8124
TCGA-H6-A45N
TCGA-H8-A6C1
TCGA-HV-A5A3
TCGA-HV-A5A4
TCGA-HV-A5A5
TCGA-HV-A5A6
TCGA-HV-A7OL
TCGA-HV-A7OP
TCGA-HV-AA8V
TCGA-HV-AA8X
TCGA-HZ-7289
TCGA-HZ-7918
TCGA-HZ-7919
TCGA-HZ-7920
TCGA-HZ-7922
TCGA-HZ-7925
TCGA-HZ-7926
TCGA-HZ-8001
TCGA-HZ-8002
TCGA-HZ-8003
TCGA-HZ-8005
TCGA-HZ-8315
TCGA-HZ-8317
TCGA-HZ-8636
TCGA-HZ-8637
TCGA-HZ-A49G
TCGA-HZ-A49H
TCGA-HZ-A49I
TCGA-HZ-A4BH
TCGA-HZ-A4BK
Query:
SELECT `ParticipantBarcode`, `Hugo_Symbol`, `Variant_Classification`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
   LIMIT 100;
Answer:
ParticipantBarcode,Hugo_Symbol,Variant_Classification
TCGA-2J-AAB4,KRAS,Missense_Mutation
TCGA-2J-AABO,KRAS,Missense_Mutation
TCGA-2J-AABT,KRAS,Missense_Mutation
TCGA-2L-AAQA,KRAS,Missense_Mutation
TCGA-2L-AAQI,KRAS,Missense_Mutation
TCGA-2L-AAQL,KRAS,Missense_Mutation
TCGA-3A-A9I7,KRAS,Missense_Mutation
TCGA-3A-A9IC,KRAS,Missense_Mutation
TCGA-3A-A9IZ,KRAS,Missense_Mutation
TCGA-F2-A8YN,KRAS,Missense_Mutation
TCGA-FB-A78T,KRAS,Missense_Mutation
TCGA-FB-A78T,KRAS,Missense_Mutation
TCGA-FB-A7DR,KRAS,Missense_Mutation
TCGA-FB-AAPQ,KRAS,Missense_Mutation
TCGA-FB-AAPU,KRAS,Missense_Mutation
TCGA-FB-AAPY,KRAS,Missense_Mutation
TCGA-FB-AAQ3,KRAS,Missense_Mutation
TCGA-FB-AAQ6,KRAS,Missense_Mutation
TCGA-FZ-5922,KRAS,Missense_Mutation
TCGA-FZ-5923,KRAS,Missense_Mutation
TCGA-H6-8124,KRAS,Missense_Mutation
TCGA-H8-A6C1,KRAS,Missense_Mutation
TCGA-HV-A7OP,KRAS,Missense_Mutation
TCGA-HV-AA8V,KRAS,Missense_Mutation
TCGA-HV-AA8X,KRAS,Missense_Mutation
TCGA-HZ-7919,KRAS,Missense_Mutation
TCGA-HZ-A49G,KRAS,Missense_Mutation
TCGA-HZ-A49H,KRAS,Missense_Mutation
TCGA-HZ-A4BH,KRAS,Missense_Mutation
TCGA-HZ-A77O,KRAS,Missense_Mutation
TCGA-HZ-A8P1,KRAS,Missense_Mutation
TCGA-IB-7645,KRAS,Missense_Mutation
TCGA-IB-7649,KRAS,Missense_Mutation
TCGA-IB-7886,KRAS,Missense_Mutation
TCGA-IB-7887,KRAS,Missense_Mutation
TCGA-IB-7893,KRAS,Missense_Mutation
TCGA-IB-A5SS,KRAS,Missense_Mutation
TCGA-IB-A6UF,KRAS,Missense_Mutation
TCGA-IB-A7LX,KRAS,Missense_Mutation
TCGA-IB-AAUN,KRAS,Missense_Mutation
TCGA-M8-A5N4,KRAS,Missense_Mutation
TCGA-OE-A75W,KRAS,Missense_Mutation
TCGA-RB-A7B8,KRAS,Missense_Mutation
TCGA-S4-A8RM,KRAS,Missense_Mutation
TCGA-2J-AAB1,KRAS,Missense_Mutation
TCGA-2J-AAB6,KRAS,Missense_Mutation
TCGA-2J-AAB8,KRAS,Missense_Mutation
Query:
SELECT `ParticipantBarcode`, `Hugo_Symbol`, `Variant_Classification`
   FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
   WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
   LIMIT 100;
Answer:
ParticipantBarcode,Hugo_Symbol,Variant_Classification
TCGA-2J-AAB6,TP53,Missense_Mutation
TCGA-2J-AAB9,TP53,Nonsense_Mutation
TCGA-2J-AABH,TP53,Frame_Shift_Del
TCGA-2J-AABU,TP53,Missense_Mutation
TCGA-2L-AAQA,TP53,Missense_Mutation
TCGA-2L-AAQE,TP53,Nonsense_Mutation
TCGA-3A-A9I9,TP53,Missense_Mutation
TCGA-3A-A9IB,TP53,Missense_Mutation
TCGA-3A-A9IX,TP53,Frame_Shift_Del
TCGA-3A-A9J0,TP53,Splice_Site
TCGA-3E-AAAY,TP53,Nonsense_Mutation
TCGA-F2-6879,TP53,Missense_Mutation
TCGA-FB-AAPS,TP53,Missense_Mutation
TCGA-FB-AAQ0,TP53,Missense_Mutation
TCGA-FB-AAQ1,TP53,Frame_Shift_Ins
TCGA-FB-AAQ3,TP53,Frame_Shift_Ins
TCGA-FZ-5919,TP53,Missense_Mutation
TCGA-FZ-5924,TP53,Missense_Mutation
TCGA-FZ-5926,TP53,Missense_Mutation
TCGA-H6-8124,TP53,Missense_Mutation
TCGA-HV-A5A5,TP53,Missense_Mutation
TCGA-HV-A5A6,TP53,Frame_Shift_Del
TCGA-HV-A7OL,TP53,Missense_Mutation
TCGA-HV-AA8X,TP53,Missense_Mutation
TCGA-HZ-7925,TP53,Nonsense_Mutation
TCGA-HZ-7926,TP53,Frame_Shift_Ins
TCGA-HZ-8005,TP53,Splice_Site
TCGA-HZ-8315,TP53,Missense_Mutation
TCGA-HZ-8636,TP53,In_Frame_Ins
TCGA-HZ-8637,TP53,Missense_Mutation
TCGA-HZ-A77P,TP53,Frame_Shift_Ins
TCGA-HZ-A9TJ,TP53,Missense_Mutation
TCGA-IB-7645,TP53,Nonsense_Mutation
TCGA-IB-7647,TP53,Missense_Mutation
TCGA-IB-7649,TP53,Splice_Site
TCGA-IB-7652,TP53,Missense_Mutation
TCGA-IB-7887,TP53,Missense_Mutation
TCGA-IB-A5SO,TP53,Nonsense_Mutation
TCGA-IB-A5SS,TP53,Missense_Mutation
TCGA-IB-A6UF,TP53,Missense_Mutation
TCGA-OE-A75W,TP53,Nonsense_Mutation
TCGA-S4-A8RO,TP53,Missense_Mutation
TCGA-XD-AAUL,TP53,Missense_Mutation
TCGA-XN-A8T3,TP53,Missense_Mutation
TCGA-2J-AAB4,TP53,Missense_Mutation
TCGA-2J-AABF,TP53,Nonsense_Mutation
TCGA-2J-AABI,TP53,Frame_Shift_Ins
Query:
SELECT DISTINCT m1.`ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
WHERE m1.`Study` = 'PAAD' AND m2.`Study` = 'PAAD'
  AND m1.`Hugo_Symbol` = 'KRAS'
  AND m2.`Hugo_Symbol` = 'TP53'
LIMIT 100;
Answer:
ParticipantBarcode
TCGA-2J-AAB6
TCGA-2J-AAB8
TCGA-2J-AABH
TCGA-2J-AABI
TCGA-2J-AABK
TCGA-2L-AAQE
TCGA-3A-A9I9
TCGA-3A-A9IB
TCGA-3A-A9IH
TCGA-FB-A5VM
TCGA-FB-AAQ0
TCGA-FZ-5919
TCGA-FZ-5920
TCGA-FZ-5921
TCGA-FZ-5924
TCGA-FZ-5926
TCGA-HV-A5A6
TCGA-HV-A7OL
TCGA-HZ-7922
TCGA-HZ-7925
TCGA-HZ-8636
TCGA-HZ-A9TJ
TCGA-IB-7644
TCGA-IB-7646
TCGA-IB-7647
TCGA-IB-8127
TCGA-IB-AAUU
TCGA-PZ-A5RE
TCGA-XN-A8T3
TCGA-YH-A8SY
TCGA-2J-AAB4
TCGA-2J-AABO
TCGA-2J-AABT
TCGA-2L-AAQA
TCGA-2L-AAQI
TCGA-2L-AAQL
TCGA-3A-A9IC
TCGA-3A-A9IZ
TCGA-F2-A8YN
TCGA-FB-A78T
TCGA-FB-AAPQ
TCGA-FB-AAPY
TCGA-FB-AAQ3
TCGA-FB-AAQ6
TCGA-H6-8124
TCGA-H8-A6C1
TCGA-HV-AA8V
TCGA-HV-AA8X
TCGA-HZ-A49G
TCGA-HZ-A4BH
TCGA-HZ-A77O
TCGA-IB-7645
TCGA-IB-7649
TCGA-IB-7886
TCGA-IB-7887
TCGA-IB-7893
TCGA-IB-A5SS
TCGA-IB-A6UF
TCGA-IB-AAUN
TCGA-M8-A5N4
TCGA-OE-A75W
TCGA-2J-AABF
TCGA-2J-AABU
TCGA-2L-AAQJ
TCGA-F2-6879
TCGA-F2-A7TX
TCGA-FB-A545
TCGA-FB-AAPZ
TCGA-FB-AAQ1
TCGA-FB-AAQ2
TCGA-HV-A5A3
TCGA-HZ-7926
TCGA-HZ-8005
TCGA-HZ-8315
TCGA-HZ-8637
TCGA-HZ-A49I
TCGA-HZ-A4BK
TCGA-HZ-A77Q
TCGA-IB-7652
TCGA-IB-7889
TCGA-IB-7890
TCGA-IB-A5SO
TCGA-IB-A5SP
TCGA-IB-A6UG
TCGA-IB-A7M4
TCGA-IB-AAUQ
TCGA-S4-A8RO
TCGA-US-A779
TCGA-XD-AAUI
TCGA-XD-AAUL
Query:
SELECT DISTINCT `ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
  AND `ParticipantBarcode` NOT IN (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
  )
LIMIT 100
Answer:
ParticipantBarcode
TCGA-2J-AABE
TCGA-3E-AAAZ
TCGA-HV-A5A4
TCGA-IB-7651
TCGA-S4-A8RP
TCGA-YY-A8LH
TCGA-3A-A9I7
TCGA-FB-A7DR
TCGA-FB-AAPU
TCGA-FZ-5922
TCGA-FZ-5923
TCGA-HV-A7OP
TCGA-HZ-7919
TCGA-HZ-A49H
TCGA-HZ-A8P1
TCGA-IB-A7LX
TCGA-RB-A7B8
TCGA-S4-A8RM
TCGA-2J-AAB1
TCGA-3A-A9IU
TCGA-F2-A44G
TCGA-HZ-A8P0
TCGA-IB-AAUM
TCGA-IB-AAUO
TCGA-Q3-AA2A
TCGA-US-A77G
TCGA-YB-A89D
Query:
SELECT DISTINCT `ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
  AND `ParticipantBarcode` NOT IN (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
  )
LIMIT 100
Answer:
ParticipantBarcode
TCGA-2J-AABP
TCGA-H6-A45N
TCGA-IB-7888
TCGA-LB-A7SX
TCGA-RB-AA9M
TCGA-XD-AAUG
TCGA-HZ-8001
TCGA-IB-7891
TCGA-LB-A9Q5
TCGA-Z5-AAPL
TCGA-2J-AAB9
TCGA-3A-A9IX
TCGA-3A-A9J0
TCGA-3E-AAAY
TCGA-FB-AAPS
TCGA-HV-A5A5
TCGA-HZ-A77P
Query:
SELECT DISTINCT `bcr_patient_barcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup`
WHERE `acronym` = 'PAAD'
LIMIT 100
Answer:
bcr_patient_barcode
TCGA-HZ-A49I
TCGA-FZ-5920
TCGA-HZ-7922
TCGA-S4-A8RO
TCGA-H8-A6C1
TCGA-XD-AAUI
TCGA-HZ-7926
TCGA-HZ-8519
TCGA-F2-A8YN
TCGA-HZ-8003
TCGA-HZ-A77O
TCGA-HZ-A77P
TCGA-HZ-7923
TCGA-FZ-5926
TCGA-L1-A7W4
TCGA-FZ-5924
TCGA-LB-A7SX
TCGA-FZ-5922
TCGA-HZ-7289
TCGA-HZ-A4BK
TCGA-IB-A6UG
TCGA-IB-A6UF
TCGA-F2-A7TX
TCGA-HZ-A77Q
TCGA-F2-A44H
TCGA-HZ-8638
TCGA-IB-AAUP
TCGA-Q3-AA2A
TCGA-HZ-7918
TCGA-IB-AAUN
TCGA-IB-AAUU
TCGA-Q3-A5QY
TCGA-HZ-7925
TCGA-FB-A78T
TCGA-FB-A7DR
TCGA-HZ-A4BH
TCGA-HZ-A49G
TCGA-IB-AAUW
TCGA-IB-A7LX
TCGA-XD-AAUL
TCGA-LB-A9Q5
TCGA-XD-AAUH
TCGA-HZ-A8P0
TCGA-HZ-8002
TCGA-HZ-8317
TCGA-HZ-7919
TCGA-RB-A7B8
TCGA-HZ-7924
TCGA-IB-AAUV
TCGA-FB-A4P5
TCGA-IB-AAUM
TCGA-PZ-A5RE
TCGA-FB-A5VM
TCGA-LB-A8F3
TCGA-IB-AAUR
TCGA-F2-A44G
TCGA-HZ-8315
TCGA-IB-AAUT
TCGA-HZ-A49H
TCGA-IB-A5ST
TCGA-HZ-8637
TCGA-H6-8124
TCGA-HZ-7920
TCGA-IB-AAUS
TCGA-FB-A4P6
TCGA-FZ-5919
TCGA-FZ-5923
TCGA-IB-AAUO
TCGA-HZ-8001
TCGA-FB-A545
TCGA-XD-AAUG
TCGA-YB-A89D
TCGA-IB-A7M4
TCGA-HZ-A9TJ
TCGA-OE-A75W
TCGA-IB-AAUQ
TCGA-H6-A45N
TCGA-HZ-A8P1
TCGA-HZ-8636
TCGA-RB-AA9M
TCGA-HZ-8005
TCGA-F2-7276
TCGA-Z5-AAPL
TCGA-S4-A8RM
TCGA-F2-7273
TCGA-2L-AAQJ
TCGA-HV-A5A5
TCGA-HV-A7OL
TCGA-2J-AABI
TCGA-F2-6879
TCGA-YH-A8SY
TCGA-3A-A9I9
TCGA-IB-8126
TCGA-3A-A9J0
TCGA-US-A77J
TCGA-XN-A8T5
TCGA-2J-AAB1
TCGA-2L-AAQL
TCGA-3A-A9I7
TCGA-2J-AABV
Query:
SELECT DISTINCT `ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.BarcodeMap`
WHERE `Study` = 'PAAD'
  AND `ParticipantBarcode` NOT IN (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` IN ('KRAS', 'TP53')
  )
LIMIT 100
Answer:
ParticipantBarcode
TCGA-2J-AABA
TCGA-2J-AABR
TCGA-2J-AABV
TCGA-3A-A9I5
TCGA-3A-A9IJ
TCGA-3A-A9IL
TCGA-3A-A9IN
TCGA-3A-A9IO
TCGA-3A-A9IR
TCGA-3A-A9IS
TCGA-3A-A9IV
TCGA-F2-6880
TCGA-F2-7273
TCGA-F2-7276
TCGA-F2-A44H
TCGA-FB-A4P5
TCGA-FB-A4P6
TCGA-HZ-7289
TCGA-HZ-7918
TCGA-HZ-7920
TCGA-HZ-7923
TCGA-HZ-7924
TCGA-HZ-8002
TCGA-HZ-8003
TCGA-HZ-8317
TCGA-HZ-8519
TCGA-HZ-8638
TCGA-IB-7654
TCGA-IB-7885
TCGA-IB-7897
TCGA-IB-8126
TCGA-IB-A5SQ
TCGA-IB-A5ST
TCGA-IB-AAUP
TCGA-IB-AAUR
TCGA-IB-AAUS
TCGA-IB-AAUT
TCGA-IB-AAUV
TCGA-IB-AAUW
TCGA-L1-A7W4
TCGA-LB-A8F3
TCGA-Q3-A5QY
TCGA-RL-AAAS
TCGA-XN-A8T5
TCGA-2L-AAQM
TCGA-FB-AAPP
TCGA-US-A774
TCGA-US-A776
TCGA-US-A77E
TCGA-US-A77J
TCGA-XD-AAUH
TCGA-07-0227
TCGA-AV-A03D
Query:
SELECT c.`bcr_patient_barcode`, c.`vital_status`, m.`Hugo_Symbol`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
ON c.`bcr_patient_barcode` = m.`ParticipantBarcode`
WHERE c.`acronym` = 'PAAD' AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
LIMIT 100
Answer:
bcr_patient_barcode,vital_status,Hugo_Symbol
TCGA-HZ-A49I,Dead,TP53
TCGA-HZ-A49I,Dead,KRAS
TCGA-FZ-5920,Dead,TP53
TCGA-FZ-5920,Dead,KRAS
TCGA-HZ-7922,Alive,TP53
TCGA-HZ-7922,Alive,KRAS
TCGA-S4-A8RO,Alive,KRAS
TCGA-S4-A8RO,Alive,TP53
TCGA-H8-A6C1,Alive,TP53
TCGA-H8-A6C1,Alive,KRAS
TCGA-XD-AAUI,Dead,KRAS
TCGA-XD-AAUI,Dead,TP53
TCGA-HZ-7926,Dead,KRAS
TCGA-HZ-7926,Dead,TP53
TCGA-F2-A8YN,Alive,TP53
TCGA-F2-A8YN,Alive,KRAS
TCGA-HZ-A77O,Dead,TP53
TCGA-HZ-A77O,Dead,KRAS
TCGA-HZ-A77P,Alive,TP53
TCGA-FZ-5926,Dead,KRAS
TCGA-FZ-5926,Dead,TP53
TCGA-FZ-5924,Dead,KRAS
TCGA-FZ-5924,Dead,TP53
TCGA-LB-A7SX,Dead,TP53
TCGA-FZ-5922,Dead,KRAS
TCGA-HZ-A4BK,Alive,KRAS
TCGA-HZ-A4BK,Alive,TP53
TCGA-IB-A6UG,Dead,KRAS
TCGA-IB-A6UG,Dead,TP53
TCGA-IB-A6UF,Alive,KRAS
TCGA-IB-A6UF,Alive,TP53
TCGA-F2-A7TX,Dead,KRAS
TCGA-F2-A7TX,Dead,TP53
TCGA-HZ-A77Q,Alive,KRAS
TCGA-HZ-A77Q,Alive,TP53
TCGA-Q3-AA2A,Alive,KRAS
TCGA-IB-AAUN,Dead,TP53
TCGA-IB-AAUN,Dead,KRAS
TCGA-IB-AAUU,Alive,TP53
TCGA-IB-AAUU,Alive,KRAS
TCGA-HZ-7925,Dead,KRAS
TCGA-HZ-7925,Dead,TP53
TCGA-FB-A78T,Dead,KRAS
TCGA-FB-A78T,Dead,KRAS
TCGA-FB-A78T,Dead,TP53
TCGA-FB-A7DR,Dead,KRAS
TCGA-HZ-A4BH,Alive,TP53
TCGA-HZ-A4BH,Alive,KRAS
TCGA-HZ-A49G,Alive,TP53
TCGA-HZ-A49G,Alive,KRAS
TCGA-IB-A7LX,Dead,KRAS
TCGA-XD-AAUL,Alive,KRAS
TCGA-XD-AAUL,Alive,TP53
TCGA-LB-A9Q5,Dead,TP53
TCGA-HZ-A8P0,Alive,KRAS
TCGA-HZ-7919,Dead,KRAS
TCGA-RB-A7B8,Dead,KRAS
TCGA-IB-AAUM,Alive,KRAS
Query:
SELECT DISTINCT `Variant_Classification`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
LIMIT 100
Answer:
Variant_Classification
Missense_Mutation
Query:
SELECT m1.`ParticipantBarcode`, c.`OS_time`
FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR` AS c
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m1
ON c.`ParticipantBarcode` = m1.`ParticipantBarcode`
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m2
ON m1.`ParticipantBarcode` = m2.`ParticipantBarcode`
WHERE c.`Study` = 'PAAD'
  AND m1.`Hugo_Symbol` = 'KRAS'
  AND m2.`Hugo_Symbol` = 'TP53'
LIMIT 100
Answer:
ParticipantBarcode,OS_time
TCGA-IB-7649,467
TCGA-OE-A75W,267
TCGA-FB-AAPQ,1130
TCGA-3A-A9IB,224
TCGA-FZ-5920,61
TCGA-IB-AAUN,144
TCGA-HV-AA8V,920
TCGA-HZ-A4BH,194
TCGA-IB-A6UG,41
TCGA-3A-A9IH,1021
TCGA-M8-A5N4,584
TCGA-HZ-7922,4
TCGA-2J-AABI,969
TCGA-XN-A8T3,951
TCGA-HV-A7OL,252
TCGA-HZ-A49G,660
TCGA-HZ-A9TJ,603
TCGA-HZ-A9TJ,603
TCGA-HZ-A9TJ,603
TCGA-HZ-A9TJ,603
TCGA-H8-A6C1,671
TCGA-HZ-A77Q,33
TCGA-HZ-A4BK,657
TCGA-YH-A8SY,388
TCGA-2J-AAB8,80
TCGA-F2-A8YN,517
TCGA-IB-A6UF,666
TCGA-2J-AABO,440
TCGA-IB-A5SP,482
TCGA-2J-AABT,319
TCGA-H6-8124,392
TCGA-HZ-8637,517
TCGA-2J-AABH,1287
TCGA-2J-AABH,1287
TCGA-FB-AAQ3,31
TCGA-S4-A8RO,525
TCGA-FB-AAPY,1059
TCGA-IB-7652,1116
TCGA-IB-7886,123
TCGA-HV-A5A3,128
TCGA-FB-AAPZ,716
TCGA-FB-AAQ0,473
TCGA-2J-AAB4,729
TCGA-IB-A7M4,483
TCGA-2J-AABK,484
TCGA-IB-8127,522
TCGA-HV-A5A6,2036
TCGA-XD-AAUL,498
TCGA-IB-AAUU,245
TCGA-FB-AAQ6,244
TCGA-F2-A7TX,95
TCGA-FB-AAQ1,123
TCGA-2L-AAQI,103
TCGA-HZ-8636,545
TCGA-HZ-A49I,308
TCGA-3A-A9IC,738
TCGA-3A-A9I9,634
TCGA-FZ-5919,741
TCGA-HV-AA8X,532
TCGA-HZ-8315,299
TCGA-2L-AAQJ,394
TCGA-FZ-5921,155
TCGA-IB-7647,666
TCGA-IB-A5SO,365
TCGA-HZ-7926,518
TCGA-2J-AABF,691
TCGA-2L-AAQL,292
TCGA-IB-7644,394
TCGA-HZ-8005,120
TCGA-IB-7893,117
TCGA-2J-AABU,277
TCGA-2J-AAB6,293
TCGA-US-A779,511
TCGA-IB-7889,481
TCGA-IB-7890,598
TCGA-PZ-A5RE,470
TCGA-2L-AAQA,143
TCGA-XD-AAUI,366
TCGA-2L-AAQE,684
TCGA-FB-A5VM,498
TCGA-FZ-5924,480
TCGA-FB-AAQ2,153
TCGA-IB-7887,110
TCGA-3A-A9IZ,308
TCGA-FZ-5926,541
TCGA-IB-7645,1502
TCGA-IB-7646,145
TCGA-IB-AAUQ,183
TCGA-IB-A5SS,460
TCGA-HZ-A77O,160
TCGA-HZ-7925,614
TCGA-FB-A78T,375
TCGA-FB-A78T,375
Query:
SELECT `ParticipantBarcode`, COUNT(*) AS `num_mutations`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
GROUP BY `ParticipantBarcode`
LIMIT 100
Answer:
ParticipantBarcode,num_mutations
TCGA-2J-AABE,1
TCGA-2J-AABF,1
TCGA-2J-AABH,2
TCGA-2J-AABU,1
TCGA-2L-AAQJ,1
TCGA-3E-AAAZ,1
TCGA-F2-6879,1
TCGA-F2-A7TX,1
TCGA-FB-A545,1
TCGA-FB-AAPZ,1
TCGA-FB-AAQ1,1
TCGA-FB-AAQ2,1
TCGA-HV-A5A3,1
TCGA-HV-A5A4,1
TCGA-HZ-7926,1
TCGA-HZ-8005,1
TCGA-HZ-8315,1
TCGA-HZ-8637,1
TCGA-HZ-A49I,1
TCGA-HZ-A4BK,1
TCGA-HZ-A77Q,1
TCGA-HZ-A9TJ,2
TCGA-IB-7651,1
TCGA-IB-7652,1
TCGA-IB-7889,1
TCGA-IB-7890,1
TCGA-IB-A5SO,1
TCGA-IB-A5SP,1
TCGA-IB-A6UG,1
TCGA-IB-A7M4,1
TCGA-IB-AAUQ,1
TCGA-S4-A8RO,1
TCGA-S4-A8RP,1
TCGA-US-A779,1
TCGA-XD-AAUI,1
TCGA-XD-AAUL,1
TCGA-YY-A8LH,1
TCGA-2J-AAB4,1
TCGA-2J-AABO,1
TCGA-2J-AABT,1
TCGA-2L-AAQA,1
TCGA-2L-AAQI,1
TCGA-2L-AAQL,1
TCGA-3A-A9I7,1
TCGA-3A-A9IC,1
TCGA-3A-A9IZ,1
TCGA-F2-A8YN,1
TCGA-FB-A78T,2
TCGA-FB-A7DR,1
TCGA-FB-AAPQ,1
TCGA-FB-AAPU,1
TCGA-FB-AAPY,1
TCGA-FB-AAQ3,1
TCGA-FB-AAQ6,1
TCGA-FZ-5922,1
TCGA-FZ-5923,1
TCGA-H6-8124,1
TCGA-H8-A6C1,1
TCGA-HV-A7OP,1
TCGA-HV-AA8V,1
TCGA-HV-AA8X,1
TCGA-HZ-7919,1
TCGA-HZ-A49G,1
TCGA-HZ-A49H,1
TCGA-HZ-A4BH,1
TCGA-HZ-A77O,1
TCGA-HZ-A8P1,1
TCGA-IB-7645,1
TCGA-IB-7649,1
TCGA-IB-7886,1
TCGA-IB-7887,1
TCGA-IB-7893,1
TCGA-IB-A5SS,1
TCGA-IB-A6UF,1
TCGA-IB-A7LX,1
TCGA-IB-AAUN,1
TCGA-M8-A5N4,1
TCGA-OE-A75W,1
TCGA-RB-A7B8,1
TCGA-S4-A8RM,1
TCGA-2J-AAB1,1
TCGA-2J-AAB6,1
TCGA-2J-AAB8,1
TCGA-2J-AABI,1
TCGA-2J-AABK,1
TCGA-2L-AAQE,1
TCGA-3A-A9I9,1
Query:
SELECT c.`ParticipantBarcode`, c.`OS`, m.`Hugo_Symbol`
FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR` AS c
INNER JOIN `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
ON c.`ParticipantBarcode` = m.`ParticipantBarcode`
WHERE c.`Study` = 'PAAD' AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
LIMIT 100
Answer:
ParticipantBarcode,OS,Hugo_Symbol
TCGA-IB-7649,1,TP53
TCGA-IB-7649,1,KRAS
TCGA-S4-A8RP,1,KRAS
TCGA-OE-A75W,1,TP53
TCGA-OE-A75W,1,KRAS
TCGA-FB-AAPQ,1,TP53
TCGA-FB-AAPQ,1,KRAS
TCGA-3A-A9IB,1,TP53
TCGA-3A-A9IB,1,KRAS
TCGA-FZ-5920,1,KRAS
TCGA-FZ-5920,1,TP53
TCGA-IB-AAUN,1,TP53
TCGA-IB-AAUN,1,KRAS
TCGA-HV-AA8V,0,TP53
TCGA-HV-AA8V,0,KRAS
TCGA-HZ-A4BH,0,TP53
TCGA-HZ-A4BH,0,KRAS
TCGA-IB-A6UG,1,KRAS
TCGA-IB-A6UG,1,TP53
TCGA-3A-A9IH,0,KRAS
TCGA-3A-A9IH,0,TP53
TCGA-M8-A5N4,0,KRAS
TCGA-M8-A5N4,0,TP53
TCGA-FB-AAPS,0,TP53
TCGA-HV-A7OP,0,KRAS
TCGA-HZ-7922,0,KRAS
TCGA-HZ-7922,0,TP53
TCGA-2J-AABI,0,TP53
TCGA-2J-AABI,0,KRAS
TCGA-XN-A8T3,0,KRAS
TCGA-XN-A8T3,0,TP53
TCGA-HV-A7OL,0,KRAS
TCGA-HV-A7OL,0,TP53
TCGA-LB-A7SX,1,TP53
TCGA-HZ-A49G,0,TP53
TCGA-HZ-A49G,0,KRAS
TCGA-HZ-A9TJ,0,KRAS
TCGA-HZ-A9TJ,0,TP53
TCGA-HZ-A9TJ,0,TP53
TCGA-HZ-A9TJ,0,KRAS
TCGA-H8-A6C1,0,TP53
TCGA-H8-A6C1,0,KRAS
TCGA-HZ-A77Q,0,KRAS
TCGA-HZ-A77Q,0,TP53
TCGA-RB-AA9M,0,TP53
TCGA-HZ-A4BK,0,KRAS
TCGA-HZ-A4BK,0,TP53
TCGA-3A-A9J0,0,TP53
TCGA-YH-A8SY,0,TP53
TCGA-YH-A8SY,0,KRAS
TCGA-2J-AAB8,0,KRAS
TCGA-2J-AAB8,0,TP53
TCGA-F2-A8YN,0,TP53
TCGA-F2-A8YN,0,KRAS
TCGA-HZ-A8P0,0,KRAS
TCGA-IB-AAUM,0,KRAS
TCGA-US-A77G,1,KRAS
TCGA-IB-A6UF,0,TP53
TCGA-IB-A6UF,0,KRAS
TCGA-2J-AABO,0,TP53
TCGA-2J-AABO,0,KRAS
TCGA-Q3-AA2A,0,KRAS
TCGA-3A-A9I7,0,KRAS
TCGA-3E-AAAZ,1,KRAS
TCGA-IB-A5SP,0,KRAS
TCGA-IB-A5SP,0,TP53
TCGA-XD-AAUG,0,TP53
TCGA-2J-AABT,0,KRAS
TCGA-2J-AABT,0,TP53
TCGA-HZ-A8P1,0,KRAS
TCGA-H6-8124,0,TP53
TCGA-H6-8124,0,KRAS
Query:
SELECT c.`bcr_patient_barcode`, c.`vital_status`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
WHERE c.`acronym` = 'PAAD' AND c.`bcr_patient_barcode` NOT IN (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` IN ('KRAS', 'TP53')
)
LIMIT 100
Answer:
bcr_patient_barcode,vital_status
TCGA-HZ-8519,Alive
TCGA-HZ-8003,Dead
TCGA-HZ-7923,Alive
TCGA-L1-A7W4,Dead
TCGA-HZ-7289,Dead
TCGA-F2-A44H,Alive
TCGA-HZ-8638,Dead
TCGA-IB-AAUP,Alive
TCGA-HZ-7918,Alive
TCGA-Q3-A5QY,Alive
TCGA-IB-AAUW,Dead
TCGA-XD-AAUH,Alive
TCGA-HZ-8002,Dead
TCGA-HZ-8317,Dead
TCGA-HZ-7924,Alive
TCGA-IB-AAUV,Alive
TCGA-FB-A4P5,Dead
TCGA-LB-A8F3,Alive
TCGA-IB-AAUR,Alive
TCGA-IB-AAUT,Alive
TCGA-IB-A5ST,Alive
TCGA-HZ-7920,Dead
TCGA-IB-AAUS,Alive
TCGA-FB-A4P6,Alive
TCGA-F2-7276,Dead
TCGA-F2-7273,Dead
TCGA-IB-8126,Alive
TCGA-US-A77J,Dead
TCGA-XN-A8T5,Alive
TCGA-2J-AABV,Dead
TCGA-RL-AAAS,Alive
TCGA-3A-A9I5,Alive
TCGA-3A-A9IJ,Alive
TCGA-FB-AAPP,Dead
TCGA-2L-AAQM,Alive
TCGA-US-A774,Dead
TCGA-US-A77E,Dead
TCGA-2J-AABA,Dead
TCGA-IB-A5SQ,Dead
TCGA-F2-6880,Alive
TCGA-US-A776,Alive
TCGA-3A-A9IS,Alive
TCGA-3A-A9IO,Alive
TCGA-3A-A9IL,Alive
TCGA-3A-A9IN,Alive
TCGA-3A-A9IV,Alive
TCGA-3A-A9IR,Alive
TCGA-2J-AABR,Alive
TCGA-IB-7885,Alive
TCGA-IB-7897,Dead
Query:
SELECT DISTINCT `HGVSp_Short`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
LIMIT 100
Answer:
HGVSp_Short
p.G12V
p.G12R
p.Q61R
p.G12D
p.G13C
p.G12A
p.Q61H
p.G12C
p.G12S
Query:
SELECT `ParticipantBarcode`, `Hugo_Symbol`, `HGVSp_Short`, `Variant_Classification`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
LIMIT 100
Answer:
ParticipantBarcode,Hugo_Symbol,HGVSp_Short,Variant_Classification
TCGA-2J-AABE,KRAS,p.G12R,Missense_Mutation
TCGA-2J-AABF,KRAS,p.G12D,Missense_Mutation
TCGA-2J-AABH,KRAS,p.G12V,Missense_Mutation
TCGA-2J-AABU,KRAS,p.G12R,Missense_Mutation
TCGA-2L-AAQJ,KRAS,p.G12D,Missense_Mutation
TCGA-3E-AAAZ,KRAS,p.G12V,Missense_Mutation
TCGA-F2-6879,KRAS,p.G12V,Missense_Mutation
TCGA-F2-A7TX,KRAS,p.G12D,Missense_Mutation
TCGA-FB-A545,KRAS,p.G12V,Missense_Mutation
TCGA-FB-AAPZ,KRAS,p.G12R,Missense_Mutation
TCGA-FB-AAQ1,KRAS,p.G12D,Missense_Mutation
TCGA-FB-AAQ2,KRAS,p.G12D,Missense_Mutation
TCGA-HV-A5A3,KRAS,p.G12D,Missense_Mutation
TCGA-HV-A5A4,KRAS,p.G12V,Missense_Mutation
TCGA-HZ-7926,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-8005,KRAS,p.Q61H,Missense_Mutation
TCGA-HZ-8315,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-8637,KRAS,p.G12V,Missense_Mutation
TCGA-HZ-A49I,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-A4BK,KRAS,p.G12D,Missense_Mutation
TCGA-HZ-A77Q,KRAS,p.G12R,Missense_Mutation
TCGA-HZ-A9TJ,KRAS,p.G12V,Missense_Mutation
TCGA-IB-7651,KRAS,p.G12D,Missense_Mutation
TCGA-IB-7652,KRAS,p.G12R,Missense_Mutation
TCGA-IB-7889,KRAS,p.G12V,Missense_Mutation
TCGA-IB-7890,KRAS,p.Q61R,Missense_Mutation
TCGA-IB-A5SO,KRAS,p.G12D,Missense_Mutation
TCGA-IB-A5SP,KRAS,p.G12D,Missense_Mutation
TCGA-IB-A6UG,KRAS,p.G12D,Missense_Mutation
TCGA-IB-A7M4,KRAS,p.G12D,Missense_Mutation
TCGA-IB-AAUQ,KRAS,p.G12D,Missense_Mutation
TCGA-S4-A8RO,KRAS,p.G12D,Missense_Mutation
TCGA-S4-A8RP,KRAS,p.G12R,Missense_Mutation
TCGA-US-A779,KRAS,p.G12D,Missense_Mutation
TCGA-XD-AAUI,KRAS,p.G12V,Missense_Mutation
TCGA-XD-AAUL,KRAS,p.G12R,Missense_Mutation
TCGA-YY-A8LH,KRAS,p.G12V,Missense_Mutation
TCGA-2J-AAB4,KRAS,p.G12V,Missense_Mutation
Query:
SELECT `Variant_Classification`, COUNT(*) AS `mutation_count`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
GROUP BY `Variant_Classification`
LIMIT 100
Answer:
Variant_Classification,mutation_count
Missense_Mutation,120
Query:
SELECT DISTINCT m.`ParticipantBarcode`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
WHERE m.`Study` = 'PAAD'
  AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
  AND m.`Variant_Classification` IN (
    'Frame_Shift_Del', 'Frame_Shift_Ins', 'In_Frame_Del', 'In_Frame_Ins',
    'Missense_Mutation', 'Nonsense_Mutation', 'Nonstop_Mutation',
    'Splice_Site', 'Translation_Start_Site'
  )
LIMIT 100
Answer:
ParticipantBarcode
TCGA-2J-AAB4
TCGA-2J-AABE
TCGA-2J-AABF
TCGA-2J-AABH
TCGA-2J-AABI
TCGA-2J-AABU
TCGA-2L-AAQJ
TCGA-2L-AAQL
TCGA-3A-A9IC
TCGA-3A-A9IZ
TCGA-3E-AAAZ
TCGA-F2-6879
TCGA-F2-A7TX
TCGA-FB-A545
TCGA-FB-AAPY
TCGA-FB-AAPZ
TCGA-FB-AAQ1
TCGA-FB-AAQ2
TCGA-FB-AAQ6
TCGA-HV-A5A3
TCGA-HV-A5A4
TCGA-HV-AA8V
TCGA-HZ-7926
TCGA-HZ-8001
TCGA-HZ-8005
TCGA-HZ-8315
TCGA-HZ-8637
TCGA-HZ-A49I
TCGA-HZ-A4BH
TCGA-HZ-A4BK
TCGA-HZ-A77Q
TCGA-HZ-A9TJ
TCGA-IB-7644
TCGA-IB-7651
TCGA-IB-7652
TCGA-IB-7886
TCGA-IB-7889
TCGA-IB-7890
TCGA-IB-7891
TCGA-IB-7893
TCGA-IB-8127
TCGA-IB-A5SO
TCGA-IB-A5SP
TCGA-IB-A6UG
TCGA-IB-A7M4
TCGA-IB-AAUN
TCGA-IB-AAUQ
TCGA-LB-A9Q5
TCGA-S4-A8RO
TCGA-S4-A8RP
TCGA-US-A779
TCGA-XD-AAUI
TCGA-XD-AAUL
TCGA-YH-A8SY
TCGA-YY-A8LH
TCGA-Z5-AAPL
TCGA-2J-AAB8
TCGA-2J-AABK
TCGA-2J-AABO
TCGA-2J-AABP
TCGA-2J-AABT
TCGA-2L-AAQA
TCGA-2L-AAQI
TCGA-3A-A9I7
TCGA-3A-A9IH
TCGA-F2-A8YN
TCGA-FB-A5VM
TCGA-FB-A78T
TCGA-FB-A7DR
TCGA-FB-AAPQ
TCGA-FB-AAPU
TCGA-FB-AAQ3
TCGA-FZ-5920
TCGA-FZ-5921
TCGA-FZ-5922
TCGA-FZ-5923
TCGA-H6-8124
TCGA-H6-A45N
TCGA-H8-A6C1
TCGA-HV-A7OP
TCGA-HV-AA8X
TCGA-HZ-7919
TCGA-HZ-7922
TCGA-HZ-A49G
TCGA-HZ-A49H
TCGA-HZ-A77O
TCGA-HZ-A8P1
TCGA-IB-7645
TCGA-IB-7646
TCGA-IB-7649
TCGA-IB-7887
TCGA-IB-7888
TCGA-IB-A5SS
TCGA-IB-A6UF
TCGA-IB-A7LX
TCGA-IB-AAUU
TCGA-LB-A7SX
TCGA-M8-A5N4
TCGA-OE-A75W
TCGA-PZ-A5RE
Query:
SELECT c.`bcr_patient_barcode`, c.`vital_status`, c.`days_to_last_followup`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_clinical_PANCAN_patient_with_followup` AS c
WHERE c.`acronym` = 'PAAD' AND c.`bcr_patient_barcode` NOT IN (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` IN ('KRAS', 'TP53')
)
LIMIT 100
Answer:
bcr_patient_barcode,vital_status,days_to_last_followup
TCGA-HZ-8519,Alive,454.0
TCGA-HZ-8003,Dead,21
TCGA-HZ-7923,Alive,314.0
TCGA-L1-A7W4,Dead,164
TCGA-HZ-7289,Dead,240
TCGA-F2-A44H,Alive,586.0
TCGA-HZ-8638,Dead,91
TCGA-IB-AAUP,Alive,431.0
TCGA-HZ-7918,Alive,969.0
TCGA-Q3-A5QY,Alive,416.0
TCGA-IB-AAUW,Dead,179
TCGA-XD-AAUH,Alive,395.0
TCGA-HZ-8002,Dead,24
TCGA-HZ-8317,Dead,16
TCGA-HZ-7924,Alive,840.0
TCGA-IB-AAUV,Alive,404.0
TCGA-FB-A4P5,Dead,4
TCGA-LB-A8F3,Alive,379.0
TCGA-IB-AAUR,Alive,338.0
TCGA-IB-AAUT,Alive,287.0
TCGA-IB-A5ST,Alive,635.0
TCGA-HZ-7920,Dead,0
TCGA-IB-AAUS,Alive,225.0
TCGA-FB-A4P6,Alive,767.0
TCGA-F2-7276,Dead,
TCGA-F2-7273,Dead,360.0
TCGA-IB-8126,Alive,462.0
TCGA-US-A77J,Dead,
TCGA-XN-A8T5,Alive,720.0
TCGA-2J-AABV,Dead,
TCGA-RL-AAAS,Alive,9.0
TCGA-3A-A9I5,Alive,1794.0
TCGA-3A-A9IJ,Alive,1854.0
TCGA-FB-AAPP,Dead,
TCGA-2L-AAQM,Alive,1383.0
TCGA-US-A774,Dead,
TCGA-US-A77E,Dead,
TCGA-2J-AABA,Dead,
TCGA-IB-A5SQ,Dead,
TCGA-F2-6880,Alive,289.0
TCGA-US-A776,Alive,1216.0
TCGA-3A-A9IS,Alive,998.0
TCGA-3A-A9IO,Alive,1942.0
TCGA-3A-A9IL,Alive,2741.0
TCGA-3A-A9IN,Alive,2084.0
TCGA-3A-A9IV,Alive,1103.0
TCGA-3A-A9IR,Alive,1542.0
TCGA-2J-AABR,Alive,438.0
TCGA-IB-7885,Alive,1257.0
TCGA-IB-7897,Dead,
Query:
SELECT m.`ParticipantBarcode`, m.`Hugo_Symbol`, COUNT(*) AS `mutation_count`
FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
WHERE m.`Study` = 'PAAD' AND m.`Hugo_Symbol` IN ('KRAS', 'TP53')
GROUP BY m.`ParticipantBarcode`, m.`Hugo_Symbol`
LIMIT 100
Answer:
ParticipantBarcode,Hugo_Symbol,mutation_count
TCGA-2J-AAB4,TP53,1
TCGA-2J-AABE,KRAS,1
TCGA-2J-AABF,KRAS,1
TCGA-2J-AABF,TP53,1
TCGA-2J-AABH,KRAS,2
TCGA-2J-AABI,TP53,1
TCGA-2J-AABU,KRAS,1
TCGA-2L-AAQJ,TP53,1
TCGA-2L-AAQJ,KRAS,1
TCGA-2L-AAQL,TP53,1
TCGA-3A-A9IC,TP53,1
TCGA-3A-A9IZ,TP53,1
TCGA-3E-AAAZ,KRAS,1
TCGA-F2-6879,KRAS,1
TCGA-F2-A7TX,KRAS,1
TCGA-FB-A545,KRAS,1
TCGA-FB-A545,TP53,1
TCGA-FB-AAPY,TP53,1
TCGA-FB-AAPZ,TP53,1
TCGA-FB-AAPZ,KRAS,1
TCGA-FB-AAQ1,KRAS,1
TCGA-FB-AAQ2,KRAS,1
TCGA-FB-AAQ6,TP53,1
TCGA-HV-A5A3,KRAS,1
TCGA-HV-A5A3,TP53,1
TCGA-HV-A5A4,KRAS,1
TCGA-HV-AA8V,TP53,1
TCGA-HZ-7926,KRAS,1
TCGA-HZ-8001,TP53,1
TCGA-HZ-8005,KRAS,1
TCGA-HZ-8315,KRAS,1
TCGA-HZ-8637,KRAS,1
TCGA-HZ-A49I,TP53,1
TCGA-HZ-A49I,KRAS,1
TCGA-HZ-A4BH,TP53,1
TCGA-HZ-A4BK,KRAS,1
TCGA-HZ-A77Q,KRAS,1
TCGA-HZ-A9TJ,KRAS,2
TCGA-HZ-A9TJ,TP53,2
TCGA-IB-7644,TP53,1
TCGA-IB-7651,KRAS,1
TCGA-IB-7652,KRAS,1
TCGA-IB-7886,TP53,1
TCGA-IB-7889,TP53,1
TCGA-IB-7889,KRAS,1
TCGA-IB-7890,TP53,1
TCGA-IB-7890,KRAS,1
TCGA-IB-7891,TP53,1
TCGA-IB-7893,TP53,1
TCGA-IB-8127,TP53,1
TCGA-IB-A5SO,KRAS,1
TCGA-IB-A5SP,KRAS,1
TCGA-IB-A5SP,TP53,1
TCGA-IB-A6UG,KRAS,1
TCGA-IB-A7M4,TP53,1
TCGA-IB-A7M4,KRAS,1
TCGA-IB-AAUN,TP53,1
TCGA-IB-AAUQ,TP53,1
TCGA-IB-AAUQ,KRAS,1
TCGA-LB-A9Q5,TP53,1
TCGA-S4-A8RO,KRAS,1
End Exploring Related Columns
Task: Using TCGA dataset, calculate the chi-squared statistic to evaluate the association between KRAS and TP53 gene mutations in patients diagnosed with pancreatic adenocarcinoma (PAAD). Incorporate clinical follow-up data and high-quality mutation annotations to accurately determine the frequency of patients with co-occurring KRAS and TP53 mutations compared to those with each mutation occurring independently. Ensure that patient records are meticulously matched based on unique identifiers to maintain data integrity. This analysis aims to identify and quantify potential correlations between KRAS and TP53 genetic alterations within the PAAD patient population.

Please answer only one complete SQL in bigquery dialect in ```sql``` format.
Usage example: ```sql
SELECT `column_name` FROM `database.schema.table` WHERE ... ``` (Replace `database`, `schema`, and `table` with actual names. Enclose column names and table identifiers with backticks.)
Follow the answer format like: ```csv
chi-squared_value
value:float
(Attention: answer in one row)
```

To evaluate the association between **KRAS** and **TP53** gene mutations in patients diagnosed with pancreatic adenocarcinoma (PAAD), the chi-squared statistic was calculated using the TCGA dataset. Clinical follow-up data and high-quality mutation annotations were incorporated to accurately determine the frequency of patients with co-occurring **KRAS** and **TP53** mutations compared to those with each mutation occurring independently. This analysis identifies and quantifies potential correlations between **KRAS** and **TP53** genetic alterations within the PAAD patient population..
Here are some useful tips for answering:
When performing a UNION operation on many tables, ensure that all table names are explicitly listed. Union first and then add condition and selection. e.g. SELECT "col1", "col2" FROM (TABLE1 UNION ALL TABLE2) WHERE ...; Don't write sqls as (SELECT col1, col2 FROM TABLE1 WHERE ...) UNION ALL (SELECT col1, col2 FROM TABLE2 WHERE ...); Don't use ['-- Include all', '-- Omit', '-- Continue', '-- Union all', '-- ...', '-- List all', '-- Replace this', '-- Each table', '-- Add other'] to omit any table. Table names here: ({database name: {schema name: {table name}}}): 
{'isb-cgc-bq': {'pancancer_atlas': ['BarcodeMap', 'Filtered_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp', 'Filtered_MC3_MAF_V5_one_per_tumor_sample', 'Filtered_TCGA_RPPA_pancan_clean', 'Filtered_all_CNVR_data_by_gene', 'Filtered_clinical_PANCAN_patient_with_followup', 'Filtered_jhu_usc_edu_PANCAN_HumanMethylation27_betaValue_whitelisted', 'Filtered_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted', 'Filtered_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted', 'Filtered_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16', 'Original_EBpp_AdjustPANCAN_IlluminaHiSeq_RNASeqV2_genExp', 'Original_TCGA_RPPA_pancan_clean', 'Original_clinical_PANCAN_patient_with_followup', 'Original_jhu_usc_edu_PANCAN_HumanMethylation27_betaValue_whitelisted', 'Original_jhu_usc_edu_PANCAN_HumanMethylation450_betaValue_whitelisted', 'Original_jhu_usc_edu_PANCAN_merged_HumanMethylation27_HumanMethylation450_betaValue_whitelisted', 'Original_pancanMiRs_EBadjOnProtocolPlatformWithoutRepsWithUnCorrectMiRs_08_04_16', 'TCGA_CDR', 'TCGA_Clinical_Data_Resource_Extra', 'Whitelist_ParticipantBarcodes', 'merged_sample_quality_annotations']}}

For string-matching scenarios, if the string is decided, don't use fuzzy query, and avoid using REGEXP. e.g. Get the object's title contains the word "book"
However, if the string is not decided, you may use fuzzy query and ignore upper or lower case. e.g. Get articles that mention "education".
When using ORDER BY, if there are duplicate values in the primary sort column, sort by an additional column as a secondary criterion.Keep all decimals to four decimal places.
Be careful of information in nested columns. e.g. When it comes to completed purchase, `hits.eCommerceAction.action_type` Indicates the type of ecommerce action and '6' represents completed purchases.
Be careful one country may have different country_name and country_region in different columns in a database.
Don't be misled by examples. For instance, a question related to Android development on StackOverflow might include tags like 'android-layout,' 'android-activity,' or 'android-intent.' However, you should not limit your analysis to just these three tags; instead, consider all tags related to Android: "tags" LIKE '%android%'.

2025-01-23 08:53:46 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:53:46 - root - INFO - ```sql
WITH
paad_patients AS (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR`
  WHERE `Study` = 'PAAD'
),
kras_patients AS (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
),
tp53_patients AS (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
),
patient_mutations AS (
  SELECT p.ParticipantBarcode,
    IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM kras_patients), 1, 0) AS Has_KRAS_Mutation,
    IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM tp53_patients), 1, 0) AS Has_TP53_Mutation
  FROM paad_patients p
),
counts AS (
  SELECT
    Has_KRAS_Mutation,
    Has_TP53_Mutation,
    COUNT(*) AS observed_count
  FROM patient_mutations
  GROUP BY Has_KRAS_Mutation, Has_TP53_Mutation
),
total_counts AS (
  SELECT SUM(observed_count) AS total_patients FROM counts
),
marginals AS (
  SELECT
    SUM(CASE WHEN Has_KRAS_Mutation = 1 THEN observed_count ELSE 0 END) AS total_kras_mutated,
    SUM(CASE WHEN Has_KRAS_Mutation = 0 THEN observed_count ELSE 0 END) AS total_kras_not_mutated,
    SUM(CASE WHEN Has_TP53_Mutation = 1 THEN observed_count ELSE 0 END) AS total_tp53_mutated,
    SUM(CASE WHEN Has_TP53_Mutation = 0 THEN observed_count ELSE 0 END) AS total_tp53_not_mutated,
    total_patients
  FROM counts CROSS JOIN total_counts
),
expected_counts AS (
  SELECT
    c.Has_KRAS_Mutation,
    c.Has_TP53_Mutation,
    c.observed_count,
    (
      (CASE WHEN c.Has_TP53_Mutation = 1 THEN m.total_tp53_mutated ELSE m.total_tp53_not_mutated END) *
      (CASE WHEN c.Has_KRAS_Mutation = 1 THEN m.total_kras_mutated ELSE m.total_kras_not_mutated END)
    ) / m.total_patients AS expected_count
  FROM counts c
  CROSS JOIN marginals m
)
SELECT
  SUM(
    ((observed_count - expected_count)*(observed_count - expected_count)) / expected_count
  ) AS chi_squared_value
FROM expected_counts;
```
2025-01-23 08:53:47 - root - INFO - itercount: 1
2025-01-23 08:53:47 - root - INFO - 400 SELECT list expression references column total_patients which is neither grouped nor aggregated at [40:5]; reason: invalidQuery, location: query, message: SELECT list expression references column total_patients which is neither grouped nor aggregated at [40:5]

Location: US
Job ID: 906dac8d-fbf2-4190-834a-ee742a417f36

2025-01-23 08:53:47 - root - INFO - Input sql:
WITH
paad_patients AS (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR`
  WHERE `Study` = 'PAAD'
),
kras_patients AS (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
),
tp53_patients AS (
  SELECT DISTINCT `ParticipantBarcode`
  FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
  WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
),
patient_mutations AS (
  SELECT p.ParticipantBarcode,
    IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM kras_patients), 1, 0) AS Has_KRAS_Mutation,
    IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM tp53_patients), 1, 0) AS Has_TP53_Mutation
  FROM paad_patients p
),
counts AS (
  SELECT
    Has_KRAS_Mutation,
    Has_TP53_Mutation,
    COUNT(*) AS observed_count
  FROM patient_mutations
  GROUP BY Has_KRAS_Mutation, Has_TP53_Mutation
),
total_counts AS (
  SELECT SUM(observed_count) AS total_patients FROM counts
),
marginals AS (
  SELECT
    SUM(CASE WHEN Has_KRAS_Mutation = 1 THEN observed_count ELSE 0 END) AS total_kras_mutated,
    SUM(CASE WHEN Has_KRAS_Mutation = 0 THEN observed_count ELSE 0 END) AS total_kras_not_mutated,
    SUM(CASE WHEN Has_TP53_Mutation = 1 THEN observed_count ELSE 0 END) AS total_tp53_mutated,
    SUM(CASE WHEN Has_TP53_Mutation = 0 THEN observed_count ELSE 0 END) AS total_tp53_not_mutated,
    total_patients
  FROM counts CROSS JOIN total_counts
),
expected_counts AS (
  SELECT
    c.Has_KRAS_Mutation,
    c.Has_TP53_Mutation,
    c.observed_count,
    (
      (CASE WHEN c.Has_TP53_Mutation = 1 THEN m.total_tp53_mutated ELSE m.total_tp53_not_mutated END) *
      (CASE WHEN c.Has_KRAS_Mutation = 1 THEN m.total_kras_mutated ELSE m.total_kras_not_mutated END)
    ) / m.total_patients AS expected_count
  FROM counts c
  CROSS JOIN marginals m
)
SELECT
  SUM(
    ((observed_count - expected_count)*(observed_count - expected_count)) / expected_count
  ) AS chi_squared_value
FROM expected_counts;
The error information is:
400 SELECT list expression references column total_patients which is neither grouped nor aggregated at [40:5]; reason: invalidQuery, location: query, message: SELECT list expression references column total_patients which is neither grouped nor aggregated at [40:5]

Location: US
Job ID: 906dac8d-fbf2-4190-834a-ee742a417f36

Please correct it and output only 1 complete SQL query.
2025-01-23 08:54:46 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:54:46 - root - INFO - ```sql
WITH
  paad_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR`
    WHERE `Study` = 'PAAD'
  ),
  kras_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
  ),
  tp53_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
  ),
  patient_mutations AS (
    SELECT
      p.ParticipantBarcode,
      IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM kras_patients), 1, 0) AS Has_KRAS_Mutation,
      IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM tp53_patients), 1, 0) AS Has_TP53_Mutation
    FROM paad_patients p
  ),
  counts AS (
    SELECT
      Has_KRAS_Mutation,
      Has_TP53_Mutation,
      COUNT(*) AS observed_count
    FROM patient_mutations
    GROUP BY Has_KRAS_Mutation, Has_TP53_Mutation
  ),
  marginals AS (
    SELECT
      SUM(CASE WHEN Has_KRAS_Mutation = 1 THEN observed_count ELSE 0 END) AS total_kras_mutated,
      SUM(CASE WHEN Has_KRAS_Mutation = 0 THEN observed_count ELSE 0 END) AS total_kras_not_mutated,
      SUM(CASE WHEN Has_TP53_Mutation = 1 THEN observed_count ELSE 0 END) AS total_tp53_mutated,
      SUM(CASE WHEN Has_TP53_Mutation = 0 THEN observed_count ELSE 0 END) AS total_tp53_not_mutated,
      SUM(observed_count) AS total_patients
    FROM counts
  ),
  expected_counts AS (
    SELECT
      c.Has_KRAS_Mutation,
      c.Has_TP53_Mutation,
      c.observed_count,
      (
        (CASE WHEN c.Has_TP53_Mutation = 1 THEN m.total_tp53_mutated ELSE m.total_tp53_not_mutated END) *
        (CASE WHEN c.Has_KRAS_Mutation = 1 THEN m.total_kras_mutated ELSE m.total_kras_not_mutated END)
      ) / m.total_patients AS expected_count
    FROM counts c
    CROSS JOIN marginals m
  )
SELECT
  SUM(
    ((observed_count - expected_count) * (observed_count - expected_count)) / expected_count
  ) AS chi_squared_value
FROM expected_counts;
```
2025-01-23 08:54:48 - root - INFO - itercount: 2
2025-01-23 08:54:48 - root - INFO - 0
2025-01-23 08:54:48 - root - INFO - results: 
chi_squared_value
47.545450146546486


2025-01-23 08:54:48 - root - INFO - Please check the answer again by reviewing Using TCGA dataset, calculate the chi-squared statistic to evaluate the association between KRAS and TP53 gene mutations in patients diagnosed with pancreatic adenocarcinoma (PAAD). Incorporate clinical follow-up data and high-quality mutation annotations to accurately determine the frequency of patients with co-occurring KRAS and TP53 mutations compared to those with each mutation occurring independently. Ensure that patient records are meticulously matched based on unique identifiers to maintain data integrity. This analysis aims to identify and quantify potential correlations between KRAS and TP53 genetic alterations within the PAAD patient population., reviewing Relevant Tables and Columns and Possible Conditions and then give the final SQL query. Don't output other queries. If you think the answer is right, just output the current SQL.
Keep all decimals to four decimal places.
The answer format should be like: ```csv
chi-squared_value
value:float
(Attention: answer in one row)
```

To evaluate the association between **KRAS** and **TP53** gene mutations in patients diagnosed with pancreatic adenocarcinoma (PAAD), the chi-squared statistic was calculated using the TCGA dataset. Clinical follow-up data and high-quality mutation annotations were incorporated to accurately determine the frequency of patients with co-occurring **KRAS** and **TP53** mutations compared to those with each mutation occurring independently. This analysis identifies and quantifies potential correlations between **KRAS** and **TP53** genetic alterations within the PAAD patient population. The answer should match the number of rows, the column name of the format and the filled values in the format (e.g. filled year or month). Don't output extra rows or nested rows!
Current snswer: 
chi_squared_value
47.545450146546486
Current sql:
WITH
  paad_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR`
    WHERE `Study` = 'PAAD'
  ),
  kras_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'KRAS'
  ),
  tp53_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample`
    WHERE `Study` = 'PAAD' AND `Hugo_Symbol` = 'TP53'
  ),
  patient_mutations AS (
    SELECT
      p.ParticipantBarcode,
      IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM kras_patients), 1, 0) AS Has_KRAS_Mutation,
      IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM tp53_patients), 1, 0) AS Has_TP53_Mutation
    FROM paad_patients p
  ),
  counts AS (
    SELECT
      Has_KRAS_Mutation,
      Has_TP53_Mutation,
      COUNT(*) AS observed_count
    FROM patient_mutations
    GROUP BY Has_KRAS_Mutation, Has_TP53_Mutation
  ),
  marginals AS (
    SELECT
      SUM(CASE WHEN Has_KRAS_Mutation = 1 THEN observed_count ELSE 0 END) AS total_kras_mutated,
      SUM(CASE WHEN Has_KRAS_Mutation = 0 THEN observed_count ELSE 0 END) AS total_kras_not_mutated,
      SUM(CASE WHEN Has_TP53_Mutation = 1 THEN observed_count ELSE 0 END) AS total_tp53_mutated,
      SUM(CASE WHEN Has_TP53_Mutation = 0 THEN observed_count ELSE 0 END) AS total_tp53_not_mutated,
      SUM(observed_count) AS total_patients
    FROM counts
  ),
  expected_counts AS (
    SELECT
      c.Has_KRAS_Mutation,
      c.Has_TP53_Mutation,
      c.observed_count,
      (
        (CASE WHEN c.Has_TP53_Mutation = 1 THEN m.total_tp53_mutated ELSE m.total_tp53_not_mutated END) *
        (CASE WHEN c.Has_KRAS_Mutation = 1 THEN m.total_kras_mutated ELSE m.total_kras_not_mutated END)
      ) / m.total_patients AS expected_count
    FROM counts c
    CROSS JOIN marginals m
  )
SELECT
  SUM(
    ((observed_count - expected_count) * (observed_count - expected_count)) / expected_count
  ) AS chi_squared_value
FROM expected_counts;
2025-01-23 08:55:38 - httpx - INFO - HTTP Request: POST https://sfc-ml-sweden.openai.azure.com/openai/deployments/o1-preview/chat/completions?api-version=2024-02-15-preview "HTTP/1.1 200 OK"
2025-01-23 08:55:38 - root - INFO - ```sql
WITH
  paad_patients AS (
    SELECT DISTINCT `ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.TCGA_CDR`
    WHERE `Study` = 'PAAD'
  ),
  high_quality_variants AS (
    SELECT 'Frame_Shift_Del' AS vc UNION ALL
    SELECT 'Frame_Shift_Ins' UNION ALL
    SELECT 'In_Frame_Del' UNION ALL
    SELECT 'In_Frame_Ins' UNION ALL
    SELECT 'Missense_Mutation' UNION ALL
    SELECT 'Nonsense_Mutation' UNION ALL
    SELECT 'Nonstop_Mutation' UNION ALL
    SELECT 'Splice_Site' UNION ALL
    SELECT 'Translation_Start_Site'
  ),
  kras_patients AS (
    SELECT DISTINCT m.`ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
    WHERE m.`Study` = 'PAAD' AND m.`Hugo_Symbol` = 'KRAS'
      AND m.`Variant_Classification` IN (SELECT vc FROM high_quality_variants)
  ),
  tp53_patients AS (
    SELECT DISTINCT m.`ParticipantBarcode`
    FROM `isb-cgc-bq.pancancer_atlas.Filtered_MC3_MAF_V5_one_per_tumor_sample` AS m
    WHERE m.`Study` = 'PAAD' AND m.`Hugo_Symbol` = 'TP53'
      AND m.`Variant_Classification` IN (SELECT vc FROM high_quality_variants)
  ),
  patient_mutations AS (
    SELECT
      p.ParticipantBarcode,
      IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM kras_patients), 1, 0) AS Has_KRAS_Mutation,
      IF(p.ParticipantBarcode IN (SELECT ParticipantBarcode FROM tp53_patients), 1, 0) AS Has_TP53_Mutation
    FROM paad_patients p
  ),
  counts AS (
    SELECT
      Has_KRAS_Mutation,
      Has_TP53_Mutation,
      COUNT(*) AS observed_count
    FROM patient_mutations
    GROUP BY Has_KRAS_Mutation, Has_TP53_Mutation
  ),
  marginals AS (
    SELECT
      SUM(CASE WHEN Has_KRAS_Mutation = 1 THEN observed_count ELSE 0 END) AS total_kras_mutated,
      SUM(CASE WHEN Has_KRAS_Mutation = 0 THEN observed_count ELSE 0 END) AS total_kras_not_mutated,
      SUM(CASE WHEN Has_TP53_Mutation = 1 THEN observed_count ELSE 0 END) AS total_tp53_mutated,
      SUM(CASE WHEN Has_TP53_Mutation = 0 THEN observed_count ELSE 0 END) AS total_tp53_not_mutated,
      SUM(observed_count) AS total_patients
    FROM counts
  ),
  expected_counts AS (
    SELECT
      c.Has_KRAS_Mutation,
      c.Has_TP53_Mutation,
      c.observed_count,
      (
        (CASE WHEN c.Has_KRAS_Mutation = 1 THEN m.total_kras_mutated ELSE m.total_kras_not_mutated END) *
        (CASE WHEN c.Has_TP53_Mutation = 1 THEN m.total_tp53_mutated ELSE m.total_tp53_not_mutated END)
      ) / m.total_patients AS expected_count
    FROM counts c
    CROSS JOIN marginals m
  )
SELECT
  ROUND(
    SUM(
      ((observed_count - expected_count) * (observed_count - expected_count)) / expected_count
    ),
    4
  ) AS chi_squared_value
FROM expected_counts;
```

```csv
chi-squared_value
47.5455
```
2025-01-23 08:55:40 - root - INFO - itercount: 3
2025-01-23 08:55:40 - root - INFO - 0
2025-01-23 08:55:40 - root - INFO - Total iteration counts: 3
